[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 100 of about 643
1. Kalteis T, Heers G, Elsner R: Adenocarcinoma of the rectum in childhood following chemotherapy and radiotherapy for a rhabdomyosarcoma--a case report. Eur J Pediatr Surg; 2005 Jun;15(3):210-2
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Adenocarcinoma of the rectum in childhood following chemotherapy and radiotherapy for a rhabdomyosarcoma--a case report.
  • We report a case of rectal adenocarcinoma in a 9-year-old boy, which took the form of a second malignant neoplasm following treatment for an early childhood malignancy.
  • At the time of diagnosis of the rectal carcinoma, the tumor had already progressed to the stage of metastatic disease.
  • Therapy consisted of deep anterior rectal resection and regional arterial chemotherapy for liver metastases.
  • The child died 18 months after the diagnosis of rectal carcinoma.
  • As survival for childhood tumors improves, rare second malignant neoplasms will become increasingly common in children and adolescents.
  • The increased risk of second malignant neoplasms and an early onset of adult-type tumors has to be considered.
  • [MeSH-major] Adenocarcinoma / surgery. Neoplasms, Second Primary. Rectal Neoplasms / surgery. Rhabdomyosarcoma, Embryonal / drug therapy. Rhabdomyosarcoma, Embryonal / radiotherapy
  • [MeSH-minor] Child. Fatal Outcome. Humans. Liver Neoplasms / secondary. Lung Neoplasms / secondary. Male. Thigh

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15999318.001).
  • [ISSN] 0939-7248
  • [Journal-full-title] European journal of pediatric surgery : official journal of Austrian Association of Pediatric Surgery ... [et al] = Zeitschrift für Kinderchirurgie
  • [ISO-abbreviation] Eur J Pediatr Surg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


2. Merino C, Molés JR, Rodrigo A, Ferrando J, García J, Primo J, Albert A, Aragó M, Serra B, Amorós I: [Uncommon etiology of gastrointestinal bleeding: duodenal metastases from renal cell carcinoma]. Gastroenterol Hepatol; 2005 Apr;28(4):221-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Transliterated title] Causa poco habitual de hemorragia digestiva alta: metástasis duodenal de adenocarcinoma renal.
  • On the one hand, patients frequently show metastases at diagnosis because of its slight manifestations, while on the other, the neoplasm can remain stable after nephrectomy and can then metastasize many years later.
  • The most frequent sites of metastases are the lung and lymph nodes, followed by the bones and liver, while duodenal involvement is rare.


3. Hori T, Wagata T, Takemoto K, Shigeta T, Takuwa H, Hata K, Uemoto S, Yokoo N: Spontaneous necrosis of solid gallbladder adenocarcinoma accompanied with pancreaticobiliary maljunction. World J Gastroenterol; 2008 Oct 14;14(38):5933-7
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Spontaneous necrosis of solid gallbladder adenocarcinoma accompanied with pancreaticobiliary maljunction.
  • We were agonized in making the qualitative diagnosis of mass-like lesions of the fundus, such as a benign tumor, cancer, or debris.
  • Although this necrotic nodule included non-viable adenocarcinoma cells, viable cancer cell nests were located in the muscularis propria and subcutaneous layer.
  • Histopathological examination confirmed a solid adenocarcinoma.
  • We therefore undertook radical surgery, including wedge resection of the liver, radical dissection of regional lymph nodes, and resection of the extrahepatic bile duct.
  • We present the first case of spontaneous necrosis of solid gallbladder adenocarcinoma, with a review of previous studies.
  • [MeSH-major] Adenocarcinoma / pathology. Biliary Tract / abnormalities. Gallbladder Neoplasms / pathology. Incidental Findings. Pancreas / abnormalities
  • [MeSH-minor] Aged. Cholangiography. Cholecystectomy, Laparoscopic. Cholecystitis, Acute / surgery. Fatal Outcome. Gallstones / surgery. Humans. Lymph Node Excision. Magnetic Resonance Imaging. Male. Necrosis. Neoplasm Staging. Tomography, X-Ray Computed. Treatment Outcome. Ultrasonography, Doppler

  • MedlinePlus Health Information. consumer health - Gallbladder Cancer.
  • The Weizmann Institute of Science GeneCards and MalaCards databases. gene/protein/disease-specific - MalaCards for gallbladder adenocarcinoma .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Eur J Surg Oncol. 2006 Mar;32(2):208-12 [16377119.001]
  • [Cites] Vnitr Lek. 2004 Oct;50(10):781-5 [15633935.001]
  • [Cites] Am J Surg. 2007 Sep;194(3):355-61 [17693282.001]
  • [Cites] J Gastrointest Surg. 2007 Sep;11(9):1188-93 [17712596.001]
  • [Cites] Postgrad Med J. 2000 Feb;76(892):96-8 [10644387.001]
  • [Cites] Hepatogastroenterology. 2000 May-Jun;47(33):631-5 [10919001.001]
  • [Cites] J Hepatobiliary Pancreat Surg. 2001;8(1):95-100 [11294297.001]
  • [Cites] Cancer. 2001 Jul 15;92(2):340-8 [11466688.001]
  • [Cites] World J Surg. 2002 Jul;26(7):867-71 [11960212.001]
  • [Cites] Ann Surg Oncol. 2003 May;10(4):447-54 [12734095.001]
  • [Cites] Cancer. 1983 Dec 1;52(11):2086-8 [6627217.001]
  • [Cites] Surg Gastroenterol. 1984;3(2):69-73 [6085899.001]
  • [Cites] Ann Surg. 1992 Apr;215(4):326-31 [1558412.001]
  • [Cites] Eur J Endocrinol. 1994 May;130(5):469-71 [8180674.001]
  • [Cites] Hepatogastroenterology. 1995 Apr;42(2):113-6 [7545638.001]
  • [Cites] Br J Urol. 1995 Oct;76(4):501-3 [7551893.001]
  • [Cites] Surg Endosc. 1997 Dec;11(12):1224-5 [9373301.001]
  • [Cites] Am J Clin Pathol. 1998 Jan;109(1):62-8 [9426519.001]
  • [Cites] Cancer Invest. 1998;16(1):64-5 [9474255.001]
  • [Cites] Cancer. 1998 Aug 1;83(3):423-7 [9690533.001]
  • [Cites] Am Surg. 1998 Aug;64(8):764-7 [9697909.001]
  • [Cites] J Clin Endocrinol Metab. 1953 Aug;13(8):997-1008 [13069604.001]
  • [Cites] World J Gastroenterol. 2006 Apr 28;12(16):2549-55 [16688800.001]
  • (PMID = 18855999.001).
  • [ISSN] 1007-9327
  • [Journal-full-title] World journal of gastroenterology
  • [ISO-abbreviation] World J. Gastroenterol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] China
  • [Number-of-references] 25
  • [Other-IDs] NLM/ PMC2751910
  •  go-up   go-down


Advertisement
4. Matsutani T, Uchida E, Yokoyama T, Matsushita A, Matsuda A, Sasajima K: A case of unresectable gallbladder cancer responding to gemcitabine after metallic biliary stent implantation. J Nippon Med Sch; 2009 Oct;76(5):253-7
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • She underwent exploratory laparotomy under a diagnosis of advanced biliary tract cancer.
  • Histological examination of a biopsy specimen of the gallbladder revealed adenocarcinoma.
  • The tumor was unresectable because of invasion into a wide area of the hepatoduodenal ligament and liver bed.
  • [MeSH-major] Adenocarcinoma / drug therapy. Antimetabolites, Antineoplastic / administration & dosage. Deoxycytidine / analogs & derivatives. Gallbladder Neoplasms / drug therapy. Stents

  • MedlinePlus Health Information. consumer health - Gallbladder Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19915309.001).
  • [ISSN] 1345-4676
  • [Journal-full-title] Journal of Nippon Medical School = Nippon Ika Daigaku zasshi
  • [ISO-abbreviation] J Nippon Med Sch
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Japan
  • [Chemical-registry-number] 0 / Antimetabolites, Antineoplastic; 0 / Metals; 0W860991D6 / Deoxycytidine; B76N6SBZ8R / gemcitabine
  •  go-up   go-down


5. Luke C, Price T, Roder D: Epidemiology of cancer of the liver and intrahepatic bile ducts in an Australian population. Asian Pac J Cancer Prev; 2010;11(6):1479-85
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Epidemiology of cancer of the liver and intrahepatic bile ducts in an Australian population.
  • The incidence of liver and intrahepatic bile duct cancer in Australia is low at about one third the world average but increases are evident.
  • Apart from recognized risk factors (e.g., hepatitis B/C infection and aflatoxins for hepatocellular carcinoma; liver-fluke infection for cholangiocarcinomas, etc.
  • Survival increases may be due to earlier diagnosis from alpha feta protein testing and diagnostic imaging, plus more aggressive treatment of localized disease.
  • [MeSH-major] Adenocarcinoma / epidemiology. Bile Duct Neoplasms / epidemiology. Carcinoma, Hepatocellular / epidemiology. Cholangiocarcinoma / epidemiology. Liver Neoplasms / epidemiology

  • Genetic Alliance. consumer health - Liver cancer.
  • MedlinePlus Health Information. consumer health - Bile Duct Cancer.
  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21338184.001).
  • [ISSN] 2476-762X
  • [Journal-full-title] Asian Pacific journal of cancer prevention : APJCP
  • [ISO-abbreviation] Asian Pac. J. Cancer Prev.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Thailand
  •  go-up   go-down


6. Braun U, Grest P, Jehle W, Kaps S, Spiess B: [Intraocular hemorrhage in a goat with thrombocytopenia and metastasis of an adenocarcinoma in the iris]. Schweiz Arch Tierheilkd; 2008 Jul;150(7):359-62
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Intraocular hemorrhage in a goat with thrombocytopenia and metastasis of an adenocarcinoma in the iris].
  • This case report describes the findings in a 10-year-old goat with metastasis of an adenocarcinoma in the iris.
  • There were neoplastic alterations in the iris, the oesophagus, the lung lobes, the liver, the kidney and in the prescapular, retropharyngeal, mediastinal and hepatic lymph nodes.
  • Histologically, a diagnosis of carcinoma was confirmed, but the origin of the tumour could not be determined.
  • [MeSH-major] Adenocarcinoma / veterinary. Eye Hemorrhage / veterinary. Goat Diseases / diagnosis. Iris Neoplasms / veterinary

  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18714940.001).
  • [ISSN] 0036-7281
  • [Journal-full-title] Schweizer Archiv für Tierheilkunde
  • [ISO-abbreviation] Schweiz. Arch. Tierheilkd.
  • [Language] ger
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Switzerland
  •  go-up   go-down


7. Civello IM, Nigro C, Matera D, Brandara F, Greco F, Brisinda G: [Total gastrectomy extended to the head of the pancreas and the liver with D4 lymphadenectomy for well-differentiated gastric carcinoma]. Suppl Tumori; 2005 May-Jun;4(3):S81
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Total gastrectomy extended to the head of the pancreas and the liver with D4 lymphadenectomy for well-differentiated gastric carcinoma].
  • [Transliterated title] Gastrectomia totale estesa alla testa del pancreas e al fegato con linfoadenectomia D4 per carcinoma gastrico ben differenziato.
  • Adenocarcinoma of the stomach is the second most common cancer worldwide.
  • Early diagnosis and an adequate surgical approach could save live.
  • [MeSH-major] Adenocarcinoma / surgery. Gastrectomy / methods. Liver / surgery. Lymph Node Excision / methods. Pancreas / surgery. Stomach Neoplasms / surgery

  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16437917.001).
  • [ISSN] 2283-5423
  • [Journal-full-title] I supplementi di Tumori : official journal of Società italiana di cancerologia ... [et al.]
  • [ISO-abbreviation] Suppl Tumori
  • [Language] ita
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Italy
  •  go-up   go-down


8. Dvorák J, Melichar B, Hyspler R, Krcmová L, Urbánek L, Kalábová H, Kasparová M, Solichová D: Intestinal permeability, vitamin A absorption, alpha-tocopherol, and neopterin in patients with rectal carcinoma treated with chemoradiation. Med Oncol; 2010 Sep;27(3):690-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Although gastrointestinal toxicity is one of the most common side effects of anticancer therapy, the diagnosis and assessment of this toxicity still depend mostly on anamnestic data.
  • [MeSH-major] Adenocarcinoma / metabolism. Antimetabolites, Antineoplastic / adverse effects. Fluorouracil / adverse effects. Intestinal Absorption. Neopterin / urine. Radiotherapy, High-Energy / adverse effects. Rectal Neoplasms / metabolism. Vitamin A / pharmacokinetics. alpha-Tocopherol / blood

  • MedlinePlus Health Information. consumer health - Vitamin A.
  • Hazardous Substances Data Bank. FLUOROURACIL .
  • Hazardous Substances Data Bank. VITAMIN E .
  • Hazardous Substances Data Bank. VITAMIN A .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Biol Trace Elem Res. 1995 Jan-Mar;47(1-3):117-23 [7779537.001]
  • [Cites] Gastroenterology. 1995 May;108(5):1566-81 [7729650.001]
  • [Cites] Anticancer Res. 2007 Nov-Dec;27(6C):4397-401 [18214051.001]
  • [Cites] Dig Dis Sci. 2002 Jul;47(7):1480-91 [12141804.001]
  • [Cites] J Natl Cancer Inst. 2000 Mar 1;92(5):388-96 [10699069.001]
  • [Cites] J Clin Invest. 1996 Jul 15;98(2):386-94 [8755649.001]
  • [Cites] J Am Coll Nutr. 2001 Dec;20(6):637-42 [11771680.001]
  • [Cites] Am J Clin Nutr. 1992 Apr;55(4):857-64 [1550069.001]
  • [Cites] Ann Clin Biochem. 2004 Mar;41(Pt 2):138-41 [15025805.001]
  • [Cites] Circulation. 1997 Feb 18;95(4):1062-71 [9054771.001]
  • [Cites] Cancer Res. 1986 Feb;46(2):950-5 [3940654.001]
  • [Cites] Free Radic Biol Med. 1996;20(7):979-83 [8743984.001]
  • [Cites] Atherosclerosis. 1994 Apr;106(2):263-71 [8060386.001]
  • [Cites] Int J Gynecol Cancer. 2006 Jan-Feb;16(1):240-52 [16445639.001]
  • [Cites] Anticancer Res. 2008 Jul-Aug;28(4C):2389-96 [18751424.001]
  • [Cites] J Intern Med. 2000 Nov;248(5):377-86 [11123502.001]
  • [Cites] J Sep Sci. 2006 Nov;29(16):2485-93 [17154129.001]
  • [Cites] Chemotherapy. 2005 Oct;51(6):336-8 [16224185.001]
  • [Cites] Adv Clin Chem. 1989;27:81-141 [2667296.001]
  • [Cites] J Clin Gastroenterol. 2001 Mar;32(3):228-30 [11246350.001]
  • [Cites] Clin Nutr. 2002 Apr;21(2):161-4 [12056790.001]
  • [Cites] J Clin Oncol. 2003 Mar 1;21(5):927-31 [12610195.001]
  • [Cites] J Nutr. 2001 May;131(5):1405-8 [11340090.001]
  • [Cites] Int J Biol Markers. 2006 Jul-Sep;21(3):190-8 [17013802.001]
  • [Cites] N Engl J Med. 2004 Oct 21;351(17):1731-40 [15496622.001]
  • [Cites] Am J Clin Nutr. 2000 Jul;72(1):181-9 [10871578.001]
  • [Cites] Scand J Gastroenterol Suppl. 1997;223:70-8 [9200310.001]
  • [Cites] J Clin Gastroenterol. 2002 Apr;34(4):385-96 [11907349.001]
  • [Cites] Am J Clin Nutr. 2004 Jun;79(6):1029-36 [15159233.001]
  • [Cites] Atherosclerosis. 1991 Aug;89(2-3):203-8 [1793448.001]
  • [Cites] J Cancer Res Clin Oncol. 2001 May;127(5):314-8 [11355146.001]
  • [Cites] Am J Clin Oncol. 2008 Dec;31(6):580-4 [19060591.001]
  • [Cites] Am J Physiol Gastrointest Liver Physiol. 2001 Jan;280(1):G95-G103 [11123202.001]
  • [Cites] Nutrition. 2000 Jun;16(6):425-8 [10869897.001]
  • [Cites] Nutrition. 1999 Jul-Aug;15(7-8):546-9 [10422084.001]
  • [Cites] Am J Clin Nutr. 2002 Dec;76(6):1358-66 [12450904.001]
  • [Cites] Anal Chim Acta. 2006 Jul 28;573-574:267-72 [17723533.001]
  • [Cites] J Clin Oncol. 2003 Jul 1;21(13):2545-50 [12829674.001]
  • [Cites] Br J Nutr. 2005 Feb;93(2):153-74 [15788108.001]
  • (PMID = 19629763.001).
  • [ISSN] 1559-131X
  • [Journal-full-title] Medical oncology (Northwood, London, England)
  • [ISO-abbreviation] Med. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antimetabolites, Antineoplastic; 0 / Antioxidants; 0 / Carbohydrates; 0 / Dietary Carbohydrates; 11103-57-4 / Vitamin A; 1D1K0N0VVC / retinol palmitate; 670-65-5 / Neopterin; H4N855PNZ1 / alpha-Tocopherol; U3P01618RT / Fluorouracil
  •  go-up   go-down


9. Tsuyuguchi T, Sakai Y, Sugiyama H, Miyakawa K, Ishihara T, Ohtsuka M, Miyazaki M, Yokosuka O: Endoscopic diagnosis of intraductal papillary mucinous neoplasm of the bile duct. J Hepatobiliary Pancreat Sci; 2010 May;17(3):230-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Endoscopic diagnosis of intraductal papillary mucinous neoplasm of the bile duct.
  • BACKGROUND/PURPOSE: Intraductal papillary mucinous neoplasm of the bile duct (IPMN-B) is considered an uncommon tumor.
  • Six of the eight patients underwent surgical treatment; five patients underwent a hepatic resection with or without extrahepatic bile duct resection and one underwent a pancreaticoduodenectomy.
  • The two remaining patients, who were considered inoperable due to major medical comorbidities, died of liver failure and cholangitis 3 and 6 months, respectively, after stent placement.
  • [MeSH-major] Adenocarcinoma, Mucinous / diagnosis. Adenocarcinoma, Papillary / pathology. Bile Duct Neoplasms / diagnosis. Bile Ducts, Extrahepatic. Bile Ducts, Intrahepatic. Endoscopy, Gastrointestinal

  • MedlinePlus Health Information. consumer health - Bile Duct Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19669677.001).
  • [ISSN] 1868-6982
  • [Journal-full-title] Journal of hepato-biliary-pancreatic sciences
  • [ISO-abbreviation] J Hepatobiliary Pancreat Sci
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Japan
  •  go-up   go-down


10. Kitajima Y, Yakabe T, Ohtsuka T, Tanaka M, Sato S, Nakafusa Y, Miyazaki K: [Complete response obtained with first-line therapy as S-1, followed by second-line 5'-DFUR plus paclitaxel therapy in a patient with multiple liver and lymph node metastases from gastric cancer]. Gan To Kagaku Ryoho; 2009 May;36(5):851-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Complete response obtained with first-line therapy as S-1, followed by second-line 5'-DFUR plus paclitaxel therapy in a patient with multiple liver and lymph node metastases from gastric cancer].
  • The histological diagnosis was poorly-differentiated adenocarcinoma, T2(MP), pN2, sH0, sP0, CY0; fStage III A.
  • Three months after the operation, two metastatic nodules were noticed on the liver.
  • [MeSH-major] Floxuridine / therapeutic use. Liver Neoplasms / drug therapy. Liver Neoplasms / secondary. Oxonic Acid / therapeutic use. Paclitaxel / therapeutic use. Stomach Neoplasms / drug therapy. Stomach Neoplasms / pathology. Tegafur / therapeutic use

  • Genetic Alliance. consumer health - Liver cancer.
  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • Hazardous Substances Data Bank. TAXOL .
  • Hazardous Substances Data Bank. FLOXURIDINE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19461193.001).
  • [ISSN] 0385-0684
  • [Journal-full-title] Gan to kagaku ryoho. Cancer & chemotherapy
  • [ISO-abbreviation] Gan To Kagaku Ryoho
  • [Language] jpn
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Japan
  • [Chemical-registry-number] 0 / Carcinoembryonic Antigen; 0 / Drug Combinations; 039LU44I5M / Floxuridine; 150863-82-4 / S 1 (combination); 1548R74NSZ / Tegafur; 5VT6420TIG / Oxonic Acid; P88XT4IS4D / Paclitaxel; V1JK16Y2JP / doxifluridine
  •  go-up   go-down


11. Gonda TA, Khan SU, Cheng J, Lewis SK, Rubin M, Green PH: Association of intussusception and celiac disease in adults. Dig Dis Sci; 2010 Oct;55(10):2899-903
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Two patients were found to have lead-point intussusceptions and both had small-bowel adenocarcinoma, and 10/14 had severe villous atrophy (subtotal or total).
  • Among those with established celiac disease, IS was detected early, within 3 years of diagnosis.
  • Adenocarcinoma needs to be excluded.
  • [MeSH-minor] Abdominal Pain / epidemiology. Abdominal Pain / pathology. Adenocarcinoma / epidemiology. Adenocarcinoma / pathology. Adult. Atrophy. Biopsy. Capsule Endoscopy. Chi-Square Distribution. Databases, Factual. Female. Follow-Up Studies. Humans. Incidental Findings. Intestinal Neoplasms / epidemiology. Intestinal Neoplasms / pathology. Male. Middle Aged

  • Genetic Alliance. consumer health - Celiac Disease.
  • MedlinePlus Health Information. consumer health - Celiac Disease.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Pediatr Infect Dis J. 2006 Jan;25(1 Suppl):S22-9 [16397426.001]
  • [Cites] Turk J Gastroenterol. 2002 Mar;13(1):63-5 [16378278.001]
  • [Cites] Ann Surg. 2005 Aug;242(2):201-7 [16041210.001]
  • [Cites] Am J Surg. 1989 Jul;158(1):25-8 [2662787.001]
  • [Cites] Clin Radiol. 2007 Aug;62(8):792-7 [17604770.001]
  • [Cites] J Pediatr Surg. 1999 Dec;34(12 ):1833-5 [10626866.001]
  • [Cites] World J Gastroenterol. 2007 Mar 21;13(11):1696-700 [17461472.001]
  • [Cites] Radiology. 1999 Sep;212(3):853-60 [10478257.001]
  • [Cites] Clin Radiol. 1978 Sep;29(5):529-34 [710039.001]
  • [Cites] Am J Surg. 1997 Feb;173(2):88-94 [9074370.001]
  • [Cites] Aust N Z J Surg. 1981 Apr;51(2):179-80 [6940547.001]
  • [Cites] Gut. 2004 May;53(5):774 [15082608.001]
  • [Cites] Radiographics. 2006 May-Jun;26(3):733-44 [16702451.001]
  • [Cites] Eur J Radiol. 2007 Aug;63(2):302-6 [17336477.001]
  • [Cites] Trop Gastroenterol. 2005 Jan-Mar;26(1):38-9 [15974238.001]
  • [Cites] N Engl J Med. 2007 Oct 25;357(17):1731-43 [17960014.001]
  • [Cites] Dig Liver Dis. 2005 Jun;37(6):402-6 [15893278.001]
  • [Cites] Ann Surg. 1997 Aug;226(2):134-8 [9296505.001]
  • [Cites] Clin Radiol. 1998 Jan;53(1):53-7 [9464437.001]
  • [Cites] South Med J. 1989 Feb;82(2):215-28 [2916150.001]
  • [Cites] Radiology. 2003 Apr;227(1):68-72 [12668740.001]
  • [Cites] Gastrointest Endosc. 2005 Jul;62(1):55-61 [15990820.001]
  • [Cites] AJR Am J Roentgenol. 1986 Mar;146(3):527-31 [3484870.001]
  • [Cites] J Magn Reson Imaging. 2006 Sep;24(3):625-9 [16888777.001]
  • (PMID = 20033844.001).
  • [ISSN] 1573-2568
  • [Journal-full-title] Digestive diseases and sciences
  • [ISO-abbreviation] Dig. Dis. Sci.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


12. Tisman G: Inhibition of HER2/estrogen receptor cross-talk, probable relation to prolonged remission of stage IV breast cancer: a case report. Tumori; 2009 Nov-Dec;95(6):804-7
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Metastatic breast cancer to the liver is considered incurable.
  • Though many patients with liver metastases may enjoy response to chemo-, immuno- and hormonal therapy, those so inflicted rarely remain disease-free from the time of diagnosis for longer than 6-11 months.
  • A 59-year-old woman with a 4.5-cm invasive ductal, ER-positive/PR-negative, grade III adenocarcinoma of the breast was treated with mastectomy.
  • Staging revealed biopsy-proven liver metastases.
  • [MeSH-major] Adenocarcinoma / drug therapy. Adenocarcinoma / metabolism. Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Breast Neoplasms / drug therapy. Breast Neoplasms / metabolism. Liver Neoplasms / drug therapy. Liver Neoplasms / metabolism. Receptor Cross-Talk / drug effects. Receptor, ErbB-2 / metabolism. Receptors, Estrogen / metabolism
  • [MeSH-minor] Androstadienes / administration & dosage. Antibodies, Monoclonal / administration & dosage. Antibodies, Monoclonal, Humanized. Female. Humans. Mastectomy, Modified Radical. Middle Aged. Neoplasm Staging. Positron-Emission Tomography. Tamoxifen / administration & dosage. Tomography, X-Ray Computed. Trastuzumab. Treatment Outcome. Vinblastine / administration & dosage. Vinblastine / analogs & derivatives

  • Genetic Alliance. consumer health - Breast Cancer.
  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • Hazardous Substances Data Bank. TAMOXIFEN .
  • Hazardous Substances Data Bank. EXEMESTANE .
  • Hazardous Substances Data Bank. Trastuzumab .
  • Hazardous Substances Data Bank. VINORELBINE .
  • Hazardous Substances Data Bank. VINBLASTINE .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20210247.001).
  • [ISSN] 0300-8916
  • [Journal-full-title] Tumori
  • [ISO-abbreviation] Tumori
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Androstadienes; 0 / Antibodies, Monoclonal; 0 / Antibodies, Monoclonal, Humanized; 0 / Receptors, Estrogen; 094ZI81Y45 / Tamoxifen; 5V9KLZ54CY / Vinblastine; EC 2.7.10.1 / ERBB2 protein, human; EC 2.7.10.1 / Receptor, ErbB-2; NY22HMQ4BX / exemestane; P188ANX8CK / Trastuzumab; Q6C979R91Y / vinorelbine
  •  go-up   go-down


13. Dong MJ, Lin XT, Zhao J, Guan YH, Zuo CT, Chen X, Dai JZ, Jiang BD: [Malignant tumor with false negative 18F-FDG PET image]. Zhonghua Zhong Liu Za Zhi; 2006 Sep;28(9):713-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Malignant tumor with false negative 18F-FDG PET image].
  • OBJECTIVE: To investigate the FDG uptake characteristics, the factors affecting 18F-FDG uptake and the extra CT diagnostic value of 18F-FDG PET/CT scan in the malignant tumor with false negative 18F-FDG PET image.
  • The results were compared with the CT and histopathological diagnosis, respectively.
  • RESULTS: Of 6 well-differentiated HCC patients confirmed by histopathological diagnosis, one had two lesions in the right lobe of the liver.
  • The false negative 18F-FDG PET images of one gastric signet ring cell carcinoma in the gastric fundus with right adnexa metastasis, 3 renal cell carcinoma, one greater omentum and peritoneal metastatic adenocarcinoma and one well-differentiated prostate cancer were caused by normal physical uptake in the digestive tract or FDG retention in the urinary system due to normal excretion.
  • CONCLUSION: False negative 18F-FDG PET in malignant tumor may be correlated with the pathologic type, differentiation degree and the lesion size.
  • Combining CT information with PET or paying attention to the scan methods during 8 F-FDG PET examination may reduce the rate of false negative 18F-FDG PET diagnosis in various kinds of malignant tumors.
  • [MeSH-major] Carcinoma, Hepatocellular / radionuclide imaging. Fluorodeoxyglucose F18. Kidney Neoplasms / radionuclide imaging. Liver Neoplasms / radionuclide imaging. Positron-Emission Tomography / methods. Stomach Neoplasms / radionuclide imaging
  • [MeSH-minor] Adenocarcinoma / radiography. Adenocarcinoma / radionuclide imaging. Adenocarcinoma / secondary. Adult. Aged. Carcinoma, Renal Cell / pathology. Carcinoma, Renal Cell / radiography. Carcinoma, Renal Cell / radionuclide imaging. Carcinoma, Signet Ring Cell / pathology. Carcinoma, Signet Ring Cell / radiography. Carcinoma, Signet Ring Cell / radionuclide imaging. False Negative Reactions. Female. Humans. Male. Middle Aged. Omentum / radiography. Omentum / radionuclide imaging. Peritoneal Neoplasms / radiography. Peritoneal Neoplasms / radionuclide imaging. Peritoneal Neoplasms / secondary. Radiographic Image Enhancement. Tomography, X-Ray Computed

  • MedlinePlus Health Information. consumer health - Kidney Cancer.
  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17274383.001).
  • [ISSN] 0253-3766
  • [Journal-full-title] Zhonghua zhong liu za zhi [Chinese journal of oncology]
  • [ISO-abbreviation] Zhonghua Zhong Liu Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  • [Chemical-registry-number] 0Z5B2CJX4D / Fluorodeoxyglucose F18
  •  go-up   go-down


14. Lin CF, DeFrias D, Lin X: Epithelioid angiosarcoma: a neoplasm with potential diagnostic challenges. Diagn Cytopathol; 2010 Feb;38(2):154-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Epithelioid angiosarcoma: a neoplasm with potential diagnostic challenges.
  • In this report, the patient is a 24-year-old man presenting with testicular pain, a pelvic mass, and innumerable liver nodules.
  • Immediate interpretation of the needle core biopsies of the pelvic mass and liver lesions initially favored a poorly differentiated adenocarcinoma.
  • Further, immunohistochemical evaluation demonstrated positive CD31 and Factor VIII staining and established the final diagnosis of epithelioid angiosarcoma.
  • This case is reported to illustrate the importance of considering the diagnosis of epithelioid angiosarcoma when encountering an "epithelioid" neoplasm particularly with unusual immunoreactivity for CK7 and CD30.
  • [MeSH-minor] Adenocarcinoma / pathology. Diagnosis, Differential. Humans. Immunohistochemistry. Liver Neoplasms / secondary. Male. Young Adult

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19813270.001).
  • [ISSN] 1097-0339
  • [Journal-full-title] Diagnostic cytopathology
  • [ISO-abbreviation] Diagn. Cytopathol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor
  •  go-up   go-down


15. Woodle ES, Gupta M, Buell JF, Neff GW, Gross TG, First MR, Hanaway MJ, Trofe J: Prostate cancer prior to solid organ transplantation: the Israel Penn International Transplant Tumor Registry experience. Transplant Proc; 2005 Mar;37(2):958-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • INTRODUCTION: Prostate adenocarcinoma (PCA) is the second leading cause of cancer-related deaths in men, and with routine prostrate specific antigen (PSA) screening, is being diagnosed with increasing frequency.
  • RESULTS: Ninety patients with preexisting PCA were identified: 77 renal, 10 heart, and three liver transplant recipients.
  • Mean age at PCA diagnosis was 61.3 +/- 6.3 years.
  • Median interval between diagnosis and transplantation was 19.3 months, and median follow-up after transplantation was 20.5 months.
  • [MeSH-major] Adenocarcinoma / complications. Heart Transplantation. Kidney Transplantation. Liver Transplantation. Prostatic Neoplasms / complications
  • [MeSH-minor] Follow-Up Studies. Humans. Male. Neoplasm Staging. Recurrence. Registries. Retrospective Studies. Survival Analysis


16. Ye J, Xu YK, Liu X, Lü GS: Targeted magnetic resonance imaging with intraperitoneal and intravenous streptavidin (SA)-DTPA-Gd: a comparative study in tumor-bearing nude mice. Nan Fang Yi Ke Da Xue Xue Bao; 2006 Feb;26(2):139-43
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • MRI was performed before and 20, 60 min and 3, 6, 9, 12 h after the injection of the contrast agents, and the MR signal intensity of the tumor and liver was determined.
  • The maximal enhancement rate of the liver was 23.7% in the intraperitoneal group and 20.4% in the intravenous group, showing no significant difference.
  • [MeSH-major] Antibodies, Monoclonal. Colorectal Neoplasms / diagnosis. Gadolinium DTPA. Magnetic Resonance Imaging / methods. Streptavidin
  • [MeSH-minor] Adenocarcinoma / diagnosis. Adenocarcinoma / metabolism. Animals. Cell Line, Tumor. Contrast Media / administration & dosage. Humans. Injections, Intraperitoneal. Injections, Intravenous. Mice. Mice, Inbred BALB C. Mice, Nude. Neoplasms, Experimental / diagnosis. Neoplasms, Experimental / metabolism. Reproducibility of Results. Sensitivity and Specificity. Transplantation, Heterologous

  • MedlinePlus Health Information. consumer health - Colorectal Cancer.
  • MedlinePlus Health Information. consumer health - MRI Scans.
  • Hazardous Substances Data Bank. GADOPENTETATE DIMEGLUMINE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16503514.001).
  • [ISSN] 1673-4254
  • [Journal-full-title] Nan fang yi ke da xue xue bao = Journal of Southern Medical University
  • [ISO-abbreviation] Nan Fang Yi Ke Da Xue Xue Bao
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] China
  • [Chemical-registry-number] 0 / Antibodies, Monoclonal; 0 / Contrast Media; 9013-20-1 / Streptavidin; K2I13DR72L / Gadolinium DTPA
  •  go-up   go-down


17. Takamori H, Kanemitsu K, Tsuji T, Kusano S, Chikamoto A, Okuma T, Iyama K: Metastatic gastric tumor secondary to pancreatic adenocarcinoma. J Gastroenterol; 2005 Feb;40(2):209-12
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Metastatic gastric tumor secondary to pancreatic adenocarcinoma.
  • Local recurrence, liver metastases, and peritoneal spread are the most common recurrent patterns after curative resection of pancreatic cancer.
  • We report a patient who suffered from gastric metastasis secondary to pancreatic adenocarcinoma 1 year after pancreatectomy.
  • The histological diagnosis was well-differentiated adenocarcinoma of the pancreas, stage IIB; T1N1M0.
  • Multiple liver metastases were detected on computed tomography (CT) in March 2003.
  • Combination chemotherapy of 5-fluorouracil hepatic arterial continuous infusion and systemic gemcitabine administration led to the disappearance of the liver metastases on CT in September 2003.
  • Histological diagnosis of the biopsy specimen was well-differentiated adenocarcinoma, and immunohistochemical studies, using anti-cytokeratin 7 and -20 monoclonal antibodies, were compatible with gastric metastasis from pancreatic carcinoma.
  • Histopatholoical examination of the resected specimen revealed submucosal growth of the metastatic cancer (well-differentiated adenocarcinoma).
  • [MeSH-major] Adenocarcinoma / secondary. Pancreatic Neoplasms / pathology. Stomach Neoplasms / secondary

  • MedlinePlus Health Information. consumer health - Pancreatic Cancer.
  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15770407.001).
  • [ISSN] 0944-1174
  • [Journal-full-title] Journal of gastroenterology
  • [ISO-abbreviation] J. Gastroenterol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Japan
  • [Chemical-registry-number] 0 / CA-19-9 Antigen
  •  go-up   go-down


18. Mizushima T, Sugiura T, Hori S, Ito T, Mizuno H, Hoki M, Souma Y, Kainuma S, Yamanaka H, Ozawa H, Kanou T, Nakamori Y, Iwase K: [A case of postoperative liver metastasis from bile duct carcinoma responding to transarterial chemoembolization]. Gan To Kagaku Ryoho; 2006 Feb;33(2):263-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [A case of postoperative liver metastasis from bile duct carcinoma responding to transarterial chemoembolization].
  • Histological diagnosis was moderately-differentiated tubular adenocarcinoma, pT 2 (ss, pHinf 0, pPanc 1, pPV 0, pA 0), pN 0, and final Stage II.
  • In September 2003, follow-up abdominal CT examinations revealed a liver tumor, 89 x 62 x 60 mm in size, at the anterior segment.
  • Transarterial chemoembolization with 5-FU, epirubicin, mitomycin C and superabsorbent polymer microsphere was initiated under the diagnosis of liver metastasis.
  • [MeSH-major] Adenocarcinoma / surgery. Antineoplastic Combined Chemotherapy Protocols / administration & dosage. Bile Duct Neoplasms / surgery. Chemoembolization, Therapeutic. Liver Neoplasms / secondary. Liver Neoplasms / therapy
  • [MeSH-minor] Aged. Drug Administration Schedule. Epirubicin / administration & dosage. Fluorouracil / administration & dosage. Hepatic Artery. Humans. Male. Microspheres. Mitomycin / administration & dosage. Polymers. Postoperative Period. Remission Induction

  • MedlinePlus Health Information. consumer health - Bile Duct Cancer.
  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • Hazardous Substances Data Bank. MITOMYCIN C .
  • Hazardous Substances Data Bank. FLUOROURACIL .
  • Hazardous Substances Data Bank. EPIRUBICIN .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16484870.001).
  • [ISSN] 0385-0684
  • [Journal-full-title] Gan to kagaku ryoho. Cancer & chemotherapy
  • [ISO-abbreviation] Gan To Kagaku Ryoho
  • [Language] jpn
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Japan
  • [Chemical-registry-number] 0 / Polymers; 3Z8479ZZ5X / Epirubicin; 50SG953SK6 / Mitomycin; U3P01618RT / Fluorouracil
  •  go-up   go-down


19. An M, Shin JA, Lee SM, Yoon T, Park WS, Choi JI, Kim CM: [Liver metastasis of colon cancer with a high serum alpha-fetoprotein level: report of a case]. Korean J Hepatol; 2006 Dec;12(4):562-7
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Liver metastasis of colon cancer with a high serum alpha-fetoprotein level: report of a case].
  • We report herein a case of 72-year-old woman in whom liver metastasis of colon cancer was presented with a marked elevation of serum alpha-fetoprotein (AFP) level.
  • She was transferred to our hospital for multiple liver masses found on ultrasonogram.
  • Abdominal computed tomogram revealed multiple low-density masses in the liver and wall thickening of the hepatic flexure of colon.
  • Colonoscopic findings of ulcerofungating mass suggested liver metastasis from colon cancer.
  • Both colon and liver biopsies revealed moderately differentiated tubular adenocarcinoma.
  • Using an immunohistochemical staining, the adenocarcinoma in liver showed focal positive to AFP, but not in colon.
  • [MeSH-major] Colonic Neoplasms / pathology. Liver Neoplasms / diagnosis. Liver Neoplasms / secondary. alpha-Fetoproteins / analysis

  • Genetic Alliance. consumer health - Liver cancer.
  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17237635.001).
  • [ISSN] 1738-222X
  • [Journal-full-title] The Korean journal of hepatology
  • [ISO-abbreviation] Korean J Hepatol
  • [Language] kor
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Korea (South)
  • [Chemical-registry-number] 0 / alpha-Fetoproteins
  •  go-up   go-down


20. Kinugasa Y, Morishige K, Kamiura S, Tsukamoto Y, Saji F: Parathyroid hormone-related protein-secreting uterine endometrioid adenocarcinoma. Jpn J Clin Oncol; 2006 Feb;36(2):113-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Parathyroid hormone-related protein-secreting uterine endometrioid adenocarcinoma.
  • The diagnosis of parathyroid hormone-related protein (PTHrP)-secreting metastatic uterine endometrioid cancer was made in a 32-year-old Japanese woman with humoral hypercalcemia of malignancy.
  • The primary endometrial cancer had been removed, and the tumor was diagnosed as Grade 1 endometrioid adenocarcinoma with shallow myometrial invasion.
  • Salvage chemotherapy (paclitaxel and calboplatin) was started from 5 months after surgery when recurrent tumors were detected in the peritoneum and liver.
  • To the best of our knowledge, this is the first reported case of hypercalcemia due to PTHrP secretion in uterine endometrioid adenocarcinoma.

  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16418186.001).
  • [ISSN] 0368-2811
  • [Journal-full-title] Japanese journal of clinical oncology
  • [ISO-abbreviation] Jpn. J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Japan
  • [Chemical-registry-number] 0 / Parathyroid Hormone-Related Protein
  •  go-up   go-down


21. Mannath J, Ragunath K: Era of Barrett's surveillance: does equipment matter? World J Gastroenterol; 2010 Oct 7;16(37):4640-5
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Barrett's esophagus is a consequence of long standing gastro-esophageal reflux disease and predisposes to the development of esophageal adenocarcinoma.
  • [MeSH-major] Barrett Esophagus / diagnosis. Barrett Esophagus / pathology. Endoscopes. Endoscopy / methods
  • [MeSH-minor] Esophageal Neoplasms / etiology. Esophageal Neoplasms / pathology. Humans. Precancerous Conditions / diagnosis. Precancerous Conditions / pathology. Prognosis

  • MedlinePlus Health Information. consumer health - Endoscopy.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Gastroenterology. 2002 Mar;122(3):633-40 [11874995.001]
  • [Cites] Endoscopy. 2010 May;42(5):351-9 [20200809.001]
  • [Cites] Gastrointest Endosc. 2002 Oct;56(4):479-87 [12297761.001]
  • [Cites] Gut. 2003 Jan;52(1):24-7 [12477754.001]
  • [Cites] Endoscopy. 2004 Feb;36(2):160-4 [14765313.001]
  • [Cites] J Biomed Opt. 2004 May-Jun;9(3):568-77 [15189095.001]
  • [Cites] Am J Gastroenterol. 2004 Oct;99(10):1877-83 [15447744.001]
  • [Cites] Gastroenterology. 1989 May;96(5 Pt 1):1249-56 [2703113.001]
  • [Cites] J Thorac Cardiovasc Surg. 1993 Mar;105(3):383-7; discussion 387-8 [8445916.001]
  • [Cites] Dysphagia. 1993;8(3):276-88 [8359051.001]
  • [Cites] Gastroenterology. 1994 Oct;107(4):945-9 [7926484.001]
  • [Cites] Gastroenterology. 1996 Jul;111(1):93-101 [8698231.001]
  • [Cites] Gut. 1996 Nov;39(5):711-6 [9014771.001]
  • [Cites] Am J Gastroenterol. 1998 Jul;93(7):1028-32 [9672324.001]
  • [Cites] Gastrointest Endosc. 1999 Feb;49(2):170-6 [9925694.001]
  • [Cites] Gastrointest Endosc. 2005 May;61(6):671-8 [15855970.001]
  • [Cites] Gastrointest Endosc. 2005 May;61(6):679-85 [15855971.001]
  • [Cites] Endoscopy. 2005 Oct;37(10):929-36 [16189764.001]
  • [Cites] Aliment Pharmacol Ther. 2006 Mar 15;23(6):735-42 [16556175.001]
  • [Cites] Gastrointest Endosc. 2006 Aug;64(2):155-66 [16860062.001]
  • [Cites] Gastrointest Endosc. 2006 Aug;64(2):167-75 [16860063.001]
  • [Cites] Gastrointest Endosc. 2006 Aug;64(2):176-85 [16860064.001]
  • [Cites] Clin Gastroenterol Hepatol. 2006 Aug;4(8):979-87 [16843068.001]
  • [Cites] Endoscopy. 2006 Sep;38(9):867-72 [16981102.001]
  • [Cites] Endoscopy. 2006 Dec;38(12):1206-12 [17163320.001]
  • [Cites] World J Gastroenterol. 2007 Jan 21;13(3):444-7 [17230616.001]
  • [Cites] Endoscopy. 2007 Jul;39(7):594-8 [17611913.001]
  • [Cites] Aliment Pharmacol Ther. 2007 Aug 1;26(3):501-7 [17635385.001]
  • [Cites] Gut. 2008 Feb;57(2):167-72 [17965067.001]
  • [Cites] J Gastrointestin Liver Dis. 2008 Mar;17(1):95-100 [18392254.001]
  • [Cites] Endoscopy. 2008 Jun;40(6):457-63 [18459090.001]
  • [Cites] Gastroenterology. 2008 Jul;135(1):24-31 [18442484.001]
  • [Cites] Endoscopy. 2009 Feb;41(2):107-12 [19214887.001]
  • [Cites] Gastrointest Endosc. 2009 Oct;70(4):645-54 [19559419.001]
  • [Cites] J Gastroenterol. 2009;44(11):1125-32 [19714289.001]
  • [Cites] Am J Gastroenterol. 2002 Mar;97(3):584-9 [11922550.001]
  • (PMID = 20872963.001).
  • [ISSN] 2219-2840
  • [Journal-full-title] World journal of gastroenterology
  • [ISO-abbreviation] World J. Gastroenterol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] China
  • [Other-IDs] NLM/ PMC2951513
  •  go-up   go-down


22. Johnson EE, Leverson GE, Pirsch JD, Heise CP: A 30-year analysis of colorectal adenocarcinoma in transplant recipients and proposal for altered screening. J Gastrointest Surg; 2007 Mar;11(3):272-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] A 30-year analysis of colorectal adenocarcinoma in transplant recipients and proposal for altered screening.
  • However, the incidence and specific risk for colorectal adenocarcinoma, although previously proposed, has been difficult to calculate.
  • We reviewed the University of Wisconsin transplant database for all cases of colorectal adenocarcinoma to assess the risk of this malignancy, as well as the need for improved screening in this population.
  • METHODS: The transplant database was queried using diagnosis codes for colorectal adenocarcinoma to configure a list of eligible patients.
  • Exclusion criteria included: age less than 18 years at the time of transplant, diagnosis of colorectal cancer or patient death less than 12 months posttransplant, and pretransplant history of colorectal cancer or proctocolectomy.
  • RESULTS: A total of 5,603 kidney, liver, or combination transplants were eligible for analysis from 1966 through 2004.
  • We identified 40 cases of colorectal adenocarcinoma.
  • Twenty-five of these cases (62%) occurred in kidney transplant recipients, 13 after liver transplant, and two after kidney-pancreas combination.
  • The median survival postcancer diagnosis was 2.3 years.
  • The 5-year survival postcancer diagnosis is 63.5% in the general population (SEER), vs. 30.7% in the transplant cohort.
  • The SEER median age at diagnosis of colorectal adenocarcinoma is 72.0 years.
  • Of the transplant recipients who developed cancer, the median age at diagnosis was 58.7 years (32.4 to 78.2), and 11 patients (27%) were diagnosed at or before age 50.
  • In the U.S. population, the annual incidence of colorectal adenocarcinoma below the age of 50 is 0.0055% (5.52/100,000) and the 10-year extrapolated incidence is 0.11%.
  • In this under-50 cohort, median time from transplant to cancer diagnosis was 7.8 years.
  • CONCLUSION: The incidence of and 5-year survival after diagnosis of colorectal adenocarcinoma in transplant recipients is markedly different than the general population.
  • [MeSH-major] Adenocarcinoma / etiology. Colorectal Neoplasms / etiology. Organ Transplantation / adverse effects
  • [MeSH-minor] Adult. Aged. Female. Follow-Up Studies. Humans. Incidence. Kidney Transplantation / adverse effects. Liver Transplantation / adverse effects. Male. Middle Aged. Pancreas Transplantation / adverse effects. Risk Factors. Survival Rate. United States / epidemiology

  • MedlinePlus Health Information. consumer health - Colorectal Cancer.
  • MedlinePlus Health Information. consumer health - Organ Transplantation.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Br Med J. 1968 Dec 21;4(5633):746-8 [4881420.001]
  • [Cites] Transplant Proc. 1995 Apr;27(2):1767-8 [7725494.001]
  • [Cites] Br J Cancer. 2003 Oct 6;89(7):1221-7 [14520450.001]
  • [Cites] Hepatogastroenterology. 1997 Jul-Aug;44(16):1172-81 [9261620.001]
  • [Cites] Dis Colon Rectum. 2004 Nov;47(11):1898-903 [15622583.001]
  • [Cites] Lancet. 2000 May 27;355(9218):1886-7 [10866449.001]
  • [Cites] Kidney Int. 2004 Jul;66(1):383-9 [15200447.001]
  • [Cites] Crit Rev Oncog. 1989;1(1):27-52 [2488123.001]
  • [Cites] Transplant Proc. 1969 Mar;1(1):106-12 [4944206.001]
  • [Cites] Am J Gastroenterol. 1999 Nov;94(11):3359-61 [10566744.001]
  • [Cites] JAMA. 1978 Aug 18;240(7):639-43 [353312.001]
  • [Cites] Int J Cancer. 1995 Jan 17;60(2):183-9 [7829213.001]
  • [Cites] Transpl Int. 2000;13 Suppl 1:S394-8 [11112040.001]
  • [Cites] Dis Colon Rectum. 1993 Oct;36(10):908-12 [8404380.001]
  • [Cites] Nephrol Dial Transplant. 1995;10 Suppl 1:74-80 [7617285.001]
  • [Cites] Laryngoscope. 2000 Aug;110(8):1257-61 [10942122.001]
  • [Cites] Cancer. 1976 Feb;37(2):729-34 [766948.001]
  • [Cites] Hepatology. 1998 Mar;27(3):685-90 [9500695.001]
  • [Cites] Hematol Oncol Clin North Am. 1993 Apr;7(2):431-45 [8468275.001]
  • [Cites] Cancer. 1999 Apr 15;85(8):1758-64 [10223570.001]
  • [Cites] J Am Acad Dermatol. 1999 Feb;40(2 Pt 1):177-86 [10025742.001]
  • [Cites] J Am Soc Nephrol. 2000 Oct;11 Suppl 15:S1-86 [11044969.001]
  • [Cites] Ann Surg Oncol. 2002 Oct;9(8):785-8 [12374662.001]
  • [Cites] J Am Soc Nephrol. 2004 Jun;15(6):1582-8 [15153569.001]
  • [Cites] Transplant Proc. 2003 Jun;35(4):1410-2 [12826174.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 1999 Dec;8(12):1117-21 [10613347.001]
  • [Cites] Gastrointest Endosc Clin N Am. 2001 Jan;11(1):199-214 [11175982.001]
  • [Cites] Clin Cancer Res. 1997 Jan;3(1):51-5 [9815537.001]
  • [Cites] Gastroenterology. 2003 Feb;124(2):544-60 [12557158.001]
  • [Cites] J Hepatol. 2001 Jan;34(1):84-91 [11211912.001]
  • [Cites] Transplant Proc. 1998 Jun;30(4):1124-6 [9636456.001]
  • (PMID = 17458597.001).
  • [ISSN] 1091-255X
  • [Journal-full-title] Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract
  • [ISO-abbreviation] J. Gastrointest. Surg.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


23. Padda M, Vadgama J, Sandhu P, Dev A, Giannikopoulos I: Clinical significance of incidental colorectal wall thickening on computed tomography scan in African-American and Hispanic patients. Dig Dis Sci; 2007 Nov;52(11):3159-64
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Histopathological findings revealed colitis in 7 (33%), adenoma in 4 (19%), hyperplastic polyps in 4 (19%), adenocarcinoma in 2 (9%), lymphoid aggregates in 2 (9%), melanosis coli in 1 (5%), and normal in 1 (5%) in the abnormal examination group.
  • [MeSH-minor] Adult. Aged. Colonoscopy. Diagnosis, Differential. Female. Humans. Hypertrophy / radiography. Male. Middle Aged. Predictive Value of Tests. Prevalence. Retrospective Studies. United States / epidemiology


24. Perez N, Castillo M, Santos Y, Truan D, Gutierrez R, Franco A, Palacin A, Bombi JA, Campo E, Fernandez PL: Carcinosarcoma of the prostate: two cases with distinctive morphologic and immunohistochemical findings. Virchows Arch; 2005 May;446(5):511-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Carcinosarcomas (CS) of the prostate are very uncommon neoplasms defined by the admixture of malignant epithelial and mesenchymal components.
  • We describe here two new examples of CS in two patients aged 66 and 77 years, the first without previous history of prostate adenocarcinoma and the second with a 5-year history of acinar type prostate adenocarcinoma.
  • The diagnosis of CS was made on the cystoprostatectomy specimen in the first case and transurethral resection in the second case.
  • Both biphasic tumours exhibited papillary areas of ductal differentiation and conventional adenocarcinoma in the epithelial component, as well as malignant fibrous histiocytoma and angiosarcomatous areas in the first case and solid, poorly differentiated epithelial areas with neuroendocrine features in the second case.
  • The clinical course of the cases was divergent; the first patient is free of disease after radical surgery and adjuvant therapy and the other died 5 months after the diagnosis of CS, having already developed liver metastases.
  • [MeSH-major] Carcinosarcoma / diagnosis. Prostatic Neoplasms / diagnosis
  • [MeSH-minor] Aged. Antigens, CD31 / analysis. Biomarkers. Biopsy, Needle. Fatal Outcome. Humans. Immunohistochemistry. Keratins / analysis. Liver Neoplasms / secondary. Male. Neprilysin / analysis. Prostate-Specific Antigen / blood. Prostatectomy. Proto-Oncogene Proteins c-kit / analysis. Receptor, ErbB-2 / analysis. Transurethral Resection of Prostate. Ultrasonography

  • MedlinePlus Health Information. consumer health - Prostate Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Urol. 1991 Nov;146(5):1370-3 [1942296.001]
  • [Cites] Prostate. 2003 Sep 1;56(4):250-5 [12858352.001]
  • [Cites] Am J Clin Pathol. 1989 Aug;92(2):131-9 [2474243.001]
  • [Cites] J Urol. 1979 Nov;122(5):709-11 [501837.001]
  • [Cites] Urol Int. 1992;48(1):105-7 [1376007.001]
  • [Cites] Acta Pathol Jpn. 1993 Apr;43(4):209-14 [8493872.001]
  • [Cites] Pathol Res Pract. 2000;196(8):569-72 [10982020.001]
  • [Cites] Cancer Res. 1990 Apr 15;50(8):2275-82 [2317815.001]
  • [Cites] Am J Surg Pathol. 1993 Apr;17(4):342-9 [8494104.001]
  • [Cites] J Urol. 2002 Jul;168(1):315-22 [12050563.001]
  • [Cites] Cancer. 1995 Sep 15;76(6):1035-42 [8625205.001]
  • [Cites] Mod Pathol. 1997 Jun;10(6):612-29 [9195581.001]
  • [Cites] Tech Urol. 2001 Dec;7(4):294-5 [11763492.001]
  • [Cites] Urology. 1981 Jul;18(1):85-8 [7257048.001]
  • [Cites] Proc Natl Acad Sci U S A. 1996 Dec 24;93(26):15152-7 [8986779.001]
  • [Cites] Prostate. 2002 Oct 1;53(2):101-8 [12242724.001]
  • [Cites] Am J Clin Pathol. 2000 Mar;113(3):374-82 [10705818.001]
  • [Cites] Cancer. 2002 Oct 15;95(8):1650-5 [12365012.001]
  • [Cites] Urology. 1992 Oct;40(4):376-80 [1329302.001]
  • [Cites] Acta Pathol Jpn. 1985 Mar;35(2):481-7 [4024945.001]
  • [Cites] Urol Int. 1997;59(1):50-2 [9313326.001]
  • [Cites] Cancer. 1992 Jun 1;69(11):2676-82 [1571897.001]
  • [Cites] Prostate. 2001 May 15;47(3):164-71 [11351345.001]
  • [Cites] Int J Urol. 2003 Feb;10(2):108-13 [12588610.001]
  • [Cites] J Urol. 1981 Mar;125(3):436-8 [7206104.001]
  • [Cites] Histol Histopathol. 2000 Apr;15(2):365-74 [10809354.001]
  • [Cites] Arch Esp Urol. 1992 Oct;45(8):779-82 [1466577.001]
  • [Cites] Cancer. 1990 Sep 1;66(5):998-1001 [2201434.001]
  • [Cites] J Urol. 1967 Mar;97(3):518-22 [6019611.001]
  • [Cites] J Urol. 1970 Jan;103(1):80-3 [5415727.001]
  • [Cites] Eur Urol. 1986;12(6):441-2 [3816901.001]
  • [Cites] World J Urol. 1999 Oct;17 (5):316-8 [10552151.001]
  • [Cites] Hum Pathol. 2003 May;34(5):450-6 [12792918.001]
  • (PMID = 15821929.001).
  • [ISSN] 0945-6317
  • [Journal-full-title] Virchows Archiv : an international journal of pathology
  • [ISO-abbreviation] Virchows Arch.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Antigens, CD31; 0 / Biomarkers; 0 / CAM 5.2 antigen; 68238-35-7 / Keratins; EC 2.7.10.1 / Proto-Oncogene Proteins c-kit; EC 2.7.10.1 / Receptor, ErbB-2; EC 3.4.21.77 / Prostate-Specific Antigen; EC 3.4.24.11 / Neprilysin
  •  go-up   go-down


25. Tjalma WA: Horner's syndrome: an ominous sign in breast cancer. Eur J Obstet Gynecol Reprod Biol; 2006 Jun 1;126(2):270-1
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-major] Adenocarcinoma / diagnosis. Breast Neoplasms / diagnosis. Horner Syndrome. Liver Neoplasms / diagnosis. Thoracic Neoplasms / diagnosis
  • [MeSH-minor] Aged. Aged, 80 and over. Diagnosis, Differential. Female. Humans. Mammography. Neoplasm Metastasis. Tomography, X-Ray Computed


26. Abbey-Toby A, Vullierme MP, Sauvanet A, Ruszniewski P, Bedossa P, Couvelard A: A clear cell malignant gastrinoma of the pancreas with cytoplasmic accumulation of lipid droplets. Virchows Arch; 2006 Jan;448(1):105-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] A clear cell malignant gastrinoma of the pancreas with cytoplasmic accumulation of lipid droplets.
  • [MeSH-major] Adenocarcinoma, Clear Cell / pathology. Gastrinoma / pathology. Pancreatic Neoplasms / pathology
  • [MeSH-minor] Adenocarcinoma, Mucinous / pathology. Carcinoma, Renal Cell / pathology. Cytoplasm / metabolism. Diagnosis, Differential. Female. Humans. Immunohistochemistry. Lipids. Liver Neoplasms / secondary. Middle Aged. Zollinger-Ellison Syndrome / complications

  • MedlinePlus Health Information. consumer health - Pancreatic Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Arch Pathol Lab Med. 2003 Feb;127(2):241-2 [12562246.001]
  • [Cites] Am J Clin Pathol. 1983 Apr;79(4):512-7 [6188363.001]
  • [Cites] Am J Surg Pathol. 1980 Oct;4(5):501-9 [7435777.001]
  • [Cites] Ann Pathol. 2000 Mar;20(2):124-9 [10740007.001]
  • [Cites] Surg Today. 2003;33(6):470-4 [12768377.001]
  • [Cites] Histopathology. 1997 Aug;31(2):157-60 [9279567.001]
  • (PMID = 16189699.001).
  • [ISSN] 0945-6317
  • [Journal-full-title] Virchows Archiv : an international journal of pathology
  • [ISO-abbreviation] Virchows Arch.
  • [Language] eng
  • [Publication-type] Case Reports; Letter
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Lipids
  •  go-up   go-down


27. Anagnostopoulos GK, Sakorafas GH, Kostopoulos P, Margantinis G, Tsiakos S, Terpos E, Pavlakis G, Fortun P, Arvanitidis D: Disseminated colon cancer with severe peripheral blood eosinophilia and elevated serum levels of interleukine-2, interleukine-3, interleukine-5, and GM-CSF. J Surg Oncol; 2005 Mar 15;89(4):273-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-minor] Adenocarcinoma / secondary. Aged. Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Cecal Neoplasms / pathology. Diagnosis, Differential. Female. Humans. Liver Neoplasms / secondary. Prognosis

  • MedlinePlus Health Information. consumer health - Eosinophilic Disorders.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15726608.001).
  • [ISSN] 0022-4790
  • [Journal-full-title] Journal of surgical oncology
  • [ISO-abbreviation] J Surg Oncol
  • [Language] eng
  • [Publication-type] Case Reports; Letter
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Interleukin-2; 0 / Interleukin-3; 0 / Interleukin-5; 83869-56-1 / Granulocyte-Macrophage Colony-Stimulating Factor
  •  go-up   go-down


28. Fraquelli M, Sciola V, Villa C, Conte D: The role of ultrasonography in patients with celiac disease. World J Gastroenterol; 2006 Feb 21;12(7):1001-4
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The aim of the present review was to summarize the current evidence on the role of ultrasonography (US) and doppler-US in the diagnosis of celiac disease.
  • Firstly, case control studies identified some of these US signs and then in a prospective series some of these parameters, due to their high specificity, have been shown to be of value in confirming CD diagnosis, whereas others, due to their high sensitivity, have been demonstrated to be useful in excluding the presence of the disease.
  • [MeSH-minor] Abdomen / blood supply. Abdomen / ultrasonography. Adenocarcinoma / diagnosis. Adenocarcinoma / ultrasonography. Algorithms. Case-Control Studies. Humans. Intestinal Neoplasms / ultrasonography. Intestine, Small / ultrasonography. Lymphoma, Non-Hodgkin / ultrasonography. Prospective Studies. Splanchnic Circulation. Ultrasonography. Ultrasonography, Doppler / methods

  • Genetic Alliance. consumer health - Celiac Disease.
  • MedlinePlus Health Information. consumer health - Celiac Disease.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] N Engl J Med. 2002 Jan 17;346(3):180-8 [11796853.001]
  • [Cites] Gastroenterology. 2005 Apr;128(4 Suppl 1):S79-86 [15825131.001]
  • [Cites] Dig Liver Dis. 2003 Apr;35(4):262-8 [12801038.001]
  • [Cites] Arch Intern Med. 2004 Jan 26;164(2):169-74 [14744840.001]
  • [Cites] Gut. 1976 Aug;17(8):612-9 [789184.001]
  • [Cites] Lancet. 1983 Jan 15;1(8316):111-5 [6129425.001]
  • [Cites] Gastroenterology. 1989 Aug;97(2):265-71 [2744350.001]
  • [Cites] Br J Radiol. 1994 Nov;67(803):1139-40 [7820411.001]
  • [Cites] Ultraschall Med. 1996 Feb;17(1):31-3 [8650520.001]
  • [Cites] Gut. 1996 Sep;39(3):369-73 [8949639.001]
  • [Cites] Clin Radiol. 1997 Mar;52(3):244-5 [9091265.001]
  • [Cites] J Ultrasound Med. 1997 Feb;16(2):85-91; quiz 93-4 [9166799.001]
  • [Cites] AJR Am J Roentgenol. 1998 Sep;171(3):629-32 [9725286.001]
  • [Cites] J Pediatr Gastroenterol Nutr. 1998 Oct;27(4):444-5 [9779975.001]
  • [Cites] BMJ. 1999 Jan 16;318(7177):164-7 [9888912.001]
  • [Cites] Gastroenterol Clin Biol. 2001 Apr;25(4 Suppl):B183-9 [11449160.001]
  • [Cites] Radiology. 1999 May;211(2):389-94 [10228518.001]
  • [Cites] Gastroenterology. 2005 Apr;128(4 Suppl 1):S38-46 [15825125.001]
  • [Cites] Gastroenterology. 2005 Apr;128(4 Suppl 1):S47-51 [15825126.001]
  • [Cites] BMJ. 2002 Mar 2;324(7336):539-41 [11872558.001]
  • (PMID = 16534837.001).
  • [ISSN] 1007-9327
  • [Journal-full-title] World journal of gastroenterology
  • [ISO-abbreviation] World J. Gastroenterol.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] China
  • [Number-of-references] 20
  • [Other-IDs] NLM/ PMC4087888
  •  go-up   go-down


29. Shah S, Gupta S, Shet T, Maheshwari A, Wuntkal R, Mohandas KM: Metastatic clear cell variant of hepatocellular carcinoma with an occult hepatic primary. Hepatobiliary Pancreat Dis Int; 2005 May;4(2):306-7
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Metastatic clear cell variant of hepatocellular carcinoma with an occult hepatic primary.
  • Diagnosis is usually made by correlation of histopathology, tumour markers and immunohistochemistry, especially HepPar 1.
  • In this unusual case of metastatic clear cell carcinoma presenting as Sister Mary Joseph's nodule, no primary evidence was observed radiologically in the liver, but the level of alfa fetoprotein was markedly elevated.
  • Metastatic clear cell carcinoma of the liver with an occult hepatic primary was diagnosed by immunohistochemical profile of the tumour.
  • [MeSH-major] Adenocarcinoma, Clear Cell / pathology. Carcinoma, Hepatocellular / pathology. Liver Neoplasms / pathology. Neoplasms, Second Primary / pathology. alpha-Fetoproteins / analysis
  • [MeSH-minor] Adult. Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Biomarkers, Tumor / analysis. Biopsy, Needle. Follow-Up Studies. Humans. Immunohistochemistry. Male. Neoplasm Staging. Risk Assessment. Treatment Outcome

  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15908336.001).
  • [ISSN] 1499-3872
  • [Journal-full-title] Hepatobiliary & pancreatic diseases international : HBPD INT
  • [ISO-abbreviation] HBPD INT
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] China
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / alpha-Fetoproteins
  •  go-up   go-down


30. Mehenni H, Resta N, Guanti G, Mota-Vieira L, Lerner A, Peyman M, Chong KA, Aissa L, Ince A, Cosme A, Costanza MC, Rossier C, Radhakrishna U, Burt RW, Picard D: Molecular and clinical characteristics in 46 families affected with Peutz-Jeghers syndrome. Dig Dis Sci; 2007 Aug;52(8):1924-33
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Germline mutations of the tumor suppressor gene LKB1/STK11 are responsible for the Peutz-Jeghers syndrome (PJS), an autosomal-dominant disorder characterized by mucocutaneous pigmentation, hamartomatous polyps, and an increased risk of associated malignancies.
  • Genotype-phenotype analysis did not yield any significant differences between patients carrying mutations in LKB1/STK11 versus those without mutations, even with respect to primary biliary adenocarcinoma.
  • This study presents the molecular characterization and cancer occurrence of a large cohort of PJS patients, increases the mutational spectrum of LKB1/STK11 allelic variants worldwide, and provides a new insight useful for clinical diagnosis and genetic counseling of PJS families.
  • [MeSH-minor] Adenocarcinoma / genetics. Adolescent. Adult. Aged. Bile Duct Neoplasms / genetics. Child. Chromosome Deletion. Female. Gene Rearrangement. Genotype. Humans. Male. Middle Aged. Phenotype. Polymorphism, Single-Stranded Conformational

  • Genetic Alliance. consumer health - Peutz Jeghers syndrome.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Med Genet. 2001 Jun;38(6):356-60 [11389158.001]
  • [Cites] Mol Cell. 2001 Jun;7(6):1307-19 [11430832.001]
  • [Cites] Hum Mol Genet. 1999 Jan;8(1):45-51 [9887330.001]
  • [Cites] Ann Intern Med. 1998 Jun 1;128(11):896-9 [9634427.001]
  • [Cites] Eur J Hum Genet. 2004 May;12(5):415-8 [14970844.001]
  • [Cites] Hum Mutat. 1999;13(6):476-81 [10408777.001]
  • [Cites] Gut. 1989 Nov;30(11):1588-90 [2599445.001]
  • [Cites] Am J Pathol. 1999 Jun;154(6):1835-40 [10362809.001]
  • [Cites] Cancer Cell. 2004 Jul;6(1):91-9 [15261145.001]
  • [Cites] Int J Oncol. 2002 Mar;20(3):577-82 [11836571.001]
  • [Cites] Hum Mutat. 2003 Feb;21(2):172 [12552571.001]
  • [Cites] Nat Cell Biol. 2003 Oct;5(10 ):889-94 [12973359.001]
  • [Cites] J Med Genet. 1998 Jan;35(1):42-4 [9475093.001]
  • [Cites] Hum Mutat. 1998;11(1):1-3 [9450896.001]
  • [Cites] Cancer Res. 2003 Mar 15;63(6):1382-8 [12649203.001]
  • [Cites] N Engl J Med. 1987 Jun 11;316(24):1511-4 [3587280.001]
  • [Cites] Cancer Res. 1998 Dec 1;58(23):5267-70 [9850045.001]
  • [Cites] Am J Hum Genet. 1998 Dec;63(6):1641-50 [9837816.001]
  • [Cites] Am J Pathol. 1998 Aug;153(2):363-6 [9708796.001]
  • [Cites] Gut. 2000 Aug;47(2):272-6 [10896921.001]
  • [Cites] Nat Genet. 1998 Jan;18(1):38-43 [9425897.001]
  • [Cites] Clin Gastroenterol Hepatol. 2004 May;2(5):366-75 [15118973.001]
  • [Cites] Am J Hum Genet. 1997 Dec;61(6):1327-34 [9399902.001]
  • [Cites] Cytogenet Genome Res. 2002;97(3-4):171-8 [12438709.001]
  • [Cites] J Clin Pathol. 2005 Oct;58(10):1091-5 [16189157.001]
  • [Cites] Clin Genet. 2002 Oct;62(4):282-7 [12372054.001]
  • [Cites] Hum Mutat. 2000;16(1):23-30 [10874301.001]
  • [Cites] J Med Genet. 1999 May;36(5):365-8 [10353780.001]
  • [Cites] Br J Cancer. 2003 Jul 21;89(2):308-13 [12865922.001]
  • [Cites] Proc Natl Acad Sci U S A. 1999 Aug 3;96(16):9248-51 [10430928.001]
  • [Cites] J Med Genet. 2004 May;41(5):327-33 [15121768.001]
  • [Cites] J Biol Chem. 2001 Aug 31;276(35):32415-8 [11445556.001]
  • [Cites] Oncogene. 2003 Jul 24;22(30):4752-6 [12879020.001]
  • [Cites] Am J Pathol. 2001 Dec;159(6):2017-22 [11733352.001]
  • [Cites] Hum Mol Genet. 2005 Aug 1;14(15):2209-19 [15987703.001]
  • [Cites] J Pathol. 1999 May;188(1):9-13 [10398133.001]
  • [Cites] Br J Cancer. 2005 Mar 28;92(6):1126-9 [15756273.001]
  • [Cites] Cancer Res. 1998 Nov 1;58(21):4799-801 [9809980.001]
  • [Cites] Mod Pathol. 2003 Jul;16(7):686-91 [12861065.001]
  • [Cites] Gastroenterology. 2004 Jun;126(7):1788-94 [15188174.001]
  • [Cites] Nat Genet. 1997 Jan;15(1):87-90 [8988175.001]
  • [Cites] Nature. 2002 Sep 12;419(6903):162-7 [12226664.001]
  • [Cites] Cancer Res. 1985 Apr;45(4):1437-43 [2983882.001]
  • [Cites] Nature. 1998 Jan 8;391(6663):184-7 [9428765.001]
  • [Cites] Genes Chromosomes Cancer. 2004 Oct;41(2):163-9 [15287029.001]
  • [Cites] Ann Oncol. 1999;10 Suppl 4:122-6 [10436802.001]
  • [Cites] Hum Mol Genet. 2001 Dec 1;10(25):2869-77 [11741830.001]
  • [Cites] J Clin Pathol. 2001 Feb;54(2):126-31 [11215281.001]
  • [Cites] Liver. 1997 Dec;17(6):281-7 [9455733.001]
  • (PMID = 17404884.001).
  • [ISSN] 0163-2116
  • [Journal-full-title] Digestive diseases and sciences
  • [ISO-abbreviation] Dig. Dis. Sci.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] EC 2.7.1.- / STK11 protein, human; EC 2.7.11.1 / Protein-Serine-Threonine Kinases
  •  go-up   go-down


31. Boberg KM, Jebsen P, Clausen OP, Foss A, Aabakken L, Schrumpf E: Diagnostic benefit of biliary brush cytology in cholangiocarcinoma in primary sclerosing cholangitis. J Hepatol; 2006 Oct;45(4):568-74
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Efforts should be made to detect early neoplastic changes that can be radically treated by liver transplantation.
  • RESULTS: Among patients with cytological low-grade (n=9; 15%) or high-grade dysplasia/adenocarcinoma (n=13; 21%), 8 (36%) proved to have cholangiocarcinoma and 7 (32%) to have high-grade dysplasia (i.e. cholangiocarcinoma in situ) in bile ducts from explanted livers.
  • The sensitivity, specificity, positive- and negative predictive values, and accuracy of brush cytology in diagnosis of biliary malignancy were 100%, 84%, 68%, 100%, and 88% for the combination of low-grade and high-grade dysplasia/adenocarcinoma and 73%, 95%, 85%, 91%, and 90% for high-grade dysplasia/adenocarcinoma only.
  • Patients with cytological low-grade and high-grade dysplasia/adenocarcinoma are currently referred for liver transplantation in our hospital.
  • [MeSH-minor] Adenocarcinoma / pathology. Adolescent. Adult. Aged. Biomarkers, Tumor. Carcinoma in Situ / pathology. Cholangiopancreatography, Endoscopic Retrograde. Female. Humans. Male. Middle Aged. Predictive Value of Tests. Prospective Studies. Sensitivity and Specificity


32. Pérez-Fidalgo JA, Oltra Ferrando A, López Jiménez A, Maestu Maiques I: Primary carcinoid tumour of the pancreas. Clin Transl Oncol; 2006 Jan;8(1):54-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Usually, the biological behaviour is indolent and diagnosis is late and often casual.
  • We present the case of a patient initially diagnosed as having liver metastasis of unknown origin.
  • PET identified a primary pancreatic site and the initial histologic diagnosis was adenocarcinoma.
  • After complete surgical resection and liver transplantation, patient remains free of disease.
  • CONCLUSIONS: The co-existence of several diseases with similar morpho-structural features makes diagnosis complicated.
  • The only curative treatment is surgical resection, with liver transplantation as a valid option in the treatment of these tumours.
  • [MeSH-major] Carcinoid Tumor / diagnosis. Diagnostic Errors. Pancreatic Neoplasms / diagnosis
  • [MeSH-minor] Adenocarcinoma / diagnosis. Adult. Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Cisplatin / administration & dosage. Combined Modality Therapy. Deoxycytidine / administration & dosage. Deoxycytidine / analogs & derivatives. Humans. Liver Neoplasms / diagnosis. Liver Neoplasms / secondary. Liver Neoplasms / surgery. Liver Transplantation. Male. Pancreatectomy. Positron-Emission Tomography. Remission Induction

  • MedlinePlus Health Information. consumer health - Carcinoid Tumors.
  • MedlinePlus Health Information. consumer health - Pancreatic Cancer.
  • Hazardous Substances Data Bank. CIS-DIAMINEDICHLOROPLATINUM .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Cancer. 1997 Feb 15;79(4):813-29 [9024720.001]
  • [Cites] Ann Surg. 1997 Apr;225(4):355-64 [9114793.001]
  • [Cites] Curr Probl Surg. 1989 Dec;26(12):835-85 [2701223.001]
  • [Cites] Am J Med. 1986 Dec 22;81(6B):14-22 [2879446.001]
  • [Cites] Endocr Rev. 2004 Aug;25(4):568-80 [15294882.001]
  • [Cites] Cancer. 2002 Jun 25;96(3):174-80 [12115306.001]
  • (PMID = 16632441.001).
  • [ISSN] 1699-048X
  • [Journal-full-title] Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
  • [ISO-abbreviation] Clin Transl Oncol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Italy
  • [Chemical-registry-number] 0W860991D6 / Deoxycytidine; B76N6SBZ8R / gemcitabine; Q20Q21Q62J / Cisplatin
  •  go-up   go-down


33. Verma A, Batey A, Greenberg E, Uzoaru I: An uncommon etiology of cholestatic jaundice: intraductal mucinous papillary tumor of the bile duct. South Med J; 2009 Apr;102(4):422-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We report a case of IPMT of the biliary tract that presented with fatigue and a persistent cholestatic pattern of liver enzyme elevation and required a high index of suspicion to make the final diagnosis.
  • [MeSH-major] Adenocarcinoma, Mucinous / complications. Bile Duct Neoplasms / complications. Carcinoma, Papillary / complications. Jaundice, Obstructive / etiology
  • [MeSH-minor] Aged. Biopsy. Cholangiopancreatography, Endoscopic Retrograde. Diagnosis, Differential. Humans. Male. Stents

  • MedlinePlus Health Information. consumer health - Bile Duct Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19279543.001).
  • [ISSN] 1541-8243
  • [Journal-full-title] Southern medical journal
  • [ISO-abbreviation] South. Med. J.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


34. Teredesai A, Wöhrmann T: Metastasizing seminal vesicle adenocarcinoma in a Wistar rat. J Vet Med A Physiol Pathol Clin Med; 2005 Apr;52(3):131-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Metastasizing seminal vesicle adenocarcinoma in a Wistar rat.
  • An adenocarcinoma in the seminal vesicles of a 15-month-old male Wistar rat from a 30-month inhalation study is described.
  • The histological features of the small nodules in the pancreas and on the surface of the liver, rectum and urinary bladder resembled those of the primary tumour in the seminal vesicles.
  • Based on these criteria, the neoplasm (mass) was diagnosed as an adenocarcinoma of the seminal vesicles.
  • The immunohistological examination confirmed the diagnosis, i.e. immunostaining was positive for cytokeratins (4, 7, 14, 15, 18, and 19), vimentin, PCNA, and ED(1).
  • [MeSH-major] Adenocarcinoma / veterinary. Genital Neoplasms, Male / veterinary. Rats, Wistar. Rodent Diseases / pathology. Seminal Vesicles

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15836444.001).
  • [ISSN] 0931-184X
  • [Journal-full-title] Journal of veterinary medicine. A, Physiology, pathology, clinical medicine
  • [ISO-abbreviation] J Vet Med A Physiol Pathol Clin Med
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] 68238-35-7 / Keratins
  •  go-up   go-down


35. Alexopoulou A, Koskinas J, Deutsch M, Delladetsima J, Kountouras D, Dourakis SP: Acute liver failure as the initial manifestation of hepatic infiltration by a solid tumor: report of 5 cases and review of the literature. Tumori; 2006 Jul-Aug;92(4):354-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Acute liver failure as the initial manifestation of hepatic infiltration by a solid tumor: report of 5 cases and review of the literature.
  • BACKGROUND: Acute liver failure is a rare complication of metastatic liver disease with a high mortality.
  • Recognition of malignant infiltration of the liver as the cause of acute liver failure could be a diagnostic challenge.
  • PATIENTS: The medical files of 5 patients with acute liver failure due to metastatic liver disease collected over a 4-year period (1997-2000) in our department were reviewed.
  • Liver imaging studies in 2 of the 5 patients were nondiagnostic and the malignant liver infiltration was confirmed postmortem.
  • Liver histology in all cases showed massive tumoral infiltration of the hepatic sinusoids with diffuse replacement of hepatocytes.
  • CONCLUSIONS: Malignant infiltration of the liver should be taken into account in the differential diagnosis of rapidly progressive liver failure.
  • Although effective chemotherapy has improved the survival of patients with metastatic liver disease, there has been no change in the course and outcome of acute liver failure due to malignant infiltration of the liver over the last 2 decades.
  • A proper diagnosis by liver biopsy is mandatory to prevent such patients from being considered for liver transplant.
  • [MeSH-major] Adenocarcinoma / secondary. Carcinoma, Small Cell / secondary. Liver Failure, Acute / etiology. Liver Neoplasms / complications. Liver Neoplasms / secondary
  • [MeSH-minor] Adult. Aged, 80 and over. Biopsy. Female. Hepatic Encephalopathy / etiology. Humans. Jaundice / etiology. Liver Function Tests. Lung Neoplasms / pathology. Male. Medical Records. Middle Aged. Retrospective Studies

  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17036530.001).
  • [ISSN] 0300-8916
  • [Journal-full-title] Tumori
  • [ISO-abbreviation] Tumori
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 23
  •  go-up   go-down


36. Li J, Zhou J, Chen G, Wang H, Wang S, Xing H, Gao Q, Lu Y, He Y, Ma D: Inhibition of ovarian cancer metastasis by adeno-associated virus-mediated gene transfer of nm23H1 in an orthotopic implantation model. Cancer Gene Ther; 2006 Mar;13(3):266-72
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Ovarian cancer is one of the most threatening malignant tumors in females due to the frequent occurrence of metastasis that precedes diagnosis.
  • Liver metastasis and animal survival time were measured after transfer of a recombinant adeno-associated viral vector expressing nm23H1 (AAV-nm23H1) into the aforementioned model.
  • (2) a 60% reduction in the number of animals developing liver metastases; and (3) a 35-day prolongation of median survival time compared with the untreated host group.
  • [MeSH-major] Dependovirus / genetics. Disease Models, Animal. Genetic Therapy. Liver Neoplasms / prevention & control. Nucleoside-Diphosphate Kinase / genetics. Ovarian Neoplasms / therapy
  • [MeSH-minor] Adenocarcinoma / genetics. Adenocarcinoma / secondary. Adenocarcinoma / therapy. Animals. Cell Line, Tumor. Female. Humans. Mice. Mice, Inbred BALB C. Mice, Nude. NM23 Nucleoside Diphosphate Kinases. Polymerase Chain Reaction

  • Genetic Alliance. consumer health - Ovarian cancer.
  • MedlinePlus Health Information. consumer health - Genes and Gene Therapy.
  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • MedlinePlus Health Information. consumer health - Ovarian Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16179930.001).
  • [ISSN] 0929-1903
  • [Journal-full-title] Cancer gene therapy
  • [ISO-abbreviation] Cancer Gene Ther.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / NM23 Nucleoside Diphosphate Kinases; EC 2.7.4.6 / Nucleoside-Diphosphate Kinase
  •  go-up   go-down


37. Donigan M, Loh BD, Norcross LS, Li S, Williamson PR, DeJesus S, Ferrara A, Gallagher JT, Baker CH: A metastatic colon cancer model using nonoperative transanal rectal injection. Surg Endosc; 2010 Mar;24(3):642-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Two mice (3.3%) from the 2.5 x 10(4) CT26-luc group showed metastatic colonic adenocarcinoma to the liver on postinjection day 50.
  • [MeSH-major] Colonic Neoplasms / secondary. Neoplasm Transplantation / methods. Rectum / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] N Engl J Med. 2004 May 13;350(20):2050-9 [15141043.001]
  • [Cites] Dig Surg. 2005;22(1-2):16-25 [15838167.001]
  • [Cites] Int J Cancer. 1989 Jul 15;44(1):177-81 [2744889.001]
  • [Cites] J Surg Res. 2009 Jun 15;154(2):299-303 [19101690.001]
  • [Cites] Cancer Res. 1975 Sep;35(9):2434-9 [1149045.001]
  • [Cites] Am J Pathol. 2007 Mar;170(3):1077-85 [17322390.001]
  • [Cites] Cancer Res. 1988 Apr 1;48(7):1943-8 [3349467.001]
  • [Cites] Arch Surg. 1995 Jun;130(6):649-53 [7763175.001]
  • [Cites] Surg Endosc. 2003 Jun;17(6):972-8 [12640542.001]
  • [Cites] Surg Endosc. 1998 Aug;12 (8):1092-5 [9685551.001]
  • [Cites] Lancet. 2002 Jun 29;359(9325):2224-9 [12103285.001]
  • [Cites] Cancer Sci. 2004 Jun;95(6):514-9 [15182433.001]
  • [Cites] Eur J Surg Oncol. 2008 Apr;34(4):476-81 [17698312.001]
  • [Cites] Surg Oncol. 1992 Jun;1(3):251-6 [1341258.001]
  • [Cites] Int J Oncol. 2005 Jul;27(1):113-20 [15942650.001]
  • [Cites] Clin Cancer Res. 2000 Jun;6(6):2556-61 [10873112.001]
  • (PMID = 19688392.001).
  • [ISSN] 1432-2218
  • [Journal-full-title] Surgical endoscopy
  • [ISO-abbreviation] Surg Endosc
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


38. Labat-Debelleix V, Carpentier E, Causse X, Kerdraon R, Bonneau C, Michenet P: [Hepatic splenosis: a rare etiology of hepatic nodules]. Gastroenterol Clin Biol; 2008 Jan;32(1 Pt. 1):83-7
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Hepatic splenosis: a rare etiology of hepatic nodules].
  • [Transliterated title] Splénose hépatique: une étiologie rare de nodules hépatiques.
  • We report a case of intrahepatic splenosis, which presented as a liver tumour on imagery in a 55-year-old man followed for lung carcinoma and chronic hepatitis C and who had undergone a splenectomy for trauma 22 years before.
  • The different characteristics and diagnostic methods of 16 cases of hepatic splenosis are presented from the literature.
  • These different reports emphasize the necessity of considering splenosis in the differential diagnosis of hepatic tumours.
  • [MeSH-major] Carcinoma, Hepatocellular / diagnosis. Liver Diseases / diagnosis. Liver Neoplasms / diagnosis. Splenosis / diagnosis
  • [MeSH-minor] Adenocarcinoma / complications. Diagnosis, Differential. Hepatitis C, Chronic / complications. Humans. Liver Cirrhosis / diagnosis. Lung Neoplasms / complications. Male. Middle Aged. Splenectomy

  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • MedlinePlus Health Information. consumer health - Liver Diseases.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18341979.001).
  • [ISSN] 0399-8320
  • [Journal-full-title] Gastroentérologie clinique et biologique
  • [ISO-abbreviation] Gastroenterol. Clin. Biol.
  • [Language] fre
  • [Publication-type] Case Reports; English Abstract; Journal Article; Review
  • [Publication-country] France
  • [Number-of-references] 24
  •  go-up   go-down


39. Chand HS, Ness SA, Kisiel W: Identification of a novel human tissue factor splice variant that is upregulated in tumor cells. Int J Cancer; 2006 Apr 1;118(7):1713-20
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We propose that high-level expression of the novel TF-A transcript, preferentially in tumor cells, may have utility in the diagnosis and staging of a variety of solid tumors.

  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16217771.001).
  • [ISSN] 0020-7136
  • [Journal-full-title] International journal of cancer
  • [ISO-abbreviation] Int. J. Cancer
  • [Language] ENG
  • [Databank-accession-numbers] GENBANK/ AY940729/ AY940730/ AY940731
  • [Grant] United States / NCI NIH HHS / CA / R01 CA058443; United States / NCI NIH HHS / CA / CA58443; United States / NHLBI NIH HHS / HL / HL64119
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / RNA, Messenger; 63231-63-0 / RNA; 9035-58-9 / Thromboplastin
  •  go-up   go-down


40. Scudiere JR, Shi C, Hruban RH, Herman JM, Fishman EK, Schulick RD, Wolfgang CL, Makary MA, Thornton K, Montgomery E, Horton KM: Sclerosing mesenteritis involving the pancreas: a mimicker of pancreatic cancer. Am J Surg Pathol; 2010 Apr;34(4):447-53
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Five of these 6 patients were originally thought to have a primary pancreatic neoplasm.
  • A dramatic response to immunosuppressive therapy is illustrated by the case of a 46-year-old woman who presented with the presumptive diagnosis of an unresectable pancreatic cancer.

  • Genetic Alliance. consumer health - Pancreatic cancer.
  • Genetic Alliance. consumer health - Sclerosing mesenteritis.
  • MedlinePlus Health Information. consumer health - Pancreatic Cancer.
  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. TAMOXIFEN .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Am Surg. 2008 Aug;74(8):743-5 [18705578.001]
  • [Cites] Mod Pathol. 2009 Jan;22(1):66-70 [18836421.001]
  • [Cites] Acta Radiol. 2008 Sep;49(7):744-6 [19143059.001]
  • [Cites] AJR Am J Roentgenol. 2000 Feb;174(2):427-31 [10658720.001]
  • [Cites] Eur J Gastroenterol Hepatol. 1999 Nov;11(11):1323-9 [10563549.001]
  • [Cites] Am J Surg Pathol. 2002 Oct;26(10):1296-301 [12360044.001]
  • [Cites] Am J Surg Pathol. 2003 Jan;27(1):110-20 [12502933.001]
  • [Cites] Radiographics. 2003 Nov-Dec;23(6):1561-7 [14615565.001]
  • [Cites] Surgery. 1977 Feb;81(2):203-11 [835091.001]
  • [Cites] Dis Colon Rectum. 1987 Dec;30(12):962-6 [3319450.001]
  • [Cites] Dig Dis Sci. 1996 Apr;41(4):684-8 [8674388.001]
  • [Cites] Am J Surg Pathol. 1997 Apr;21(4):392-8 [9130985.001]
  • [Cites] Am J Gastroenterol. 1997 Jun;92(6):1059-60 [9177537.001]
  • [Cites] Gastroenterology. 1998 Jun;114(6):1313-7 [9609769.001]
  • [Cites] Endoscopy. 1998 Oct;30(8):S94-5 [9865579.001]
  • [Cites] AJR Am J Roentgenol. 1999 Mar;172(3):625-9 [10063848.001]
  • [Cites] Pancreas. 1999 Apr;18(3):316-21 [10206491.001]
  • [Cites] Dis Colon Rectum. 2004 Nov;47(11):1974-7 [15622594.001]
  • [Cites] Australas Radiol. 2005 Feb;49(1):84-7 [15727618.001]
  • [Cites] Radiographics. 2006 Jan-Feb;26(1):245-64 [16418255.001]
  • [Cites] Eur J Gastroenterol Hepatol. 2006 Dec;18(12):1285-7 [17099377.001]
  • [Cites] Clin Gastroenterol Hepatol. 2007 May;5(5):589-96; quiz 523-4 [17478346.001]
  • [Cites] CA Cancer J Clin. 2008 Mar-Apr;58(2):71-96 [18287387.001]
  • [Cites] J Gastrointestin Liver Dis. 2008 Mar;17(1):91-4 [18392253.001]
  • (PMID = 20351487.001).
  • [ISSN] 1532-0979
  • [Journal-full-title] The American journal of surgical pathology
  • [ISO-abbreviation] Am. J. Surg. Pathol.
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / CA062924-149002; United States / NCI NIH HHS / CA / P50 CA062924; United States / NCI NIH HHS / CA / CA62924; United States / NCI NIH HHS / CA / P50 CA062924-149002
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Glucocorticoids; 094ZI81Y45 / Tamoxifen
  • [Other-IDs] NLM/ NIHMS181132; NLM/ PMC2861335
  •  go-up   go-down


41. Hirano H, Yoshida T, Sakamoto T, Yoshimura H, Fukuoka M, Tachibana S, Saito H, Ohkubo E, Nakasho K, Nishigami T: Pulmonary pleomorphic carcinoma producing hCG. Pathol Int; 2007 Oct;57(10):698-702
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • On histology the tumor consisted mostly of intermingled spindle and polygonal cells, while evidence of poorly differentiated adenocarcinoma was seen in a few areas.
  • A diagnosis of PC was made due to hCG expression in approximately 20% of the spindle and polygonal cells on immunohistology.
  • Six months after the operation metastasis to the liver and adrenal gland was seen on CT.
  • [MeSH-major] Adenocarcinoma / metabolism. Biomarkers, Tumor / metabolism. Carcinoma, Non-Small-Cell Lung / metabolism. Carcinosarcoma / metabolism. Chorionic Gonadotropin / metabolism. Lung Neoplasms / metabolism

  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17803660.001).
  • [ISSN] 1320-5463
  • [Journal-full-title] Pathology international
  • [ISO-abbreviation] Pathol. Int.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Australia
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Chorionic Gonadotropin
  •  go-up   go-down


42. Takamori H, Hiraoka T, Kanemitsu K, Tsuji T, Hamada C, Baba H: Identification of prognostic factors associated with early mortality after surgical resection for pancreatic cancer--under-analysis of cumulative survival curve. World J Surg; 2006 Feb;30(2):213-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Eighteen SSG patients (58.1 %) died of hepatic metastases, whereas no LSG patients died of hepatic metastases.
  • CONCLUSIONS: The high hazard rate in the early postoperative period was closely linked with death due to liver metastases.
  • [MeSH-major] Adenocarcinoma / mortality. Adenocarcinoma / surgery. Cause of Death. Pancreatectomy / methods. Pancreatic Neoplasms / mortality. Pancreatic Neoplasms / surgery
  • [MeSH-minor] Adult. Age Factors. Aged. Analysis of Variance. Cohort Studies. Female. Humans. Male. Middle Aged. Neoplasm Staging. Postoperative Complications / diagnosis. Postoperative Complications / epidemiology. Postoperative Period. Probability. Prognosis. Proportional Hazards Models. Retrospective Studies. Risk Assessment. Sex Factors. Survival Analysis

  • Genetic Alliance. consumer health - Pancreatic cancer.
  • MedlinePlus Health Information. consumer health - Pancreatic Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Br J Surg. 1994 Jan;81(1):102-7 [7906180.001]
  • [Cites] World J Surg. 2003 Mar;27(3):324-9 [12607060.001]
  • [Cites] Biochem Biophys Res Commun. 1991 Sep 16;179(2):713-9 [1716885.001]
  • [Cites] Int J Pancreatol. 1990 Aug-Nov;7(1-3):201-7 [1964472.001]
  • [Cites] Ann Surg. 2004 Jun;239(6):763-9; discussion 769-71 [15166955.001]
  • [Cites] Br J Cancer. 1990 Oct;62(4):607-13 [2121220.001]
  • [Cites] J Gastrointest Surg. 2000 Nov-Dec;4(6):567-79 [11307091.001]
  • [Cites] Pancreas. 2000 Jul;21(1):52-6 [10881932.001]
  • [Cites] Oncogene. 1999 Aug 12;18(32):4554-63 [10467400.001]
  • [Cites] Surgery. 1992 May;111(5):489-94 [1317976.001]
  • [Cites] Hepatogastroenterology. 2004 Sep-Oct;51(59):1500-3 [15362786.001]
  • [Cites] Pancreas. 2004 Oct;29(3):188-92 [15367884.001]
  • [Cites] Ann Surg. 1996 May;223(5):506-11; discussion 511-2 [8651741.001]
  • [Cites] Cancer Res. 2001 Jun 15;61(12):4923-32 [11406572.001]
  • [Cites] Hepatogastroenterology. 1996 May-Jun;43(9):748-55 [8799425.001]
  • (PMID = 16425074.001).
  • [ISSN] 0364-2313
  • [Journal-full-title] World journal of surgery
  • [ISO-abbreviation] World J Surg
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


43. Kasper HU, Drebber U, Dries V, Dienes HP: [Liver metastases: incidence and histogenesis]. Z Gastroenterol; 2005 Oct;43(10):1149-57
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Liver metastases: incidence and histogenesis].
  • Metastases are the most common malignant tumors of the liver.
  • In the files of the Institute of Pathology of the University of Cologne 12,161 liver tissue cases are registered.
  • Liver metastases of solid tumors were the largest group of the neoplasias with 611 cases (5.0%) followed by hepatocellular carcinoma (380 cases; 3.1%).
  • Other entities were rare and include cholangiolar carcinoma (0.5%), vascular tumors (0.4%), lymphomas (0.4%), focal nodular hyperplasias (0.36%) and liver cell adenomas (0.23%).
  • Neuroendocrine carcinomas are the second largest group with 16% of liver filiae.
  • The gross findings, the histology, the differential diagnosis including immunohistochemistry and the value of the liver biopsy is discussed.
  • [MeSH-major] Adenocarcinoma / pathology. Adenocarcinoma / secondary. Carcinoma, Hepatocellular / pathology. Carcinoma, Neuroendocrine / pathology. Carcinoma, Neuroendocrine / secondary. Liver / pathology. Liver Neoplasms / pathology. Liver Neoplasms / secondary. Registries
  • [MeSH-minor] Adolescent. Adult. Age Factors. Aged. Aged, 80 and over. Biopsy. Breast Neoplasms. Child. Child, Preschool. Colorectal Neoplasms. Diagnosis, Differential. Female. Germany. Humans. Immunohistochemistry. Incidence. Infant. Lung Neoplasms. Male. Middle Aged. Pancreatic Neoplasms. Sex Factors

  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16220456.001).
  • [ISSN] 0044-2771
  • [Journal-full-title] Zeitschrift für Gastroenterologie
  • [ISO-abbreviation] Z Gastroenterol
  • [Language] ger
  • [Publication-type] Comparative Study; English Abstract; Journal Article; Review
  • [Publication-country] Germany
  • [Number-of-references] 45
  •  go-up   go-down


44. Wang C, Zhou XG: [Role of CDX2 immunostaining in diagnosis of gastrointestinal adenocarcinoma]. Zhonghua Bing Li Xue Za Zhi; 2006 Apr;35(4):228-31
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Role of CDX2 immunostaining in diagnosis of gastrointestinal adenocarcinoma].
  • OBJECTIVE: To study the expression of CDX2 in normal and tumor tissues, and to evaluate the value of CDX2 immunostaining in the diagnosis of gastrointestinal adenocarcinoma.
  • RESULTS: CDX2 was strongly expressed in surface epithelium of 13 samples of normal intestine and in ductal epithelium of 8 samples of normal pancreas, as well as in 47 samples (92.2%) of colonic adenocarcinoma and 58 samples (66.9%) of gastric adenocarcinoma.
  • The positivity rates were as follows: ovarian mucinous adenocarcinoma 15.6% (10/64), pancreatic cancer 33.3% (3/9), thyroid cancer 27.3% (3/11) and extrahepatic biliary cancer 25% (4/16).
  • On the other hand, primary tumors of breast, prostate, kidney, adrenal and liver were negative for CDX2.
  • CONCLUSIONS: CDX2 is expressed mainly in normal epithelium of intestinal tract and small pancreatic ducts, as well as in primary adenocarcinoma of gastrointestinal tract.
  • CDX2 may thus play an important role in distinguishing primary non-intestinal adenocarcinoma from metastatic adenocarcinoma of gastric or colorectal primary.
  • [MeSH-major] Adenocarcinoma / diagnosis. Gastrointestinal Neoplasms / diagnosis. Homeodomain Proteins / metabolism
  • [MeSH-minor] Colonic Neoplasms / diagnosis. Colonic Neoplasms / metabolism. Female. Gastrointestinal Tract / chemistry. Gastrointestinal Tract / pathology. Humans. Immunohistochemistry. Male. Stomach Neoplasms / diagnosis. Stomach Neoplasms / metabolism. Tissue Array Analysis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16776981.001).
  • [ISSN] 0529-5807
  • [Journal-full-title] Zhonghua bing li xue za zhi = Chinese journal of pathology
  • [ISO-abbreviation] Zhonghua Bing Li Xue Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  • [Chemical-registry-number] 0 / CDX2 protein, human; 0 / Homeodomain Proteins
  •  go-up   go-down


45. Nishimura R, Teramoto N, Tanada M, Kurita A, Mogami H: Inflammatory pseudotumor of the liver associated with malignant disease: report of two cases and a review of the literature. Virchows Arch; 2005 Sep;447(3):660-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Inflammatory pseudotumor of the liver associated with malignant disease: report of two cases and a review of the literature.
  • Two cases of inflammatory pseudotumor (IPT) of the liver associated with gastrointestinal tract cancer are reported.
  • In addition, the etiological correlation between IPT and abscesses of the liver in cancer patients is discussed.
  • The first patient was a 63-year-old woman who underwent distal gastrectomy and partial hepatectomy under a diagnosis of stomach cancer with liver metastasis.
  • The second patient was a 66-year-old man who had undergone surgery for rectal cancer 6 years previously and underwent partial hepatectomy under a diagnosis of metastasis of rectal cancer to the liver.
  • The gastric cancer was a papillary adenocarcinoma limited to the mucosa, and the rectal cancer was a moderately differentiated adenocarcinoma limited to the subserosa.
  • The resected liver tumor in the first case measured 5.5 x 5.0 x 4.0 cm and was 2.5 x 1.9 x 1.6 cm in the second.
  • Obliterating phlebitis suggesting infection via the portal vein was seen in the adjacent liver tissue in both cases.
  • According to previous cases reported in the literature, there are three types of cancers associated with hepatic IPT: gastrointestinal tract cancer, biliary tract cancer, and cancers that need strong systemic chemotherapy.
  • The underlying cancer types of IPT of the liver are almost similar to those associated with pyogenic liver abscesses suggesting the etiological correlation between IPT and abscesses of the liver.
  • [MeSH-major] Adenocarcinoma / complications. Adenocarcinoma / pathology. Granuloma, Plasma Cell / complications. Granuloma, Plasma Cell / pathology. Liver Diseases / pathology
  • [MeSH-minor] Aged. Female. Humans. Immunohistochemistry. Liver Abscess / complications. Liver Abscess / pathology. Male. Middle Aged. Rectal Neoplasms / pathology. Rectal Neoplasms / surgery. Stomach Neoplasms / pathology. Stomach Neoplasms / surgery

  • Genetic Alliance. consumer health - Liver Disease.
  • MedlinePlus Health Information. consumer health - Liver Diseases.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Arch Surg. 1993 Dec;128(12):1358-64; discussion 1364 [8250709.001]
  • [Cites] Intern Med. 1998 Jun;37(6):542-5 [9678690.001]
  • [Cites] Arch Surg. 1998 Mar;133(3):242-5 [9517733.001]
  • [Cites] Am J Surg Pathol. 1993 Mar;17(3):231-8 [8382011.001]
  • [Cites] Am J Surg Pathol. 1996 Jun;20(6):747-53 [8651355.001]
  • [Cites] Surg Today. 2000;30(6):530-3 [10883465.001]
  • [Cites] Am J Surg Pathol. 2001 Jun;25(6):761-8 [11395553.001]
  • [Cites] Am J Gastroenterol. 1991 Feb;86(2):238-40 [1992642.001]
  • [Cites] AJR Am J Roentgenol. 1999 Oct;173(4):1049-54 [10511176.001]
  • [Cites] J Gastroenterol. 2000;35(4):304-9 [10777162.001]
  • [Cites] Pathol Res Pract. 1997;193(7):519-25; discussion 526 [9342759.001]
  • [Cites] Cancer. 1990 Apr 1;65(7):1583-90 [2155699.001]
  • [Cites] J Gastroenterol. 1995 Jun;30(3):408-12 [7647910.001]
  • [Cites] Am J Surg Pathol. 2001 Jun;25(6):721-31 [11395549.001]
  • [Cites] Eur J Pediatr Surg. 1999 Oct;9(5):343-6 [10584199.001]
  • [Cites] Clin Diagn Lab Immunol. 2004 Jan;11(1):123-30 [14715558.001]
  • [Cites] Med Pediatr Oncol. 1992;20(2):172-5 [1310343.001]
  • [Cites] Eur Radiol. 2002 Oct;12(10):2484-7 [12271389.001]
  • (PMID = 15968548.001).
  • [ISSN] 0945-6317
  • [Journal-full-title] Virchows Archiv : an international journal of pathology
  • [ISO-abbreviation] Virchows Arch.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Germany
  •  go-up   go-down


46. Gütgemann I, Standop J, Fischer HP: Primary intrahepatic malignant mesothelioma of epithelioid type. Virchows Arch; 2006 May;448(5):655-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Primary intrahepatic malignant mesothelioma of epithelioid type.
  • [MeSH-major] Liver Neoplasms / pathology. Mesothelioma / pathology
  • [MeSH-minor] Adenocarcinoma / pathology. Cholangiocarcinoma / pathology. Diagnosis, Differential. Epithelioid Cells / pathology. Humans. Immunohistochemistry. Male. Microscopy, Electron, Transmission. Middle Aged

  • Genetic Alliance. consumer health - Mesothelioma, malignant.
  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • MedlinePlus Health Information. consumer health - Mesothelioma.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Am J Clin Pathol. 1989 Nov;92(5):566-71 [2479255.001]
  • [Cites] Magn Reson Imaging. 2003 Nov;21(9):1091-3 [14684216.001]
  • [Cites] Science. 1990 Aug 24;249(4971):844 [2168090.001]
  • [Cites] Cancer. 1983 Nov 1;52(9):1662-5 [6193863.001]
  • [Cites] Acta Cytol. 1995 Jul-Aug;39(4):721-4 [7631546.001]
  • [Cites] Ann Diagn Pathol. 1998 Feb;2(1):19-24 [9845719.001]
  • [Cites] APMIS. 2002 Nov;110(11):789-94 [12588419.001]
  • [Cites] Cancer. 1989 Sep 1;64(5):1096-102 [2474368.001]
  • [Cites] Pathologe. 2004 Sep;25(5):349-55 [15205913.001]
  • [Cites] Virchows Arch A Pathol Anat Histopathol. 1990;417(5):443-7 [2122588.001]
  • [Cites] Surg Today. 1998;28(9):929-31 [9744402.001]
  • [Cites] Int J Surg Pathol. 2004 Jan;12(1):87-91 [14765281.001]
  • (PMID = 16541281.001).
  • [ISSN] 0945-6317
  • [Journal-full-title] Virchows Archiv : an international journal of pathology
  • [ISO-abbreviation] Virchows Arch.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Germany
  •  go-up   go-down


47. Unal B, Bilgili Y, Kara S, Erdal HH: Transient arterial enhancement in a hepatic peritumoral fat-spared area. Diagn Interv Radiol; 2005 Sep;11(3):159-62
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Transient arterial enhancement in a hepatic peritumoral fat-spared area.
  • Focal sparing in diffusely fatty liver is also a well recognized entity.
  • However, both conditions occasionally create problems in the diagnosis of hepatic mass lesions.
  • In addition, focal sparing can be the only clue for a space occupying lesion in the liver.
  • We present here the ultrasonography and magnetic resonance imaging findings of a case with liver metastasis from pancreas cancer which caused a wedge-shaped fat-spared enhancing area on dynamic magnetic resonance imaging.
  • [MeSH-major] Adenocarcinoma / diagnosis. Fatty Liver / pathology. Liver Neoplasms / diagnosis. Pancreatic Neoplasms / diagnosis
  • [MeSH-minor] Abdominal Pain / etiology. Diagnosis, Differential. Humans. Magnetic Resonance Imaging. Male. Middle Aged. Neoplasm Metastasis. Tomography, X-Ray Computed

  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • MedlinePlus Health Information. consumer health - Pancreatic Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16206058.001).
  • [ISSN] 1305-3825
  • [Journal-full-title] Diagnostic and interventional radiology (Ankara, Turkey)
  • [ISO-abbreviation] Diagn Interv Radiol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Turkey
  •  go-up   go-down


48. Girelli CM, Porta P, Malacrida V, Barzaghi F, Rocca F: Clinical outcome of patients examined by capsule endoscopy for suspected small bowel Crohn's disease. Dig Liver Dis; 2007 Feb;39(2):148-54
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • AIM AND METHODS: To verify the accuracy of capsule endoscopy in a cohort of patients with suspected Crohn's disease of the small bowel, taking as 'gold standard' the final diagnosis made after a long follow-up.
  • Three had surgery (Group A) and Crohn's disease was confirmed in two; the remainder had ileal adenocarcinoma in a pathological context of chronic inflammation.
  • [MeSH-major] Capsule Endoscopy. Crohn Disease / diagnosis. Ileitis / diagnosis

  • Genetic Alliance. consumer health - Crohn Disease.
  • MedlinePlus Health Information. consumer health - Crohn's Disease.
  • ClinicalTrials.gov. clinical trials - ClinicalTrials.gov .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] Dig Liver Dis. 2007 Feb;39(2):154-5 [17196451.001]
  • (PMID = 17196893.001).
  • [ISSN] 1590-8658
  • [Journal-full-title] Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
  • [ISO-abbreviation] Dig Liver Dis
  • [Language] eng
  • [Publication-type] Clinical Trial; Journal Article
  • [Publication-country] Netherlands
  •  go-up   go-down


49. Ychou M, Azria D, Menkarios C, Faurous P, Quenet F, Saint-Aubert B, Rouanet P, Pèlegrin M, Bascoul-Mollevi C, Guerreau D, Saccavini JC, Mach JP, Artus JC, Pèlegrin A: Adjuvant radioimmunotherapy trial with iodine-131-labeled anti-carcinoembryonic antigen monoclonal antibody F6 F(ab')2 after resection of liver metastases from colorectal cancer. Clin Cancer Res; 2008 Jun 1;14(11):3487-93
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Adjuvant radioimmunotherapy trial with iodine-131-labeled anti-carcinoembryonic antigen monoclonal antibody F6 F(ab')2 after resection of liver metastases from colorectal cancer.
  • PURPOSE: To evaluate the feasibility of radioimmunotherapy (RIT) with radiolabeled anti-carcinoembryonic antigen antibodies after complete resection of liver metastases (LM) from colorectal cancer.
  • 131I-F(ab')2 uptake was analyzed using direct radioactivity counting, and tumor-to-normal liver ratios were recorded.
  • Ten patients with tumor-to-normal liver ratios of >5 and three others were treated with a therapeutic injection [180-200 mCi 131I/50 mg F(ab')2] 30 to 64 days after surgery.
  • No human anti-mouse antibody response was observed after the diagnosis dose; however, 10 of the 13 treated patients developed human anti-mouse antibody approximately 3 months later.
  • Two treated patients presented extrahepatic metastases at the time of RIT (one bone and one abdominal node) and two relapsed within 3 months of RIT (one in the lung and the other in the liver).
  • [MeSH-major] Adenocarcinoma / radiotherapy. Antibodies, Monoclonal / therapeutic use. Immunoglobulin Fab Fragments / therapeutic use. Iodine Radioisotopes / therapeutic use. Liver Neoplasms / radiotherapy. Radioimmunotherapy / methods

  • Genetic Alliance. consumer health - Colorectal Cancer.
  • Genetic Alliance. consumer health - Liver cancer.
  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • HAL archives ouvertes. Full text from .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Int J Cancer. 1998 Feb 9;75(4):615-9 [9466665.001]
  • [Cites] Br J Surg. 1997 Jul;84(7):977-80 [9240140.001]
  • [Cites] Ann Surg. 1998 Dec;228(6):756-62 [9860474.001]
  • [Cites] Langenbecks Arch Surg. 1999 Jun;384(3):243-9 [10437612.001]
  • [Cites] BMC Cancer. 2004 Oct 15;4:75 [15488142.001]
  • [Cites] N Engl J Med. 2005 Feb 17;352(7):734-5 [15716576.001]
  • [Cites] Clin Cancer Res. 2005 Jul 1;11(13):4637-8 [16000553.001]
  • [Cites] J Clin Oncol. 2005 Sep 20;23(27):6763-70 [16170184.001]
  • [Cites] Am J Clin Oncol. 2005 Dec;28(6):547-54 [16317262.001]
  • [Cites] J Clin Oncol. 2006 Feb 10;24(5):823-34 [16380412.001]
  • [Cites] J Clin Oncol. 2006 Nov 1;24(31):4976-82 [17075115.001]
  • [Cites] Ann Surg Oncol. 2007 Sep;14(9):2577-90 [17570017.001]
  • [Cites] Clin Cancer Res. 2000 Feb;6(2):406-14 [10690517.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2000 Apr 1;47(1):13-47 [10758303.001]
  • [Cites] CA Cancer J Clin. 1999 Jul-Aug;49(4):231-55 [11198884.001]
  • [Cites] J Clin Oncol. 2001 Oct 1;19(19):3918-28 [11579112.001]
  • [Cites] N Engl J Med. 2002 Jan 24;346(4):235-42 [11807147.001]
  • [Cites] Hepatogastroenterology. 2001 Nov-Dec;48(42):1685-91 [11813601.001]
  • [Cites] Cancer. 2002 Feb 15;94(4 Suppl):1373-81 [11877768.001]
  • [Cites] J Clin Oncol. 2002 Mar 15;20(6):1499-505 [11896097.001]
  • [Cites] J Clin Oncol. 2002 May 15;20(10):2453-63 [12011122.001]
  • [Cites] Clin Cancer Res. 2003 Dec 1;9(16 Pt 1):5842-52 [14676105.001]
  • [Cites] Cancer Res. 1989 Sep 1;49(17):4852-8 [2474375.001]
  • [Cites] J Clin Oncol. 1990 Nov;8(11):1894-906 [2230877.001]
  • [Cites] Eur J Cancer. 1993;29A(8):1105-11 [8518021.001]
  • [Cites] J Clin Oncol. 1994 Aug;12(8):1561-71 [8040668.001]
  • [Cites] Surgery. 1994 Oct;116(4):703-10; discussion 710-1 [7940169.001]
  • [Cites] J Nucl Med. 1995 Mar;36(3):420-9 [7884504.001]
  • [Cites] World J Surg. 1995 Jan-Feb;19(1):59-71 [7740812.001]
  • [Cites] World J Surg. 1995 Mar-Apr;19(2):252-63 [7754632.001]
  • [Cites] J Nucl Med. 1995 Oct;36(10):1910-2 [7562063.001]
  • [Cites] J Clin Oncol. 1997 Mar;15(3):938-46 [9060531.001]
  • [Cites] J Nucl Med. 1997 Mar;38(3):409-18 [9074529.001]
  • [Cites] Hepatogastroenterology. 1998 May-Jun;45(21):805-11 [9684138.001]
  • (PMID = 18519781.001).
  • [ISSN] 1078-0432
  • [Journal-full-title] Clinical cancer research : an official journal of the American Association for Cancer Research
  • [ISO-abbreviation] Clin. Cancer Res.
  • [Language] eng
  • [Publication-type] Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antibodies, Monoclonal; 0 / Carcinoembryonic Antigen; 0 / Immunoglobulin Fab Fragments; 0 / Iodine Radioisotopes
  • [Other-IDs] NLM/ HALMS292535; NLM/ PMC2695247
  •  go-up   go-down


50. Landen S, Ballet T, Kessler R, Badic B, Costache M, Dobos S, Delugeau V: Tuberculosis diagnosed after major hepatectomy for suspected malignancy. Acta Chir Belg; 2010 Mar-Apr;110(2):221-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • A patient with a history of surgery and adjuvant chemotherapy 2 1/2 years previously for Dukes C colonic adenocarcinoma was diagnosed with a focal liver lesion on follow-up examinations.
  • Positron emission tomography scan showed intense uptake, corroborating the diagnosis of a colonic liver metastasis.
  • In developed countries liver tuberculosis remains extremely rare, particularly the macronodular form.
  • The diagnosis is often made only after hepatectomy for suspected malignancy.
  • The increasing use of potent anticancer chemotherapy may favour the reactivation of quiescent tuberculosis, posing a difficult differential diagnosis with liver metastases.
  • [MeSH-major] Hepatectomy. Liver Neoplasms / diagnosis. Tuberculosis, Hepatic / diagnosis
  • [MeSH-minor] Adenocarcinoma / complications. Aged. Colonic Neoplasms / complications. Diagnosis, Differential. Humans. Male

  • Genetic Alliance. consumer health - Tuberculosis.
  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20514839.001).
  • [ISSN] 0001-5458
  • [Journal-full-title] Acta chirurgica Belgica
  • [ISO-abbreviation] Acta Chir. Belg.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Belgium
  •  go-up   go-down


51. Zhang J, Li XJ, Teng HH: [Colon hepatoid adenocarcinoma with live metastasis]. Zhonghua Bing Li Xue Za Zhi; 2005 Apr;34(4):249-50
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Colon hepatoid adenocarcinoma with live metastasis].
  • [MeSH-major] Adenocarcinoma / secondary. Carcinoma, Hepatocellular / secondary. Colonic Neoplasms / pathology. Liver Neoplasms / secondary
  • [MeSH-minor] Carcinoembryonic Antigen / metabolism. Colectomy. Diagnosis, Differential. Humans. Keratin-18 / metabolism. Male. Middle Aged. alpha-Fetoproteins / metabolism

  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16091187.001).
  • [ISSN] 0529-5807
  • [Journal-full-title] Zhonghua bing li xue za zhi = Chinese journal of pathology
  • [ISO-abbreviation] Zhonghua Bing Li Xue Za Zhi
  • [Language] chi
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] China
  • [Chemical-registry-number] 0 / Carcinoembryonic Antigen; 0 / Keratin-18; 0 / alpha-Fetoproteins
  •  go-up   go-down


52. Mori H, Shibuya T, Osada T, Kodani T, Higashihara Y, Serizawa N, Kato J, Nagahara A, Ogihara T, Watanabe S: Response to chemotherapy in a case of gastric adenocarcinoma producing granulocyte colony-stimulating factor. Med Sci Monit; 2010 Oct;16(10):CS119-23
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Response to chemotherapy in a case of gastric adenocarcinoma producing granulocyte colony-stimulating factor.
  • Gastrointestinal endoscopy showed type 3 gastric cancer, and the biopsy specimens were histologically proven to include moderately to well differentiated adenocarcinoma with positive expression of G-CSF.
  • Abdominal computed tomography showed a lymph node lesion and multiple hepatic metastatic lesions.
  • We treated the patient with 3 chemotherapy regimens, and he survived for almost 2 years after diagnosis.
  • This unusual gastric cancer should be treated as soon as possible after diagnosis.
  • [MeSH-major] Adenocarcinoma / metabolism. Granulocyte Colony-Stimulating Factor / biosynthesis. Stomach Neoplasms / drug therapy. Stomach Neoplasms / metabolism
  • [MeSH-minor] Aged. Antineoplastic Combined Chemotherapy Protocols. Bone Marrow / pathology. Humans. Leukocytosis / drug therapy. Leukocytosis / etiology. Liver Neoplasms / pathology. Liver Neoplasms / secondary. Lymphatic Metastasis. Male. Treatment Outcome

  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20885355.001).
  • [ISSN] 1643-3750
  • [Journal-full-title] Medical science monitor : international medical journal of experimental and clinical research
  • [ISO-abbreviation] Med. Sci. Monit.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Poland
  • [Chemical-registry-number] 143011-72-7 / Granulocyte Colony-Stimulating Factor
  •  go-up   go-down


53. Imai K, Mitsunaga A, Araida T, Onizawa S, Shin Y, Nakano M: Advanced gastric cancer associated with nodular gastritis in a young patient. Clin J Gastroenterol; 2009 Aug;2(4):275-278
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Biopsy of the ulcerative lesion yielded a diagnosis of poorly differentiated adenocarcinoma.
  • A distal gastrectomy was performed on the basis of a diagnosis of gastric cancer associated with nodular gastritis.
  • The pathological findings revealed poorly differentiated adenocarcinoma showing invasive growth with fibrosis on the corpus and large and superficial lymphoid follicles on the miliary nodules at the antrum.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Gastroenterol Hepatol. 2003 Dec;18(12):1384-91 [14675267.001]
  • [Cites] Dig Dis Sci. 2003 May;48(5):968-75 [12772798.001]
  • [Cites] Dig Liver Dis. 2002 Nov;34(11):819-20 [12546520.001]
  • [Cites] J Pediatr Gastroenterol Nutr. 1990 Oct;11(3):310-6 [2246711.001]
  • [Cites] J Natl Cancer Inst. 2000 Dec 6;92(23):1881-8 [11106679.001]
  • [Cites] Gut. 1996 Dec;39(6):787-94 [9038658.001]
  • [Cites] N Engl J Med. 2001 Sep 13;345(11):784-9 [11556297.001]
  • (PMID = 26192424.001).
  • [ISSN] 1865-7257
  • [Journal-full-title] Clinical journal of gastroenterology
  • [ISO-abbreviation] Clin J Gastroenterol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Japan
  • [Keywords] NOTNLM ; Gastric cancer / Helicobacter pylori / Nodular gastritis
  •  go-up   go-down


54. Albores-Saavedra J, Henson DE, Moran-Portela D, Lino-Silva S: Cribriform carcinoma of the gallbladder: a clinicopathologic study of 7 cases. Am J Surg Pathol; 2008 Nov;32(11):1694-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Three patients with high nuclear grade cribriform carcinomas died as a result of the tumor which infiltrated the liver by direct extension; 3 patients with low nuclear grade cribriform carcinomas confined to the gallbladder wall survived 4 to 7 years after cholecystectomy and 1 patient was lost to follow-up.
  • [MeSH-major] Adenocarcinoma / pathology. Gallbladder Neoplasms / pathology
  • [MeSH-minor] Adult. Aged. Breast Neoplasms / pathology. Diagnosis, Differential. Female. Humans. Immunohistochemistry. Male. Middle Aged

  • MedlinePlus Health Information. consumer health - Gallbladder Cancer.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18769339.001).
  • [ISSN] 1532-0979
  • [Journal-full-title] The American journal of surgical pathology
  • [ISO-abbreviation] Am. J. Surg. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


55. Fanni D, Nemolato S, Ganga R, Senes G, Gerosa C, Van Eyken P, Geboes K, Faa G: Cytokeratin 20-positive hepatocellular carcinoma. Eur J Histochem; 2009 Oct-Dec;53(4):269-73
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The differential diagnosis between hepatocellular carcinoma (HCC), cholangiocarcinoma (CC) and metastatic colorectal adenocarcinoma (MCA) may be difficult when only based on morphology.
  • For this purpose immunohistochemical analyses are often required, utilizing antibodies directed against CK8- 18, Hep-Par1, glypican 3, CK7, CK19, CK20.
  • Ultrasonography revealed two nodular areas in the right liver lobe.
  • Liver needle biopsy revealed micro-macronodular cirrhosis associated with HCC with trabecular and pseudoglandular patterns.
  • Immunohistochemically, tumour cells were diffusely positive for CK8- 18 and also diffusely immunostained by glypican 3 and Hep- Par1.
  • The tumor behaved aggressively, with a rapid diffusion to the whole liver.
  • These findings underline that the interpretation of the expression of CK20 alone in the differential diagnosis among HCC, CC and MCA should be done with caution because a diffuse immunoreactivity for CK20 alone may not rule out the diagnosis of HCC.
  • [MeSH-major] Carcinoma, Hepatocellular. Keratin-20 / metabolism. Liver Neoplasms
  • [MeSH-minor] Aged. Diagnosis, Differential. Fatal Outcome. Follow-Up Studies. Humans. Immunohistochemistry. Male

  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20007098.001).
  • [ISSN] 1121-760X
  • [Journal-full-title] European journal of histochemistry : EJH
  • [ISO-abbreviation] Eur J Histochem
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Italy
  • [Chemical-registry-number] 0 / Keratin-20
  •  go-up   go-down


56. Lee SA, Choi SR, Jang JS, Lee JH, Roh MH, Kim SO, Kim MC, Kim SJ, Jeong JS: Expression of VEGF, EGFR, and IL-6 in gastric adenomas and adenocarcinomas by endoscopic submucosal dissection. Dig Dis Sci; 2010 Jul;55(7):1955-63
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Despite recent medical advancements, gastric adenoma or adenocarcinoma remains a considerable therapeutic challenge.
  • Endoscopic submucosal dissection (ESD) is a more recent approach that is now commonly used for radical resection of gastric adenoma and adenocarcinoma.
  • AIM AND METHODS: The expression of vascular endothelial growth factor (VEGF), epidermal growth factor receptor (EGFR), and interleukin-6 (IL-6) are related to the prognosis of gastric adenocarcinoma.
  • However, the expression of these factors in gastric adenoma/adenocarcinoma following ESD has not been clearly evaluated.
  • Here, we report on our study of the expression of VEGF, EGFR, and IL-6 by immunohistochemical staining in extracted tissue from adenoma or adenocarcinoma of the stomach by ESD and subsequent evaluation of the correlation of VEGF, EGFR, and IL-6 with other clinicopathological parameters.
  • The patient cohort consisted of 102 patients with adenoma or adenocarcinoma of the stomach.
  • RESULTS: Immunohistochemical staining for VEGF and IL-6 was significantly higher in both high grade dysplasia and adenocarcinoma than in low grade dysplasia (P < 0.05).
  • Histological differentiation of adenocarcinoma was related to IL-6 expression (P = 0.028).
  • CONCLUSION: The immunohistochemical expression of IL-6 and VEGF can be considered to be useful for clinical diagnosis and follow-up of adenoma or adenocarcinoma of the stomach.
  • [MeSH-major] Adenocarcinoma / pathology. Adenoma / pathology. Interleukin-6 / metabolism. Receptor, Epidermal Growth Factor / metabolism. Stomach Neoplasms / pathology. Vascular Endothelial Growth Factor A / metabolism

  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Br J Cancer. 2004 Jan 12;90(1):206-15 [14710231.001]
  • [Cites] Virchows Arch. 2004 Apr;444(4):324-31 [14991403.001]
  • [Cites] J Gastroenterol Hepatol. 2002 Nov;17(11):1165-9 [12453275.001]
  • [Cites] J Pathol. 2000 Jul;191(3):239-44 [10878544.001]
  • [Cites] Mol Cancer Ther. 2007 Mar;6(3):1123-32 [17363505.001]
  • [Cites] Cancer Res. 1990 Mar 15;50(6):1774-8 [2155059.001]
  • [Cites] J Biomed Sci. 2004 Jul-Aug;11(4):517-27 [15153787.001]
  • [Cites] Histol Histopathol. 2000 Apr;15(2):455-62 [10809364.001]
  • [Cites] Cancer. 1999 Jun 1;85(11):2340-6 [10357403.001]
  • [Cites] World J Surg. 2007 Jul;31(7):1458-68 [17516110.001]
  • [Cites] Clin Gastroenterol Hepatol. 2003 Nov;1(6):438-45 [15017643.001]
  • [Cites] J Clin Oncol. 2005 Apr 10;23(11):2445-59 [15753456.001]
  • [Cites] J Clin Oncol. 2003 Jul 15;21(14):2787-99 [12860957.001]
  • [Cites] Cancer. 1996 Mar 1;77(5):858-63 [8608475.001]
  • [Cites] Endocr Rev. 1997 Feb;18(1):4-25 [9034784.001]
  • [Cites] Ann Surg Oncol. 2003 Apr;10(3):234-41 [12679307.001]
  • [Cites] Dig Liver Dis. 2008 Jul;40(7):504-9 [18486572.001]
  • [Cites] Clin Cancer Res. 1999 Jul;5(7):1823-9 [10430087.001]
  • [Cites] J Natl Cancer Inst. 1990 Jan 3;82(1):4-6 [1688381.001]
  • [Cites] Mod Pathol. 2004 May;17(5):579-87 [15073595.001]
  • [Cites] Am J Obstet Gynecol. 1991 Apr;164(4):1038-42; discussion 1042-3 [2014824.001]
  • [Cites] J Surg Oncol. 2006 Dec 1;94(7):624-30 [17111394.001]
  • [Cites] Oncology. 1995 May-Jun;52(3):182-8 [7715901.001]
  • [Cites] J Clin Invest. 1989 Dec;84(6):2008-11 [2592570.001]
  • [Cites] Cancer. 1997 Jan 15;79(2):206-13 [9010092.001]
  • [Cites] Blood. 1989 Sep;74(4):1360-7 [2788466.001]
  • [Cites] Lancet. 1994 Dec 3;344(8936):1576-7 [7983975.001]
  • [Cites] J Urol. 1992 Dec;148(6):1778-81; discussion 1781-2 [1433606.001]
  • [Cites] J Clin Invest. 1989 Nov;84(5):1470-8 [2478587.001]
  • [Cites] Cancer. 1997 Jul 1;80(1):98-106 [9210714.001]
  • [Cites] Jpn J Cancer Res. 1994 Oct;85(10):1045-9 [7525523.001]
  • [Cites] J Surg Oncol. 2001 Oct;78(2):132-7 [11579392.001]
  • [Cites] Immunol Today. 1990 Dec;11(12):443-9 [2127356.001]
  • [Cites] Clin Cancer Res. 1997 Jun;3(6):861-5 [9815760.001]
  • [Cites] Carcinogenesis. 2000 Jun;21(6):1111-5 [10836997.001]
  • [Cites] Anticancer Res. 2006 Sep-Oct;26(5A):3547-50 [17094480.001]
  • [Cites] Am J Gastroenterol. 1996 Jul;91(7):1417-22 [8678006.001]
  • [Cites] J Urol. 1992 Sep;148(3):791-4 [1512827.001]
  • [Cites] Dig Liver Dis. 2008 Aug;40(8):641-9 [18424243.001]
  • [Cites] Science. 1988 Aug 5;241(4866):708-12 [3041594.001]
  • (PMID = 19757047.001).
  • [ISSN] 1573-2568
  • [Journal-full-title] Digestive diseases and sciences
  • [ISO-abbreviation] Dig. Dis. Sci.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Interleukin-6; 0 / Vascular Endothelial Growth Factor A; EC 2.7.10.1 / Receptor, Epidermal Growth Factor
  •  go-up   go-down


57. Sen E, Kaya A, Erol S, Savas I, Gonullu U: [Lung cancer in women: clinical features and factors related to survival]. Tuberk Toraks; 2008;56(3):266-74
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In the study group histopathological diagnosis were as follows; adenocarcinoma (44.9%), small cell lung cancer (SCLC) (19.3%), squamous cell (10.1%), non-small cell lung cancer (NSCLC) --undefined (22.0%), carsinoid tumors (2.8%), in non-smokers adenocarcinoma was significantly higher than smokers (44.9%/17.7%) (p< 0.001).
  • The most common sites of metastasis were bone (28.4%), liver (22.9%), and brain (11.9%), there were multiple metastasis in 10 patients.
  • [MeSH-minor] Adenocarcinoma / epidemiology. Adenocarcinoma / genetics. Adenocarcinoma / mortality. Adenocarcinoma / pathology. Bone Neoplasms / secondary. Brain Neoplasms / secondary. Carcinoma, Non-Small-Cell Lung / epidemiology. Carcinoma, Non-Small-Cell Lung / genetics. Carcinoma, Non-Small-Cell Lung / mortality. Carcinoma, Non-Small-Cell Lung / pathology. Carcinoma, Small Cell / epidemiology. Carcinoma, Small Cell / genetics. Carcinoma, Small Cell / mortality. Carcinoma, Small Cell / pathology. Carcinoma, Squamous Cell / epidemiology. Carcinoma, Squamous Cell / genetics. Carcinoma, Squamous Cell / mortality. Carcinoma, Squamous Cell / pathology. Female. Genetic Predisposition to Disease. Humans. Liver Neoplasms / secondary. Middle Aged. Multivariate Analysis. Neoplasm Staging. Prevalence. Prognosis. Risk Factors. Sex Factors. Survival Analysis. Turkey / epidemiology

  • Genetic Alliance. consumer health - Lung Cancer.
  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • MedlinePlus Health Information. consumer health - Smoking.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18932027.001).
  • [ISSN] 0494-1373
  • [Journal-full-title] Tüberküloz ve toraks
  • [ISO-abbreviation] Tuberk Toraks
  • [Language] tur
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Turkey
  •  go-up   go-down


58. Eser G, Karabacakoglu A, Karakose S, Eser C, Kayacetin E: Mangafodipir trisodium-enhanced magnetic resonance imaging for evaluation of pancreatic mass and mass-like lesions. World J Gastroenterol; 2006 Mar 14;12(10):1603-6
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Three of these 5 lesions were focal pancreatitis and the other 2 were adenocarcinoma.
  • MnDPDP facilitates staging of pancreatic tumors by detection of metastatic lesions in the liver.
  • In addition, diminished heteregenous uptake of MnDPDP in patients with pancreatitis may be helpful in differential diagnosis.
  • [MeSH-major] Contrast Media. Edetic Acid / analogs & derivatives. Magnetic Resonance Imaging / methods. Pancreatic Neoplasms / diagnosis. Pyridoxal Phosphate / analogs & derivatives
  • [MeSH-minor] Adenocarcinoma / diagnosis. Adult. Aged. Aged, 80 and over. Female. Humans. Liver Neoplasms / diagnosis. Liver Neoplasms / secondary. Male. Middle Aged. Neoplasm Staging. Pancreas / pathology. Pancreatitis / diagnosis

  • MedlinePlus Health Information. consumer health - MRI Scans.
  • MedlinePlus Health Information. consumer health - Pancreatic Cancer.
  • Hazardous Substances Data Bank. Disodium EDTA .
  • Hazardous Substances Data Bank. ETHYLENEDIAMINE TETRAACETIC ACID .
  • Hazardous Substances Data Bank. DISODIUM CALCIUM EDTA .
  • SciCrunch. DrugBank: Data: Chemical .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Magn Reson Imaging. 2000 Aug;12(2):261-8 [10931589.001]
  • [Cites] Eur Radiol. 2002 Dec;12(12):2998-3008 [12439582.001]
  • [Cites] Radiol Clin North Am. 1989 Jan;27(1):105-19 [2535683.001]
  • [Cites] Arch Surg. 1990 Feb;125(2):230-3 [2154172.001]
  • [Cites] Radiology. 1991 Aug;180(2):337-9 [1906189.001]
  • [Cites] Radiology. 1992 Apr;183(1):87-95 [1312736.001]
  • [Cites] J Comput Assist Tomogr. 1992 Sep-Oct;16(5):704-8 [1355779.001]
  • [Cites] Radiology. 1993 Mar;186(3):795-8 [8430190.001]
  • [Cites] Radiology. 1994 Mar;190(3):745-51 [8115622.001]
  • [Cites] Clin Radiol. 1997 Jan;52(1):24-30 [9022576.001]
  • [Cites] Acta Radiol. 1997 Jul;38(4 Pt 2):660-4 [9245961.001]
  • [Cites] Acta Radiol. 1997 Jul;38(4 Pt 2):690-9 [9245964.001]
  • [Cites] J Magn Reson Imaging. 1999 Feb;9(2):280-4 [10077025.001]
  • [Cites] Eur Radiol. 1999;9(8):1496-512 [10525857.001]
  • [Cites] Eur J Radiol. 2001 May;38(2):78-93 [11335090.001]
  • [Cites] Cancer. 1985 Jul 15;56(2):397-402 [4005804.001]
  • (PMID = 16570354.001).
  • [ISSN] 1007-9327
  • [Journal-full-title] World journal of gastroenterology
  • [ISO-abbreviation] World J. Gastroenterol.
  • [Language] eng
  • [Publication-type] Evaluation Studies; Journal Article
  • [Publication-country] China
  • [Chemical-registry-number] 0 / Contrast Media; 5V5IOJ8338 / Pyridoxal Phosphate; 9G34HU7RV0 / Edetic Acid; P28BIW0UTB / N,N'-bis(pyridoxal-5-phosphate)ethylenediamine-N,N'-diacetic acid
  • [Other-IDs] NLM/ PMC4124294
  •  go-up   go-down


59. Choi J, Kim SG, Kim JS, Jung HC, Song IS: Comparison of endoscopic ultrasonography (EUS), positron emission tomography (PET), and computed tomography (CT) in the preoperative locoregional staging of resectable esophageal cancer. Surg Endosc; 2010 Jun;24(6):1380-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-major] Endosonography / methods. Esophageal Neoplasms / diagnosis. Esophagectomy. Neoplasm Staging / methods. Positron-Emission Tomography / methods. Preoperative Care / methods. Tomography, X-Ray Computed / methods
  • [MeSH-minor] Adenocarcinoma / diagnosis. Adenocarcinoma / surgery. Carcinoma, Squamous Cell / diagnosis. Carcinoma, Squamous Cell / surgery. Carcinosarcoma / diagnosis. Carcinosarcoma / surgery. Diagnosis, Differential. Female. Follow-Up Studies. Humans. Male. Middle Aged. Prospective Studies. Reproducibility of Results. Sensitivity and Specificity

  • Genetic Alliance. consumer health - Esophageal Cancer.
  • MedlinePlus Health Information. consumer health - CT Scans.
  • MedlinePlus Health Information. consumer health - Esophageal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] Surg Endosc. 2011 Apr;25(4):1344-5; author reply 1346 [20725745.001]
  • [Cites] Br J Cancer. 2008 Feb 12;98(3):547-57 [18212745.001]
  • [Cites] J Nucl Med. 2000 May;41(5):808-15 [10809196.001]
  • [Cites] Mol Imaging Biol. 2005 Nov-Dec;7(6):422-30 [16270235.001]
  • [Cites] Am J Gastroenterol. 2000 Oct;95(10 ):2813-5 [11051353.001]
  • [Cites] Scand J Gastroenterol. 1999 Dec;34(12 ):1178-82 [10636063.001]
  • [Cites] Gastrointest Endosc Clin N Am. 1995 Jul;5(3):537-47 [7582580.001]
  • [Cites] J Gastrointest Surg. 2005 Jan;9(1):54-61 [15623445.001]
  • [Cites] Gastrointest Endosc. 2007 Sep;66(3):475-82 [17725937.001]
  • [Cites] Gastrointest Endosc. 2000 Mar;51(3):309-13 [10699776.001]
  • [Cites] N Engl J Med. 2003 Dec 4;349(23):2241-52 [14657432.001]
  • [Cites] Radiology. 1991 Feb;178(2):328-30 [1987587.001]
  • [Cites] Dig Dis Sci. 2008 Sep;53(9):2405-14 [18097752.001]
  • [Cites] Cancer. 1993 May 15;71(10 ):2910-7 [8490818.001]
  • [Cites] Ann Surg Oncol. 2003 Oct;10(8):954-60 [14527917.001]
  • [Cites] Gastrointest Endosc. 1994 Jul-Aug;40(4):442-6 [7926534.001]
  • [Cites] Gastrointest Endosc. 2001 Jun;53(7):751-7 [11375583.001]
  • [Cites] Ann Thorac Surg. 1997 Sep;64(3):765-9 [9307471.001]
  • [Cites] Gastrointest Endosc. 2001 Dec;54(6):714-9 [11726846.001]
  • [Cites] Gastrointest Endosc. 2007 Mar;65(3):377-84 [17321235.001]
  • [Cites] World J Gastroenterol. 2008 Mar 14;14 (10 ):1479-90 [18330935.001]
  • [Cites] Eur J Surg Oncol. 2004 Nov;30(9):942-7 [15498638.001]
  • [Cites] Ann Thorac Surg. 2009 May;87(5):1564-8 [19379906.001]
  • (PMID = 20033712.001).
  • [ISSN] 1432-2218
  • [Journal-full-title] Surgical endoscopy
  • [ISO-abbreviation] Surg Endosc
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


60. Wang Y, Yang H, Liu H, Huang J, Song X: Effect of staurosporine on the mobility and invasiveness of lung adenocarcinoma A549 cells: an in vitro study. BMC Cancer; 2009;9:174
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Effect of staurosporine on the mobility and invasiveness of lung adenocarcinoma A549 cells: an in vitro study.
  • BACKGROUND: Lung cancer is one of the most malignant tumors, representing a significant threat to human health.
  • Lung cancer patients often exhibit tumor cell invasion and metastasis before diagnosis which often render current treatments ineffective.
  • Here, we investigated the effect of staurosporine, a potent protein kinase C (PKC) inhibitor on the mobility and invasiveness of human lung adenocarcinoma A549 cells.
  • METHODS: All experiments were conducted using human lung adenocarcinoma A549 cells that were either untreated or treated with 1 nmol/L, 10 nmol/L, or 100 nmol/L staurosporine.
  • [MeSH-major] Adenocarcinoma / pathology. Cell Movement / drug effects. Lung Neoplasms / pathology. Staurosporine / pharmacology
  • [MeSH-minor] Antigens, CD29 / metabolism. Apoptosis / drug effects. Cadherins / metabolism. Cell Adhesion / drug effects. Cell Growth Processes / drug effects. Cell Line, Tumor. Humans. Matrix Metalloproteinase 9 / metabolism. Neoplasm Invasiveness. Protein Kinase C-alpha / antagonists & inhibitors. Protein Kinase C-alpha / metabolism. Urokinase-Type Plasminogen Activator / metabolism

  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Clin Exp Metastasis. 1999 Jul;17(5):377-87 [10651304.001]
  • [Cites] Med Oncol. 2006;23(2):245-50 [16720925.001]
  • [Cites] Am J Physiol Gastrointest Liver Physiol. 2004 Feb;286(2):G204-13 [12958018.001]
  • [Cites] Anticancer Drugs. 2004 Mar;15(3):265-8 [15014360.001]
  • [Cites] Oncogene. 2004 Mar 11;23(10):1885-95 [14981539.001]
  • [Cites] Curr Cancer Drug Targets. 2004 Mar;4(2):125-46 [15032665.001]
  • [Cites] Am J Physiol Gastrointest Liver Physiol. 2004 Sep;287(3):G582-91 [15117677.001]
  • [Cites] Chin J Physiol. 2004 Jun 30;47(2):73-8 [15481789.001]
  • [Cites] Biochem Biophys Res Commun. 1994 Oct 14;204(1):264-72 [7945369.001]
  • [Cites] Acta Haematol. 1997;97(1-2):29-39 [8980608.001]
  • [Cites] J Cell Sci. 1998 Oct;111 ( Pt 20):3119-27 [9739085.001]
  • [Cites] Clin Cancer Res. 1997 Feb;3(2):227-31 [9815677.001]
  • [Cites] Curr Pharm Des. 2005;11(3):403-11 [15723634.001]
  • [Cites] Acta Pharmacol Sin. 2005 Apr;26(4):492-9 [15780200.001]
  • [Cites] Cancer Res. 2005 May 15;65(10):4261-72 [15899818.001]
  • [Cites] Gastroenterology. 2005 Aug;129(2):639-51 [16083718.001]
  • [Cites] Biochem Biophys Res Commun. 2005 Oct 7;335(4):1017-25 [16102725.001]
  • [Cites] Acta Pharmacol Sin. 2005 Nov;26(11):1365-72 [16225760.001]
  • [Cites] J Nutr Biochem. 2006 Feb;17(2):117-25 [16111875.001]
  • [Cites] FEBS Lett. 2006 Jan 23;580(2):385-92 [16380122.001]
  • [Cites] Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2003 Jun;95(6):710-6 [12789153.001]
  • (PMID = 19500428.001).
  • [ISSN] 1471-2407
  • [Journal-full-title] BMC cancer
  • [ISO-abbreviation] BMC Cancer
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Antigens, CD29; 0 / Cadherins; EC 2.7.11.13 / Protein Kinase C-alpha; EC 3.4.21.73 / Urokinase-Type Plasminogen Activator; EC 3.4.24.35 / Matrix Metalloproteinase 9; H88EPA0A3N / Staurosporine
  • [Other-IDs] NLM/ PMC2702389
  •  go-up   go-down


61. Lin HL, Kuo LC, Chen CW, Lin YK, Lee WC: Pancreatic tail cancer with sole manifestation of left flank pain: a very rare presentation. Kaohsiung J Med Sci; 2008 Jun;24(6):324-7
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-major] Flank Pain / diagnosis. Pancreatic Neoplasms / diagnosis
  • [MeSH-minor] Adenocarcinoma / diagnosis. Adenocarcinoma / pathology. Fatal Outcome. Female. Humans. Liver Neoplasms / pathology. Liver Neoplasms / secondary. Medical Oncology / methods. Middle Aged. Neoplasm Metastasis. Prognosis. Tomography, X-Ray Computed

  • Genetic Alliance. consumer health - Pancreatic cancer.
  • MedlinePlus Health Information. consumer health - Pancreatic Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18635419.001).
  • [ISSN] 1607-551X
  • [Journal-full-title] The Kaohsiung journal of medical sciences
  • [ISO-abbreviation] Kaohsiung J. Med. Sci.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] China (Republic : 1949- )
  •  go-up   go-down


62. Geramizadeh B, Boub R, Rahsaz M: Histologic differentiation of hepatocellular carcinoma from adenocarcinoma by a simple panel: evaluation of the pitfalls. Indian J Pathol Microbiol; 2007 Jul;50(3):507-10
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Histologic differentiation of hepatocellular carcinoma from adenocarcinoma by a simple panel: evaluation of the pitfalls.
  • The histological differentiation of Hepatocellular carcinoma (HCC) from cholangiocarcinoma (CC) and metastatic adenocarcinoma (MA) of the liver is difficult in some cases and immunohistochemistry (IHC) is necessary for the diagnosis.
  • HepPar-1 is a recently available antibody which seems to be very specific and sensitive for the diagnosis of HCC.
  • In this study we tried to apply these two markers for the diagnosis of HCC cases as a simple, useful and reliable panel.
  • We selected 101 liver tumors which had proven diagnosis by several antibodies and cilinicopathologic correlation.
  • The tumors with confirmed histologic diagnosis including 35 HCC, 58 MA, 7 CC and 1 combined HCC-CC.. HepPar-1 was positive in 30 of 35 cases of HCC; none of the other tumors were reactive for HepPar1 except for a case of metastatic gall bladder adenocarcinoma which showed areas of hepatoid differentiation in the H&E slides.
  • These two reliable markers are recommended for the initial step of differential diagnosis between HCC and MA and for the confirmation of the histologic diagnosis.
  • [MeSH-major] Adenocarcinoma / secondary. Antibodies, Monoclonal. Carcinoma, Hepatocellular / diagnosis. Cholangiocarcinoma / diagnosis. Liver Neoplasms / diagnosis
  • [MeSH-minor] Adult. Aged. Biomarkers, Tumor / immunology. Biomarkers, Tumor / metabolism. Diagnosis, Differential. Humans. Immunohistochemistry. Membrane Glycoproteins / immunology. Middle Aged

  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17883119.001).
  • [ISSN] 0377-4929
  • [Journal-full-title] Indian journal of pathology & microbiology
  • [ISO-abbreviation] Indian J Pathol Microbiol
  • [Language] eng
  • [Publication-type] Evaluation Studies; Journal Article
  • [Publication-country] India
  • [Chemical-registry-number] 0 / Antibodies, Monoclonal; 0 / Biomarkers, Tumor; 0 / Membrane Glycoproteins
  •  go-up   go-down


63. Pouessel D, Thezenas S, Culine S, Becht C, Senesse P, Ychou M: Hepatic metastases from carcinomas of unknown primary site. Gastroenterol Clin Biol; 2005 Dec;29(12):1224-32
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Hepatic metastases from carcinomas of unknown primary site.
  • AIM: Hepatic metastases are often present at diagnosis of carcinoma of unknown primary site (CUP).
  • METHODS: One hundred and eighteen patients were treated at the Cancer Center of Montpellier from 1993 to 2002 for CUP initially metastatic to the liver.
  • RESULTS: The most frequent histological types observed were adenocarcinoma, undifferentiated, neuroendocrine and squamous-cell carcinomas.
  • Hepatic metastases revealed the cancer in 66 patients and were isolated in 32 patients.
  • CONCLUSIONS: According to this study, pretreatment evaluations, which were very extensive in some patients, were insufficient to identify the primary site of liver metastases.
  • [MeSH-major] Liver Neoplasms / mortality. Liver Neoplasms / secondary. Neoplasms, Unknown Primary / pathology

  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16518276.001).
  • [ISSN] 0399-8320
  • [Journal-full-title] Gastroentérologie clinique et biologique
  • [ISO-abbreviation] Gastroenterol. Clin. Biol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] France
  • [Chemical-registry-number] EC 1.1.1.27 / L-Lactate Dehydrogenase
  •  go-up   go-down


64. Behrends K, Strunk H, Flacke S: [Erroneous diagnosis of liver metastasis as benign tumor in the contrast media aided "Low-MI-Real-Time" sonography with SonoVue]. Rofo; 2005 Jun;177(6):900-2
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Erroneous diagnosis of liver metastasis as benign tumor in the contrast media aided "Low-MI-Real-Time" sonography with SonoVue].
  • [MeSH-major] Adenocarcinoma / secondary. Adenocarcinoma / ultrasonography. Contrast Media. Diagnostic Errors. Liver Neoplasms / secondary. Liver Neoplasms / ultrasonography. Phospholipids. Sulfur Hexafluoride
  • [MeSH-minor] Humans. Laparotomy. Liver / pathology. Male. Middle Aged. Sensitivity and Specificity. Time Factors. Tomography, X-Ray Computed. Ultrasonography, Doppler, Color

  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • Hazardous Substances Data Bank. SULFUR HEXAFLUORIDE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] Rofo. 2005 Dec;177(12):1722-3; author reply 1723 [16382508.001]
  • (PMID = 15902642.001).
  • [ISSN] 1438-9029
  • [Journal-full-title] RöFo : Fortschritte auf dem Gebiete der Röntgenstrahlen und der Nuklearmedizin
  • [ISO-abbreviation] Rofo
  • [Language] ger
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Contrast Media; 0 / Phospholipids; 0 / contrast agent BR1; WS7LR3I1D6 / Sulfur Hexafluoride
  •  go-up   go-down


65. Nart D, Ertan Y, Pala EE, Zeytunlu M, Kilic M, Yilmaz F: Intrahepatic cholangiocarcinoma arising in chronic viral hepatitis-associated cirrhosis: two transplant cases. Transplant Proc; 2008 Dec;40(10):3813-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Herein we have reported two cases of HCV- and HBV-related cirrhosis with ICC in whom the pretransplant diagnosis was HCC.
  • Serum tumor marker levels, carcinoembryonic antigen (CEA), alphafetoprotein (AFP), and carbohydrate antigen 19-9 (CA 19-9) were determined before live donor liver transplantation (LDLT).
  • On microscopic examination, all nodules exhibited typical morphological findings of adenocarcinoma.
  • In cirrhotic patients with active malignancy who are candidates for LDLT, ICC should be considered in the differential diagnosis.
  • [MeSH-major] Bile Duct Neoplasms / etiology. Bile Ducts, Intrahepatic. Cholangiocarcinoma / etiology. Hepatitis B / complications. Hepatitis B / surgery. Hepatitis C, Chronic / complications. Hepatitis C, Chronic / surgery. Liver Transplantation


66. Deme D, Ragán M, Kalmár K, Kovács L, Varga E, Varga T, Rakonczai E: [Metastatic prostate cancer complicated with chronic disseminated intravascular coagulopathy causing acute renal failure, mimicking thrombotic thrombocytopenic purpura and hemolytic uremic syndrome: pathomechanism, differential diagnosis and therapy related to a case]. Magy Onkol; 2010 Dec;54(4):351-7
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Metastatic prostate cancer complicated with chronic disseminated intravascular coagulopathy causing acute renal failure, mimicking thrombotic thrombocytopenic purpura and hemolytic uremic syndrome: pathomechanism, differential diagnosis and therapy related to a case].
  • A 71 years old male patient with known chronic obstructive pulmonary disease, benign prostatic hyperplasia, significant carotid artery stenosis, gastric ulcer and alcoholic liver disease was admitted to another hospital with melena.
  • Laboratory results showed hyperkalemia, elevated kidney function tests, indirect hyperbilirubinemia, increased liver function tests, leukocytosis, anemia, thrombocytopenia and elevated international normalized ratio (INR).
  • Prostate biopsy revealed adenocarcinoma (Gleason: 4+4 for left lobe and 3+3 for right lobe).
  • Thrombocytopenia of uncertain origin with normal or raised INR, APTT, elevated D-dimer, normal fibrinogen and reticulocyte count prove the diagnosis of chronic DIC.
  • Metastatic prostate cancer complicated with chronic disseminated intravascular coagulopathy causing acute renal failure mimicking thrombotic thrombocytopenic purpura and hemolytic uremic syndrome: pathomechanism, differential diagnosis and therapy related to a case.
  • [MeSH-major] Acute Kidney Injury / etiology. Adenocarcinoma / diagnosis. Adenocarcinoma / drug therapy. Disseminated Intravascular Coagulation / diagnosis. Disseminated Intravascular Coagulation / therapy. Prostatic Neoplasms / diagnosis. Prostatic Neoplasms / drug therapy
  • [MeSH-minor] Aged. Androgen Antagonists / therapeutic use. Antineoplastic Agents, Hormonal / therapeutic use. Bone Neoplasms / secondary. Chronic Disease. Diagnosis, Differential. Hemolytic-Uremic Syndrome / diagnosis. Humans. Male. Purpura, Thrombotic Thrombocytopenic / diagnosis


67. Fang H, Wang XY, Wang JW, Zhang HG, Feng FY, Shi YK: [Analysis of prognostic factors in 300 colorectal cancer patients with liver metastases]. Zhonghua Zhong Liu Za Zhi; 2009 Mar;31(3):220-2
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Analysis of prognostic factors in 300 colorectal cancer patients with liver metastases].
  • OBJECTIVE: To analyse the clinical characteristics and potential prognostic factors of colorectal cancer patients with liver metastases.
  • METHODS: The clinical and pathological data of 300 colorectal cancer patients with liver metastases were retrospectively reviewed and analyzed.
  • The 1-, 2- and 5-year survival rates after liver metastases were 79.0%, 29.0% and 3.0%, respectively.
  • Univariate analysis revealed that performance status (KPS), histological grading, primary tumor, N status, lymphatic and vascular invasion, stage at diagnosis, the number, size and distribution of liver metastases and other accompanied metastases were prognostic factors.
  • Multivariate analysis showed that KPS, lymphatic and vascular invasion, the number and size of liver metastases were independent prognostic factors of colorectal cancer with liver metastases.
  • CONCLUSION: Performance status, lymphatic and vascular invasion, the number and size of liver metastases are independent prognostic factors of colorectal cancer with liver metastases.
  • [MeSH-major] Adenocarcinoma / secondary. Colonic Neoplasms / pathology. Liver Neoplasms / secondary. Rectal Neoplasms / pathology
  • [MeSH-minor] Adenocarcinoma, Mucinous / drug therapy. Adenocarcinoma, Mucinous / pathology. Adenocarcinoma, Mucinous / secondary. Adenocarcinoma, Mucinous / surgery. Adult. Aged. Aged, 80 and over. Combined Modality Therapy. Female. Follow-Up Studies. Humans. Lymphatic Metastasis. Male. Middle Aged. Neoplasm Staging. Neoplastic Cells, Circulating. Proportional Hazards Models. Retrospective Studies. Survival Rate. Tumor Burden. Young Adult

  • Genetic Alliance. consumer health - Colorectal Cancer.
  • Genetic Alliance. consumer health - Liver cancer.
  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19615265.001).
  • [ISSN] 0253-3766
  • [Journal-full-title] Zhonghua zhong liu za zhi [Chinese journal of oncology]
  • [ISO-abbreviation] Zhonghua Zhong Liu Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  •  go-up   go-down


68. Pai MR, Mathai AM, Kumar S, Prabhu S: Coexistent gastric primary choriocarcinoma and adenocarcinoma. Indian J Pathol Microbiol; 2009 Oct-Dec;52(4):537-9
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Coexistent gastric primary choriocarcinoma and adenocarcinoma.
  • We herein describe a case of primary gastric choriocarcinoma with liver metastasis in a 69-year-old male.
  • The histopathologic findings of the resected tumor were that of an extensively necrotic and hemorrhagic neoplasm with combined choriocarcinomatous and adenocarcinomatous element.
  • A strongly positive immunohistochemical staining for beta- subunit of human chorionic gonadotropin (beta-HCG) in the choriocarcinomatous component and a proper correlation with elevated serum beta-HCG levels confirmed the diagnosis.
  • [MeSH-major] Adenocarcinoma / complications. Adenocarcinoma / diagnosis. Choriocarcinoma / complications. Choriocarcinoma / diagnosis. Stomach Neoplasms / diagnosis. Stomach Neoplasms / pathology
  • [MeSH-minor] Aged. Chorionic Gonadotropin, beta Subunit, Human / analysis. Histocytochemistry. Humans. Immunohistochemistry. Liver Neoplasms / pathology. Liver Neoplasms / secondary. Male. Pyloric Antrum / pathology. Pylorus / pathology. Radiography, Abdominal

  • Genetic Alliance. consumer health - Choriocarcinoma.
  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19805966.001).
  • [ISSN] 0974-5130
  • [Journal-full-title] Indian journal of pathology & microbiology
  • [ISO-abbreviation] Indian J Pathol Microbiol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] India
  • [Chemical-registry-number] 0 / Chorionic Gonadotropin, beta Subunit, Human
  •  go-up   go-down


69. Pouessel D, Gallet B, Bibeau F, Avancès C, Iborra F, Sénesse P, Culine S: Liver metastases in prostate carcinoma: clinical characteristics and outcome. BJU Int; 2007 Apr;99(4):807-11
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Liver metastases in prostate carcinoma: clinical characteristics and outcome.
  • OBJECTIVE: To assess the clinical characteristics and outcome of patients with liver metastases in prostate carcinoma.
  • The clinical characteristics and outcome of 28 patients who developed liver metastases during the course of the disease were analysed.
  • RESULTS: Six patients had liver metastases as the first site of metastatic disease, and for one of them, liver was the only metastatic site.
  • Six patients had a pathological analysis; there were two different histological patterns in liver biopsies, i.e. four were adenocarcinomas with a moderate (one patient) or poor (three) differentiation and two were neuroendocrine carcinomas.
  • One patient had hormone therapy for synchronous liver metastases at diagnosis as the first-line treatment; other patients were treated with chemotherapy.
  • The median (range) overall survival was 6 (1-27) months; the median survival of patients for whom liver was part of the initial metastatic pattern was 14 months.
  • CONCLUSION: Liver metastases are not very rare but appear to be a rather late event in the course of the disease.
  • [MeSH-major] Adenocarcinoma / secondary. Carcinoma, Neuroendocrine / secondary. Liver Neoplasms / secondary. Prostatic Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • MedlinePlus Health Information. consumer health - Prostate Cancer.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17155968.001).
  • [ISSN] 1464-4096
  • [Journal-full-title] BJU international
  • [ISO-abbreviation] BJU Int.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Chromogranin A
  •  go-up   go-down


70. Stavropoulos S, Larghi A, Verna E, Battezzati P, Stevens P: Intraductal ultrasound for the evaluation of patients with biliary strictures and no abdominal mass on computed tomography. Endoscopy; 2005 Aug;37(8):715-21
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The aim of this prospective study was to determine the value of intraductal ultrasound (IDUS) in distinguishing between benign and malignant biliary strictures in this clinical setting.
  • Histopathological confirmation or clinical follow-up was used to establish the final diagnosis.
  • The diagnostic performances of IDUS, ERCP, and IDUS plus ERCP in the identification of malignant strictures were evaluated.
  • RESULTS: Forty-three patients had malignant strictures and 18 had benign strictures.
  • ERCP produced 25 false-negative diagnoses, 22 of which were identified as malignant by IDUS.
  • The proportion of patients with malignant strictures who tested positive with IDUS was 2.06 times that of ERCP (95 % CI, 1.37 - 3.10; 83.3 % vs. 40.5 %, P = 0.0004).
  • [MeSH-minor] Adenocarcinoma / complications. Adult. Aged. Aged, 80 and over. Bile Duct Neoplasms / complications. Bile Ducts, Intrahepatic. Cholangiocarcinoma / complications. Cholangiopancreatography, Endoscopic Retrograde. Constriction, Pathologic. Humans. Male. Middle Aged. Pancreatic Neoplasms / complications. Sensitivity and Specificity

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16032489.001).
  • [ISSN] 0013-726X
  • [Journal-full-title] Endoscopy
  • [ISO-abbreviation] Endoscopy
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


71. Landoni L, Falconi M, Salvia R, Capelli P, Bettini R, Pederzoli P: A case of intraductal papillary mucinous tumour following recurrent attacks of pancreatitis lasting 26 years. Dig Liver Dis; 2007 Jun;39(6):585-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • At that time, medical history, absence of alcohol abuse, and radiological imaging suggested a diagnosis of idiopathic chronic pancreatitis.
  • This report represents a slippery case of misdiagnosis and demonstrates that follow-up is always mandatory following a diagnosis of idiopathic chronic pancreatitis.
  • [MeSH-major] Adenocarcinoma, Mucinous / etiology. Carcinoma, Pancreatic Ductal / etiology. Pancreatic Neoplasms / etiology. Pancreatitis / complications

  • Genetic Alliance. consumer health - Pancreatitis.
  • MedlinePlus Health Information. consumer health - Pancreatic Cancer.
  • MedlinePlus Health Information. consumer health - Pancreatitis.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16843740.001).
  • [ISSN] 1590-8658
  • [Journal-full-title] Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
  • [ISO-abbreviation] Dig Liver Dis
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 0 / Mucins
  •  go-up   go-down


72. Otsuki Y, Shimizu S, Hosoda Y, Nagasawa M, Sato Y, Kobayashi H: Hepatocellular carcinoma with mesothelioma-like dissemination. Pathol Int; 2005 Nov;55(11):738-44
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • No signs of tumor, fibrosis, or cirrhosis were found in the liver, except for a small nodule in the hepatic triangular ligament.
  • The origin of this tumor and its differential diagnosis (malignant mesothelioma, hepatoid adenocarcinoma, and hepatoid yolk sac tumor) are discussed.
  • [MeSH-major] Carcinoma, Hepatocellular / pathology. Liver Neoplasms / pathology. Mesothelioma / pathology. Peritoneal Neoplasms / pathology
  • [MeSH-minor] Adenocarcinoma / chemistry. Adenocarcinoma / diagnosis. Adenocarcinoma / pathology. Calbindin 2. Carcinoembryonic Antigen / analysis. Carcinoembryonic Antigen / immunology. Diagnosis, Differential. Humans. Immunohistochemistry. Keratins / analysis. Keratins / immunology. Male. Middle Aged. Mucin-1 / analysis. Mucin-1 / immunology. S100 Calcium Binding Protein G / analysis. S100 Calcium Binding Protein G / immunology. Vimentin / analysis. Vimentin / immunology. alpha-Fetoproteins / analysis. alpha-Fetoproteins / immunology

  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • MedlinePlus Health Information. consumer health - Mesothelioma.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16271087.001).
  • [ISSN] 1320-5463
  • [Journal-full-title] Pathology international
  • [ISO-abbreviation] Pathol. Int.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Australia
  • [Chemical-registry-number] 0 / CALB2 protein, human; 0 / Calbindin 2; 0 / Carcinoembryonic Antigen; 0 / Mucin-1; 0 / S100 Calcium Binding Protein G; 0 / Vimentin; 0 / alpha-Fetoproteins; 68238-35-7 / Keratins
  •  go-up   go-down


73. Nakamura H, Kuirhara Y, Matsushita K, Sakai A, Yamaguchi T, Nakajima Y: Extrarenal multiorgan metastases of collecting duct carcinoma of the kidney: a case series. J Med Case Rep; 2008;2:304
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • These lesions were biopsied, resulting in a histological diagnosis of metastatic adenocarcinoma.
  • Autopsy demonstrated the primary tumor to be collecting duct carcinoma, with metastases to lung, liver, spleen, bone marrow, right adrenal gland, and para-aortic lymph node.
  • Computed tomography done while the patient was alive detected lung, liver, and para-aortic lymph node metastases.
  • Computed tomography revealed a progressively enlarging right renal lesion, multiple liver masses, enlargement of the para-aortic lymph nodes, and multiple osteoblastic and osteoclastic lesions.
  • Autopsy revealed a primary tumor of collecting duct carcinoma with metastases to the liver, right adrenal gland, right upper ureter, bone marrow, para-aortic and mediastinal lymph nodes, and bone.
  • CONCLUSION: We present the radiological findings of lung, liver, lymph node, and bone metastases in two patients with collecting duct carcinoma.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Histopathology. 1986 Nov;10(11):1131-41 [3542784.001]
  • [Cites] Hum Pathol. 1990 Apr;21(4):449-56 [2318486.001]
  • [Cites] J Urol. 2003 Apr;169(4):1287-90 [12629344.001]
  • [Cites] AJR Am J Roentgenol. 2001 Mar;176(3):627-33 [11222193.001]
  • [Cites] Histopathology. 1991 Feb;18(2):115-22 [1707029.001]
  • [Cites] J Urol. 2000 Apr;163(4):1090-5; quiz 1295 [10737472.001]
  • [Cites] Eur J Radiol. 2006 Mar;57(3):453-60 [16266796.001]
  • [Cites] Semin Diagn Pathol. 1998 Feb;15(1):54-67 [9503506.001]
  • [Cites] J Comput Assist Tomogr. 1996 May-Jun;20(3):399-403 [8626899.001]
  • [Cites] Arch Esp Urol. 2000 Sep;53(7):611-6 [11037654.001]
  • (PMID = 18798981.001).
  • [ISSN] 1752-1947
  • [Journal-full-title] Journal of medical case reports
  • [ISO-abbreviation] J Med Case Rep
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC2556681
  •  go-up   go-down


74. Nihon-Yanagi Y, Park Y, Ooshiro M, Aoki H, Suzuki Y, Hiruta N, Kameda N, Katoh R: A case of recurrent invasive lobular carcinoma of the breast found as metastasis to the duodenum. Breast Cancer; 2009;16(1):83-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Blood chemical tests showed elevated levels of liver enzymes and bilirubin.
  • A biopsy yielded a diagnosis of poorly differentiated adenocarcinoma.
  • [MeSH-major] Breast Neoplasms / pathology. Carcinoma, Lobular / pathology. Carcinoma, Lobular / secondary. Duodenal Neoplasms / secondary. Neoplasm Recurrence, Local / pathology


75. Génébès C, Brouchet L, Kamar N, Lepage B, Prévot G, Rostaing L, Didier A, Mazières J: Characteristics of thoracic malignancies that occur after solid-organ transplantation. J Thorac Oncol; 2010 Nov;5(11):1789-95
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The most frequent histologic types were squamous cell carcinoma (n = 11, 46%) and adenocarcinoma (n = 9, 37%).
  • The median time period between transplantation and diagnosis of lung cancer was 6.6 years.
  • Ten lung malignancies occurred after kidney transplantation (0.5%), eight after liver transplantation (1.3%), and six after heart transplantation (2.8%).
  • [MeSH-major] Adenocarcinoma / etiology. Carcinoma, Squamous Cell / etiology. Lung Neoplasms / etiology. Mesothelioma / etiology. Organ Transplantation / adverse effects. Small Cell Lung Carcinoma / etiology
  • [MeSH-minor] Adult. Aged. Cohort Studies. Female. Humans. Male. Middle Aged. Neoplasm Staging. Prognosis. Retrospective Studies. Risk Factors. Survival Rate


76. Lasithiotakis K, Petrakis I, Georgiadis G, Paraskakis S, Chalkiadakis G, Chrysos E: Pancreatic resection for metastasis to the pancreas from colon and lung cancer, and osteosarcoma. JOP; 2010;11(6):593-6
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • All the pancreatic lesions were located in the head of the pancreas, and the intervals between the diagnosis of the primary cancer and the pancreatic metastases were 6, 14 and 24 months.
  • During exploration of the abdomen, additional metastatic lesions in the small intestine and liver were detected and resected in two patients.
  • [MeSH-minor] Adenocarcinoma / pathology. Adenocarcinoma / surgery. Adolescent. Female. Humans. Male. Middle Aged. Pancreatectomy / methods


77. Scaringi S, Nesi G, Bargellini T, Batignani G, Tonelli F: Iterative surgical resection of a recurrent gallbladder carcinoma with long-term survival: report of a case. In Vivo; 2010 Mar-Apr;24(2):215-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Unfortunately, at the time of diagnosis, patients usually have advanced disease (T3-T4) and long-term survival is dismal, ranging from 5 to 12% in the literature.
  • However, this cancer can be successfully treated when the tumour is organ-confined (T1-T2 tumours), as happens in the case of incidental diagnosis at the time of cholecystectomy for gallstones.
  • [MeSH-major] Adenocarcinoma / surgery. Gallbladder Neoplasms / surgery. Liver Neoplasms / surgery. Neoplasm Recurrence, Local / surgery

  • MedlinePlus Health Information. consumer health - Gallbladder Cancer.
  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20363997.001).
  • [ISSN] 0258-851X
  • [Journal-full-title] In vivo (Athens, Greece)
  • [ISO-abbreviation] In Vivo
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Greece
  •  go-up   go-down


78. Lossius A, Elvsåshagen T, Taubøll E: [A 58-year-old woman with stroke, elevated troponin and hypercoagulability]. Tidsskr Nor Laegeforen; 2008 Mar 13;128(6):706-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • MATERIAL AND METHODS: A 58-year-old woman with bilateral pulmonary embolism and ischemic infarctions of the heart, brain, liver and kidneys is presented.
  • RESULTS AND INTERPRETATION: Our patient developed Trousseau's syndrom due to a mucinous ventricular adenocarcinoma.
  • [MeSH-minor] Adenocarcinoma, Mucinous / complications. Adenocarcinoma, Mucinous / diagnosis. Biomarkers, Tumor / blood. Brain Infarction / diagnosis. Brain Infarction / etiology. Diagnosis, Differential. Fatal Outcome. Female. Humans. Infarction / diagnosis. Infarction / etiology. Kidney / blood supply. Liver / blood supply. Magnetic Resonance Imaging. Middle Aged. Myocardial Infarction / diagnosis. Myocardial Infarction / etiology. Pulmonary Embolism / diagnosis. Pulmonary Embolism / etiology. Stomach Neoplasms / complications. Stomach Neoplasms / diagnosis. Syndrome. Tomography, X-Ray Computed

  • MedlinePlus Health Information. consumer health - Blood Clots.
  • MedlinePlus Health Information. consumer health - Stroke.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] Tidsskr Nor Laegeforen. 2008 Mar 13;128(6):709 [18365335.001]
  • (PMID = 18365333.001).
  • [ISSN] 0807-7096
  • [Journal-full-title] Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række
  • [ISO-abbreviation] Tidsskr. Nor. Laegeforen.
  • [Language] nor
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Norway
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Troponin
  •  go-up   go-down


79. Kalaitzis J, Filippou G, Zizi-Sermpetzoglou A, Marinis A, Hadjimarcou A, Paschalidis N, Rizos S: Case of a sigmoid colon cancer with metachronous metastases to the mesorectum and the abdominal wall. World J Surg Oncol; 2010;8:17
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Sigmoid colon cancer metachronous metastases commonly occur in the liver and lungs with sporadic reports also to the spleen, stomach, thyroid gland, abdominal wall and upper urinary tract.
  • [MeSH-major] Abdominal Neoplasms / secondary. Adenocarcinoma / secondary. Rectal Neoplasms / secondary. Sigmoid Neoplasms / pathology
  • [MeSH-minor] Aged. Colonoscopy. Diagnosis, Differential. Female. Humans. Tomography, X-Ray Computed

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] CA Cancer J Clin. 2004 Nov-Dec;54(6):295-308 [15537574.001]
  • [Cites] Cancer. 1998 Aug 15;83(4):666-72 [9708929.001]
  • [Cites] Ann Intern Med. 1998 Jul 1;129(1):27-35 [9652996.001]
  • [Cites] J Laryngol Otol. 1996 Feb;110(2):192-5 [8729514.001]
  • [Cites] Dis Colon Rectum. 1996 Feb;39(2):200-7 [8620788.001]
  • [Cites] J Clin Oncol. 2003 Aug 1;21(15):2912-9 [12885809.001]
  • [Cites] Dis Colon Rectum. 2009 May;52(5):942-9 [19502860.001]
  • [Cites] Dis Colon Rectum. 2001 Sep;44(9):1333-6 [11584211.001]
  • [Cites] Cancer. 2001 Jul 15;92(2):452 [11466702.001]
  • [Cites] Arch Pathol Lab Med. 2000 Jul;124(7):979-94 [10888773.001]
  • [Cites] Ann Surg. 2009 Jun;249(6):960-4 [19474698.001]
  • [Cites] Nihon Shokakibyo Gakkai Zasshi. 2009 May;106(5):653-9 [19420869.001]
  • [Cites] Ann Surg Oncol. 2003 Apr;10(3):213-8 [12679304.001]
  • (PMID = 20302675.001).
  • [ISSN] 1477-7819
  • [Journal-full-title] World journal of surgical oncology
  • [ISO-abbreviation] World J Surg Oncol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC2848135
  •  go-up   go-down


80. Han AR, Sung CO, Kim KM, Park CK, Min BH, Lee JH, Kim JY, Chang DK, Kim YH, Rhee PL, Rhee JC, Kim JJ: The clinicopathological features of gastric hyperplastic polyps with neoplastic transformations: a suggestion of indication for endoscopic polypectomy. Gut Liver; 2009 Dec;3(4):271-5
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • However, the pathology findings from the EP or surgical specimen revealed neoplastic transformation in 14 cases (5.2%; 4 with dysplasia and 10 with adenocarcinoma).
  • Therefore, EP should be considered for gastric hyperplastic polyps >1 cm for the accurate diagnosis and definitive treatment.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Pathol Annu. 1985;20 Pt 1:303-29 [3991240.001]
  • [Cites] Hum Pathol. 2002 Oct;33(10):1016-22 [12395375.001]
  • [Cites] Am J Gastroenterol. 1981 Apr;75(4):275-81 [7258173.001]
  • [Cites] Surg Endosc. 1995 Jun;9(6):714-8 [7482172.001]
  • [Cites] Gastrointest Endosc. 1993 Nov-Dec;39(6):830-3 [7794291.001]
  • [Cites] Am J Gastroenterol. 1995 Dec;90(12):2152-9 [8540506.001]
  • [Cites] Dig Dis Sci. 1996 Feb;41(2):377-86 [8601386.001]
  • [Cites] South Med J. 1996 Apr;89(4):453-4 [8614897.001]
  • [Cites] Am J Gastroenterol. 1996 Apr;91(4):714-7 [8677935.001]
  • [Cites] Gut. 2000 Aug;47(2):251-5 [10896917.001]
  • [Cites] Endoscopy. 1978 Feb;10(1):63-5 [631098.001]
  • [Cites] Am J Gastroenterol. 1990 Dec;85(12):1629-34 [2252031.001]
  • [Cites] Am J Gastroenterol. 1990 Mar;85(3):327-8 [2309688.001]
  • [Cites] J Clin Gastroenterol. 1989 Feb;11(1):110-5 [2921485.001]
  • [Cites] Am J Gastroenterol. 1987 Oct;82(10):1016-25 [3661508.001]
  • [Cites] Gut. 2002 Apr;50(4):465-70 [11889063.001]
  • [Cites] Endoscopy. 1983 Jan;15(1):8-11 [6822229.001]
  • (PMID = 20431760.001).
  • [ISSN] 2005-1212
  • [Journal-full-title] Gut and liver
  • [ISO-abbreviation] Gut Liver
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Korea (South)
  • [Other-IDs] NLM/ PMC2852734
  • [Keywords] NOTNLM ; Endoscopic polypectomy / Hyperplastic polyp / Neoplastic transformation
  •  go-up   go-down


81. Macrì A, Saladino E, Basile A, Pettineo G, Pruiti V, Versaci A, Famulari C: Quintuple primitive malignant neoplasms. A case report. Acta Chir Belg; 2010 Jan-Feb;110(1):95-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Quintuple primitive malignant neoplasms. A case report.
  • The authors describe the case of a patient who developed during 31 months, five malignant tumours, three synchronous and two metachronous.
  • The primitive origin and the long interval of time between the occurrence of each tumour, allow to set them in the group of Multiple Primitive Malignant Neoplasm.
  • [MeSH-major] Adenocarcinoma / diagnosis. Colonic Neoplasms / diagnosis. Liver Neoplasms / diagnosis. Neoplasms, Multiple Primary / diagnosis. Stomach Neoplasms / diagnosis
  • [MeSH-minor] Aged. Biopsy. Diagnosis, Differential. Digestive System Surgical Procedures / methods. Endoscopy, Digestive System. Fatal Outcome. Female. Humans

  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20306921.001).
  • [ISSN] 0001-5458
  • [Journal-full-title] Acta chirurgica Belgica
  • [ISO-abbreviation] Acta Chir. Belg.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Belgium
  •  go-up   go-down


82. Kanoh T, Ohnishi T, Danno K, Watanabe A, Nakamura H, Tsukao Y, Inatome J, Kim C, Kagara N, Taniguchi H, Kimura Y, Tono T, Nakano Y, Monden T, Imaoka S: [A case of successfully treated lower rectal cancer with both inguinal lymph nodes by chemoradiotherapy]. Gan To Kagaku Ryoho; 2010 Nov;37(12):2611-3
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The histological diagnosis was well to moderately differentiated adenocarcinoma.
  • Nine months after radiation therapy, however, multiple lung and liver metastases were observed by a computed tomography, which were treated by systemic chemotherapy with FOLFOX and bevacizumab.
  • [MeSH-major] Adenocarcinoma / therapy. Lymphatic Metastasis. Rectal Neoplasms / therapy

  • Genetic Alliance. consumer health - Rectal Cancer.
  • Hazardous Substances Data Bank. FLUOROURACIL .
  • Hazardous Substances Data Bank. LEUCOVORIN .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21224655.001).
  • [ISSN] 0385-0684
  • [Journal-full-title] Gan to kagaku ryoho. Cancer & chemotherapy
  • [ISO-abbreviation] Gan To Kagaku Ryoho
  • [Language] jpn
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Japan
  • [Chemical-registry-number] 0 / Angiogenesis Inhibitors; 0 / Antibodies, Monoclonal; 0 / Antibodies, Monoclonal, Humanized; 0 / Organoplatinum Compounds; 2S9ZZM9Q9V / Bevacizumab; Q573I9DVLP / Leucovorin; U3P01618RT / Fluorouracil; Folfox protocol
  •  go-up   go-down


83. Ponti G, Luppi G, Losi L, Giannetti A, Seidenari S: Leser-Trélat syndrome in patients affected by six multiple metachronous primitive cancers. J Hematol Oncol; 2010;3:2
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Leser-Trélat syndrome is characterized by the eruptive appearance of multiple seborrheic keratoses in association with underlying malignant disease.
  • Usually, the sign of Leser-Trélat is associated with adenocarcinoma, most frequently of the colon, breast, or stomach, but also of the lung, kidney, liver, and pancreas.
  • Herein, we present a case that we believe is the first report of the sign of Leser-Trélat in association with occult gastric adenocarcinoma and the anamnestic oncologic history of five other multiple primitive cancers.
  • Patients with the sign of Leser-Trélat should undergo a diagnostic screening programme for malignant disease along with patients with known Leser-Trélat syndrome who present with a recent acute and florid eruption of their seborrheic keratoses.
  • [MeSH-major] Adenocarcinoma / diagnosis. Intestinal Neoplasms / diagnosis. Neoplasms, Second Primary / diagnosis. Neoplastic Syndromes, Hereditary / diagnosis. Stomach Neoplasms / diagnosis
  • [MeSH-minor] Aged, 80 and over. Humans. Keratosis, Seborrheic / complications. Keratosis, Seborrheic / diagnosis. Male

  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Am Acad Dermatol. 1992 Jun;26(6):947-50 [1535080.001]
  • [Cites] J Med Genet. 2005 Nov;42(11):801-10 [15958502.001]
  • [Cites] Lancet Oncol. 2005 Dec;6(12):980-7 [16321766.001]
  • [Cites] Lancet Oncol. 2008 May;9(5):462-72 [18452857.001]
  • [Cites] Clin Exp Dermatol. 1988 May;13(3):177-9 [2977576.001]
  • [Cites] Acta Derm Venereol. 1991;71(2):166-9 [1675530.001]
  • [Cites] J Am Acad Dermatol. 2000 Aug;43(2 Pt 2):386-90 [10901731.001]
  • [Cites] N Engl J Med. 1987 Dec 17;317(25):1582-7 [2825016.001]
  • [Cites] Aust Fam Physician. 2009 Jul;38(7):498-505 [19575068.001]
  • (PMID = 20064244.001).
  • [ISSN] 1756-8722
  • [Journal-full-title] Journal of hematology & oncology
  • [ISO-abbreviation] J Hematol Oncol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC2820021
  •  go-up   go-down


84. Pandey M, Kumar V, Shukla M, Kumar M: Thyroid swelling in a 32-year-old male. BMJ Case Rep; 2009;2009
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Patients with intrathyroidal metastasis may present with previous history of malignancy or they may present with a secondary neoplasm prompting us to search for the primary site.
  • Fine-needle aspiration cytology from the thyroid swelling revealed deposits from the mucinous adenocarcinoma.
  • The further diagnostic and metastatic work-up identified a diffuse carcinoma of the stomach as the primary site with liver as secondary and retroperitoneal lymph nodes having mucinous deposits with associated Peutz-Jeghers polyposis.
  • Preoperative diagnosis, proper evaluation and high degree of suspicion may avoid unnecessary thyroidectomy and effective palliation can be achieved with chemotherapy in view of disseminated disease.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Eur J Surg Oncol. 2004 Aug;30(6):583-8 [15256229.001]
  • [Cites] Langenbecks Arch Surg. 2006 Nov;391(6):581-7 [16983577.001]
  • [Cites] Anticancer Res. 2008 Sep-Oct;28(5B):2885-8 [19031929.001]
  • [Cites] Cancer. 1997 Feb 1;79(3):574-8 [9028370.001]
  • [Cites] Ann Intern Med. 1998 Jun 1;128(11):896-9 [9634427.001]
  • [Cites] World J Surg. 1999 Feb;23(2):177-80; discussion 181 [9880428.001]
  • [Cites] Am J Pathol. 1999 Jan;154(1):127-35 [9916927.001]
  • (PMID = 21686341.001).
  • [ISSN] 1757-790X
  • [Journal-full-title] BMJ case reports
  • [ISO-abbreviation] BMJ Case Rep
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC3028274
  •  go-up   go-down


85. Ikeda T, Ohgaki K, Miura M, Aishima S, Shimizu T, Maehara Y: Granulocyte-colony stimulating factor-producing gallbladder cancer without recurrence more than 2 years after resection: report of a case. Surg Today; 2005;35(7):590-3
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We performed cholecystectomy with extended right lobectomy of the liver and lymph node dissection.
  • A histological diagnosis of moderately differentiated gallbladder carcinoma with sarcomatous change invading the hepatic parenchyma was confirmed.
  • An immunohistochemical examination using polyclonal antibody against G-CSF was performed to stain the tumor cells, which confirmed the diagnosis of a G-CSF-producing tumor.
  • [MeSH-major] Adenocarcinoma / metabolism. Gallbladder Neoplasms / metabolism. Granulocyte Colony-Stimulating Factor / biosynthesis
  • [MeSH-minor] Cholecystectomy. Female. Hepatectomy. Humans. Middle Aged. Neoplasm Recurrence, Local

  • MedlinePlus Health Information. consumer health - Gallbladder Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Nihon Shokakibyo Gakkai Zasshi. 2000 Apr;97(4):478-83 [10793573.001]
  • [Cites] Nihon Shokakibyo Gakkai Zasshi. 1982 Jun;79(6):1336-40 [6982357.001]
  • [Cites] Jpn J Clin Oncol. 1986 Mar;16(1):87-96 [3486302.001]
  • [Cites] Am J Gastroenterol. 1999 Jan;94(1):273-5 [9934773.001]
  • [Cites] Jpn J Med. 1989 Nov-Dec;28(6):722-6 [2534486.001]
  • [Cites] Gastroenterol Jpn. 1990 Dec;25(6):762-7 [1703976.001]
  • [Cites] Nihon Shokakibyo Gakkai Zasshi. 2000 Sep;97(9):1165-9 [11021096.001]
  • [Cites] Int J Cell Cloning. 1985 Sep;3(5):294-303 [3900241.001]
  • [Cites] Blood. 1977 May;49(5):845-52 [300638.001]
  • (PMID = 15976958.001).
  • [ISSN] 0941-1291
  • [Journal-full-title] Surgery today
  • [ISO-abbreviation] Surg. Today
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Japan
  • [Chemical-registry-number] 143011-72-7 / Granulocyte Colony-Stimulating Factor
  •  go-up   go-down


86. Baichi MM, Arifuddin RM, Mantry PS: Small-bowel masses found and missed on capsule endoscopy for obscure bleeding. Scand J Gastroenterol; 2007 Sep;42(9):1127-32
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Most (80%) of the lesions were potentially malignant: adenocarcinoma (n=4), neuroendocrine carcinoma (n=1), leiomyosarcoma (n=1), and GI stroma cell tumors (GISTs) (n=2).
  • CE findings led directly to tumor diagnosis in 7 of the 10 cases.
  • Our large single-center experience shows that most lesions are of malignant potential.
  • [MeSH-major] Capsule Endoscopy. Intestinal Neoplasms / diagnosis


87. Segawa N, Inamoto T, Ibuki N, Mizutani Y, Azuma H, Tsuji M, Katsuoka Y: [Neuroendocrine differentiation in adenocarcinoma of the prostate during hormonal treatment : a case report]. Hinyokika Kiyo; 2010 Jan;56(1):49-54
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Neuroendocrine differentiation in adenocarcinoma of the prostate during hormonal treatment : a case report].
  • A case of neuroendocrine (NE) differentiated prostate cancer is reported herein, which was progressed with NE differentiation during hormonal treatment in adenocarcinoma of the prostate.
  • A prostate biopsy was performed and histological examinations indicated poorly differentiated adenocarcinoma with a Gleason score of 5 + 4 = 9.
  • However, he had liver metastases 3 months later.
  • His condition worsened rapidly and he died at 8 months after definite diagnosis.
  • [MeSH-major] Adenocarcinoma / drug therapy. Adenocarcinoma / pathology. Antineoplastic Agents, Hormonal / therapeutic use. Leuprolide / therapeutic use. Prostatic Neoplasms / drug therapy. Prostatic Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Prostate Cancer.
  • Hazardous Substances Data Bank. LEUPROLIDE .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20104011.001).
  • [ISSN] 0018-1994
  • [Journal-full-title] Hinyokika kiyo. Acta urologica Japonica
  • [ISO-abbreviation] Hinyokika Kiyo
  • [Language] jpn
  • [Publication-type] Case Reports; English Abstract; Journal Article; Review
  • [Publication-country] Japan
  • [Chemical-registry-number] 0 / Antineoplastic Agents, Hormonal; EC 3.4.21.77 / Prostate-Specific Antigen; EC 4.2.1.11 / Phosphopyruvate Hydratase; EFY6W0M8TG / Leuprolide
  • [Number-of-references] 26
  •  go-up   go-down


88. Yi L, Wang Y: [Mixed prostatic carcinoma: a report of 5 patients and literature review]. Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2009 Jul;34(7):646-50
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: We reviewed the clinical data of 5 patients with prostatic mixed tumor and relevant literature to explore diagnosis and treatment for it.
  • RESULTS: Patient 1 with mixed small cell carcinoma and adenocarcinoma of the prostate who underwent transurethral electrovaporization of the prostate (TUVP) and flumamide therapy died of lung metastasis 7 months later.
  • Patient 2 with mixed small cell carcinoma and adenocarcinoma of the prostate who underwent TUVP and bilateral testicular resection died of lung metastasis 10 months later.
  • Patient 3 with adenosquamous carcinoma of the prostate who underwent TUVP, radiation therapy and flumamide therapy died of multiple organ failure 8 months later because of the lung, liver, and multiple bone metastasis.
  • Its diagnosis relies on detailed pathological examination and immunohistochemical techniques.
  • Patients with prostate adenocarcinoma should be followed up timely after endocrine treatment or radiotherapy.
  • [MeSH-major] Adenocarcinoma / pathology. Carcinoma, Adenosquamous / pathology. Carcinoma, Small Cell / pathology. Prostatic Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Prostate Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19648679.001).
  • [ISSN] 1672-7347
  • [Journal-full-title] Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences
  • [ISO-abbreviation] Zhong Nan Da Xue Xue Bao Yi Xue Ban
  • [Language] chi
  • [Publication-type] Case Reports; English Abstract; Journal Article; Review
  • [Publication-country] China
  •  go-up   go-down


89. Abdulkareem FB, Rotimi O: Immunophenotypical categorization of omental and liver metastatic tumours in Lagos, Nigeria. Nig Q J Hosp Med; 2008 Oct-Dec;18(4):198-201
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Immunophenotypical categorization of omental and liver metastatic tumours in Lagos, Nigeria.
  • This study was aimed at evaluating the use of immunohistochemistry in differential diagnosis of omental and liver metastases.
  • MATERIALS AND METHODS: Materials consisted of the formalin fixed paraffin embedded blocks of omental and liver metastatic tumours diagnosed in Lagos between January 1995 and February 2007.
  • RESULTS: A total of 83 cases of omental (67) and liver (16) metastatic tumours were identified representing 11.6% of all gastrointestinal (GIT) malignancies.
  • Immunostaining was carried out on 44 cases (53%) consisting of 32 (75%) of omental and 11 (25%) of liver tumours; M: F of 1.4:1 and mean age of 43 years.
  • Three liver metastases negative for all the 6 antibodies could not be classified.
  • CONCLUSION: This study has further corroborated previous studies that adenocarcinoma is the most common metastatic omental and liver metastases and the common primary sites are within the gastrointestinal tract.
  • [MeSH-major] Adenocarcinoma / secondary. Biomarkers, Tumor / analysis. Liver Neoplasms / pathology. Omentum / pathology. Peritoneal Neoplasms / pathology
  • [MeSH-minor] Adolescent. Adult. Aged. Child. Diagnosis, Differential. Female. Humans. Immunohistochemistry. Immunophenotyping. Male. Middle Aged. Neoplasms, Unknown Primary / genetics. Neoplasms, Unknown Primary / pathology. Nigeria

  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19391319.001).
  • [ISSN] 0189-2657
  • [Journal-full-title] Nigerian quarterly journal of hospital medicine
  • [ISO-abbreviation] Nig Q J Hosp Med
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Nigeria
  • [Chemical-registry-number] 0 / Biomarkers, Tumor
  •  go-up   go-down


90. Mannai S, Kraïem T, Gharbi L, Haoues N, Mestiri H, Khalfallah MT: [Congenital cystic dilatation of bile ducts]. Ann Chir; 2006 Jul-Aug;131(6-7):369-74
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Anatomopathologic examination showed an adenocarcinoma of a common bile duct cyst.
  • Three patients with segmental dilatation of intrahepatic bile ducts (type V) underwent liver resection.
  • [MeSH-minor] Acute Disease. Adolescent. Adult. Aged. Aged, 80 and over. Anastomosis, Surgical. Bile Ducts, Intrahepatic / abnormalities. Caroli Disease / diagnosis. Caroli Disease / surgery. Child. Child, Preschool. Cholangitis / etiology. Cholecystitis / complications. Dilatation. Dilatation, Pathologic / congenital. Drainage. Female. Hepatectomy. Humans. Jejunum / surgery. Liver / surgery. Male. Middle Aged. Postoperative Complications. Retrospective Studies

  • MedlinePlus Health Information. consumer health - Bile Duct Diseases.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16630531.001).
  • [ISSN] 0003-3944
  • [Journal-full-title] Annales de chirurgie
  • [ISO-abbreviation] Ann Chir
  • [Language] fre
  • [Publication-type] Comparative Study; English Abstract; Journal Article
  • [Publication-country] France
  •  go-up   go-down


91. Yasuda M, Senju T, Aratake Y, Nakamura T, Horikawa Y, Yokota M, Sumii T, Iguchi H, Funakoshi A, Nishiyama K: [A case of pancreatic ductal adenocarcinoma with rapid progress in a young man]. Nihon Shokakibyo Gakkai Zasshi; 2006 Feb;103(2):194-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [A case of pancreatic ductal adenocarcinoma with rapid progress in a young man].
  • Various imaging studies showed a solid tumor (4cm in diameter) in the tail of the pancreas, multiple hypovascular tumors in liver.
  • Biopsy of hepatic tumor demonstrated that tumor cells had eosinophilic cytoplasm generally and unevenly distributed polymorphic nucleus.
  • Final diagnosis of autopsy was pancreatic ductal adenocarcinoma.
  • Pancreatic ductal adenocarcinoma in the young patients is rare, and we reported this case in addition to consideration on literature.
  • [MeSH-major] Adenocarcinoma / diagnosis. Pancreatic Ducts. Pancreatic Neoplasms / diagnosis

  • MedlinePlus Health Information. consumer health - Pancreatic Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16506669.001).
  • [ISSN] 0446-6586
  • [Journal-full-title] Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology
  • [ISO-abbreviation] Nihon Shokakibyo Gakkai Zasshi
  • [Language] jpn
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Japan
  •  go-up   go-down


92. Murguia E, Quiroga D, Canteros G, Sanmartino C, Barreiro M, Herrera J: Gallbladder metastases from ductal papillary carcinoma of the breast. J Hepatobiliary Pancreat Surg; 2006;13(6):591-3
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Liver, gastrointestinal, and biliary tract involvement are infrequent.
  • Histopathological evaluation of the focal broad-based lesion of the gallbladder revealed poorly differentiated adenocarcinoma infiltration, without mucosal involvement.
  • The final pathological diagnosis was breast ductal papillary carcinoma metastases to the gallbladder.

  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • MedlinePlus Health Information. consumer health - Gallbladder Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17139439.001).
  • [ISSN] 0944-1166
  • [Journal-full-title] Journal of hepato-biliary-pancreatic surgery
  • [ISO-abbreviation] J Hepatobiliary Pancreat Surg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Japan
  •  go-up   go-down


93. Venkitaraman R, George M, Weerasooriya S, Selva-Nayagam S: Late solitary testicular metastasis from rectal cancer. J Cancer Res Ther; 2010 Jan-Mar;6(1):89-91
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • He developed a painless testicular nodule while on follow-up, five years after the diagnosis of primary rectal cancer.
  • Histopathology and immunohistochemistry of orchidectomy specimen were compatible with a metastatic adenocarcinoma of rectal origin.
  • [MeSH-major] Adenocarcinoma / secondary. Rectal Neoplasms / pathology. Testicular Neoplasms / secondary
  • [MeSH-minor] Aged. Chemotherapy, Adjuvant. Combined Modality Therapy. Digestive System Surgical Procedures. Fluorouracil / therapeutic use. Humans. Liver Neoplasms / secondary. Lung Neoplasms / secondary. Male. Radiotherapy, Adjuvant

  • Genetic Alliance. consumer health - Rectal Cancer.
  • Genetic Alliance. consumer health - Testicular cancer.
  • MedlinePlus Health Information. consumer health - Testicular Cancer.
  • Hazardous Substances Data Bank. FLUOROURACIL .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20479555.001).
  • [ISSN] 1998-4138
  • [Journal-full-title] Journal of cancer research and therapeutics
  • [ISO-abbreviation] J Cancer Res Ther
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] India
  • [Chemical-registry-number] U3P01618RT / Fluorouracil
  •  go-up   go-down


94. Lacout A, El Hajjam M, Julie C, Lacombe P, Pelage JP: Liver metastasis of a mucinous colonic carcinoma mimicking a haemangioma in T2-weighted sequences. J Med Imaging Radiat Oncol; 2008 Dec;52(6):580-2
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Liver metastasis of a mucinous colonic carcinoma mimicking a haemangioma in T2-weighted sequences.
  • We report the case of a patient with a single liver metastasis of a mucinous colonic carcinoma that mimics a haemangioma in T2-weighted sequences.
  • In patients with a history of neoplasia, the diagnosis of benign liver nodules should be made with caution.
  • [MeSH-major] Adenocarcinoma, Mucinous / diagnosis. Adenocarcinoma, Mucinous / secondary. Colonic Neoplasms / diagnosis. Hemangioma / diagnosis. Liver Neoplasms / diagnosis. Liver Neoplasms / secondary. Magnetic Resonance Imaging / methods
  • [MeSH-minor] Diagnosis, Differential. False Negative Reactions. Humans. Male. Middle Aged

  • MedlinePlus Health Information. consumer health - Birthmarks.
  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • MedlinePlus Health Information. consumer health - MRI Scans.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19178633.001).
  • [ISSN] 1754-9485
  • [Journal-full-title] Journal of medical imaging and radiation oncology
  • [ISO-abbreviation] J Med Imaging Radiat Oncol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Australia
  •  go-up   go-down


95. Kitagawa D, Taketomi A, Aishima S, Kuroda Y, Gion T, Shirabe K, Shimada M, Maehara Y: Recurrence of intrahepatic cholangiocarcinoma nine years after surgical resection. Hepatogastroenterology; 2008 May-Jun;55(84):1085-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The patient underwent right hepatic trisegmentectomy with lymph node dissection and biliary tract reconstruction for a tumor in the right lobe of the liver.
  • Nine years after the operation a rise of tumor markers and a recurrent lesion in the remnant liver were recognized and the patient underwent S2 subsegmentectomy with tumor thrombectomy and biliary tract reconstruction.
  • The resected specimen showed well differentiated adenocarcinoma, which consisted of chiefly intraductal growth component.
  • [MeSH-major] Bile Duct Neoplasms / surgery. Bile Ducts, Intrahepatic / surgery. Cholangiocarcinoma / surgery. Neoplasm Recurrence, Local / surgery
  • [MeSH-minor] Antigens, Neoplasm / blood. Biomarkers, Tumor / blood. Diagnosis, Differential. Female. Follow-Up Studies. Hepatectomy. Humans. Liver Function Tests. Lymph Node Excision. Middle Aged. Reoperation. Tomography, X-Ray Computed

  • Genetic Alliance. consumer health - Intrahepatic cholangiocarcinoma.
  • MedlinePlus Health Information. consumer health - Bile Duct Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18705334.001).
  • [ISSN] 0172-6390
  • [Journal-full-title] Hepato-gastroenterology
  • [ISO-abbreviation] Hepatogastroenterology
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Greece
  • [Chemical-registry-number] 0 / Antigens, Neoplasm; 0 / Biomarkers, Tumor; 0 / DU-PAN-2 antigen, human; 0 / pancreatic associated antigen, SPan-1
  •  go-up   go-down


96. van den Bos IC, Hussain SM, Dwarkasing RS, Stoop H, Zondervan PE, Krestin GP, de Man RA: Hepatoid adenocarcinoma of the gallbladder: a mimicker of hepatocellular carcinoma. Br J Radiol; 2007 Dec;80(960):e317-20
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Hepatoid adenocarcinoma of the gallbladder: a mimicker of hepatocellular carcinoma.
  • We present a case of a large gallbladder tumour in a patient with no known liver disease and elevated alpha-fetoprotein (AFP), in whom a differential diagnosis from hepatocellular carcinoma (HCC) in a non-cirrhotic liver was particularly difficult given the combination of the size of the tumour, solitary nature, elevated AFP and striking resemblance with HCC at histology.
  • In presenting this patient, we would like to emphasise the role of MRI as a problem-solving tool for analysis of rare tumours of non-hepatocellular origin, including hepatoid adenocarcinoma of the gallbladder.
  • [MeSH-major] Adenocarcinoma / diagnosis. Carcinoma, Hepatocellular / diagnosis. Gallbladder Neoplasms / diagnosis. Liver Neoplasms / diagnosis
  • [MeSH-minor] Diagnosis, Differential. Female. Humans. Magnetic Resonance Imaging. Middle Aged

  • MedlinePlus Health Information. consumer health - Gallbladder Cancer.
  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18065642.001).
  • [ISSN] 1748-880X
  • [Journal-full-title] The British journal of radiology
  • [ISO-abbreviation] Br J Radiol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  •  go-up   go-down


97. van Vliet EP, Steyerberg EW, Eijkemans MJ, Kuipers EJ, Siersema PD: Detection of distant metastases in patients with oesophageal or gastric cardia cancer: a diagnostic decision analysis. Br J Cancer; 2007 Oct 8;97(7):868-76
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • CT showed sensitivities for detecting metastases in celiac lymph nodes, liver and lung of 69, 73, and 90%, respectively, which was higher than the sensitivities of US abdomen (44% for celiac lymph nodes and 65% for liver metastases), EUS (38% for celiac lymph nodes), and chest X-ray (68% for lung metastases).
  • In contrast, US neck showed a higher sensitivity for the detection of malignant supraclavicular lymph nodes than CT (85 vs 28%).
  • Slightly higher specificities (97-99%) were achieved if liver and/or lung metastases found on CT, were confirmed by US abdomen or chest X-ray, respectively (two-positive scenario).
  • [MeSH-major] Adenocarcinoma / secondary. Carcinoma, Squamous Cell / secondary. Cardia / pathology. Esophageal Neoplasms / pathology. Lymph Nodes / pathology. Stomach Neoplasms / pathology
  • [MeSH-minor] Biopsy, Fine-Needle. Databases as Topic. Female. Humans. Lymphatic Metastasis / diagnosis. Male. Middle Aged. Prospective Studies. Sensitivity and Specificity. Tomography, X-Ray Computed. Ultrasonography

  • MedlinePlus Health Information. consumer health - Esophageal Cancer.
  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Radiology. 1985 Apr;155(1):171-5 [3975398.001]
  • [Cites] Rays. 2006 Jan-Mar;31(1):9-12 [16999368.001]
  • [Cites] Surgery. 1988 Mar;103(3):344-50 [3344487.001]
  • [Cites] Br J Surg. 1989 Oct;76(10):1036-9 [2532050.001]
  • [Cites] Gastrointest Radiol. 1992 Fall;17(4):305-10 [1426845.001]
  • [Cites] Br J Radiol. 1993 Mar;66(783):203-8 [8472112.001]
  • [Cites] Am J Surg. 1993 May;165(5):558-60 [8488936.001]
  • [Cites] Ann Thorac Surg. 1994 May;57(5):1180-3 [8179382.001]
  • [Cites] J Surg Oncol. 1996 Mar;61(3):214-7 [8637210.001]
  • [Cites] Eur J Cancer. 1996 May;32A(5):893-5 [9081373.001]
  • [Cites] Abdom Imaging. 1997 Mar-Apr;22(2):138-42 [9013521.001]
  • [Cites] Chest. 1998 Mar;113(3):687-95 [9515844.001]
  • [Cites] Br J Surg. 1998 Jul;85(7):994-8 [9692582.001]
  • [Cites] Ann Surg. 1999 Jan;229(1):62-6 [9923801.001]
  • [Cites] Am J Gastroenterol. 1999 Jan;94(1):20-9 [9934727.001]
  • [Cites] Clin Radiol. 2000 Sep;55(9):696-701 [10988048.001]
  • [Cites] Gastrointest Endosc. 2001 Jun;53(7):751-7 [11375583.001]
  • [Cites] Ann Surg. 2001 Oct;234(4):520-30; discussion 530-1 [11573045.001]
  • [Cites] Gastrointest Endosc. 2001 Dec;54(6):714-9 [11726846.001]
  • [Cites] Surg Oncol. 2001 Nov;10(3):103-11 [11750229.001]
  • [Cites] Ann Thorac Surg. 2002 Mar;73(3):916-20; discussion 920-1 [11899201.001]
  • [Cites] Psychol Methods. 2002 Jun;7(2):147-77 [12090408.001]
  • [Cites] Ann Thorac Surg. 2002 Oct;74(4):1026-32 [12400740.001]
  • [Cites] World J Surg. 2003 Oct;27(10):1105-12 [12917769.001]
  • [Cites] AJR Am J Roentgenol. 1983 Nov;141(5):951-8 [6605068.001]
  • [Cites] Ann Thorac Surg. 1999 Feb;67(2):319-21; discussion 322 [10197647.001]
  • [Cites] Gastrointest Endosc. 1999 Sep;50(3):352-6 [10462655.001]
  • [Cites] J Clin Oncol. 2005 Jul 10;23(20):4483-9 [16002838.001]
  • [Cites] Abdom Imaging. 2006 Jan-Feb;31(1):25-35 [16333707.001]
  • [Cites] Am J Gastroenterol. 2006 Feb;101(2):234-42 [16454824.001]
  • [Cites] Gastrointest Endosc. 2006 Jun;63(7):938-47 [16733107.001]
  • [Cites] J Clin Ultrasound. 1985 Mar-Apr;13(3):153-60 [3920276.001]
  • (PMID = 17848957.001).
  • [ISSN] 0007-0920
  • [Journal-full-title] British journal of cancer
  • [ISO-abbreviation] Br. J. Cancer
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC2360396
  •  go-up   go-down


98. Coban S, Ozkan H, Köklü S, Yüksel O, Koçkar MC, Akar T, Ormeci N: The utility of serum receptor-binding cancer antigen expressed on SiSo cells in gastrointestinal tract cancers. Can J Gastroenterol; 2006 Sep;20(9):593-6
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Among GI tract cancers, RCAS1 had lowest and highest sensitivity for esophagus and colon cancer diagnosis, respectively.
  • [MeSH-major] Antigens, Neoplasm / blood. Biomarkers, Tumor / blood. Gastrointestinal Neoplasms / immunology
  • [MeSH-minor] Adenocarcinoma / immunology. Adult. Aged. CA-19-9 Antigen / blood. Carcinoembryonic Antigen / blood. Carcinoma, Squamous Cell / immunology. Case-Control Studies. Colonic Neoplasms / immunology. Esophageal Neoplasms / immunology. Female. Humans. Lymphatic Metastasis. Male. Middle Aged. Neoplasm Invasiveness. Neoplasm Staging. Predictive Value of Tests. Sensitivity and Specificity. Stomach Neoplasms / immunology

  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Clin Pathol. 2003 Oct;56(10):764-8 [14514780.001]
  • [Cites] Hepatogastroenterology. 2003 Sep-Oct;50(53):1669-74 [14571813.001]
  • [Cites] Mod Pathol. 2003 Jul;16(7):679-85 [12861064.001]
  • [Cites] Int J Cancer. 2003 Sep 1;106(3):310-5 [12845666.001]
  • [Cites] Pancreas. 2003 Jan;26(1):49-55 [12499917.001]
  • [Cites] Oncology. 2003;64(1):83-9 [12457035.001]
  • [Cites] Int J Cancer. 2002 May 20;99(3):418-23 [11992411.001]
  • [Cites] Cancer Lett. 2002 Mar 8;177(1):101-5 [11809537.001]
  • [Cites] Br J Cancer. 2001 Dec 14;85(12):1922-7 [11747335.001]
  • [Cites] Cancer. 2001 Jul 15;92(2):446-51 [11466701.001]
  • [Cites] Cancer Lett. 2001 Jul 26;168(2):197-202 [11403925.001]
  • [Cites] Int J Cancer. 2001 Jul 1;93(1):91-6 [11391627.001]
  • [Cites] Int J Cancer. 2000 Nov 20;89(6):488-93 [11102892.001]
  • [Cites] Oncol Rep. 2003 Nov-Dec;10(6):1891-4 [14534714.001]
  • [Cites] Gastroenterol Clin North Am. 1996 Dec;25(4):805-20 [8960894.001]
  • [Cites] Cancer. 1996 Apr 15;77(8):1501-9 [8608535.001]
  • [Cites] Dig Liver Dis. 2004 Sep;36(9):622-7 [15460847.001]
  • [Cites] Oncol Rep. 2004 Aug;12(2):259-67 [15254686.001]
  • [Cites] Int J Hematol. 2004 May;79(4):340-4 [15218962.001]
  • [Cites] Cancer Sci. 2004 Mar;95(3):260-5 [15016327.001]
  • [Cites] Anticancer Res. 2003 Nov-Dec;23(6D):4967-71 [14981953.001]
  • [Cites] J Hepatol. 2003 Oct;39(4):559-63 [12971966.001]
  • (PMID = 17001401.001).
  • [ISSN] 0835-7900
  • [Journal-full-title] Canadian journal of gastroenterology = Journal canadien de gastroenterologie
  • [ISO-abbreviation] Can. J. Gastroenterol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Canada
  • [Chemical-registry-number] 0 / Antigens, Neoplasm; 0 / Biomarkers, Tumor; 0 / CA-19-9 Antigen; 0 / Carcinoembryonic Antigen; 0 / EBAG9 protein, human
  • [Other-IDs] NLM/ PMC2659945
  •  go-up   go-down


99. Radić V, Kukura V, Ciglar S: Adenosquamous carcinoma of the uterine cervix--adjuvant chemotherapeutic treatment with paclitaxel and carboplatin; a case report. Eur J Gynaecol Oncol; 2005;26(4):449-50
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Adenosquamous carcinoma of the uterine cervix is a rare mixture of malignant glandular and squamous epithelial elements.
  • Solitary liver metastases were treated by ultrasound guided percutaneous sclerotherapy with 95% ethanol.
  • The patient died 20 months after establishing the diagnosis.
  • Paclitaxel in combination with carboplatin as adjuvant chemotherapeutic treatment could be another promising agent for patients with advanced metastatic cervical adenocarcinoma.
  • [MeSH-major] Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Carcinoma, Adenosquamous / therapy. Liver Neoplasms / therapy. Uterine Cervical Neoplasms / therapy
  • [MeSH-minor] Carboplatin / administration & dosage. Epirubicin / administration & dosage. Ethanol / administration & dosage. Fatal Outcome. Female. Gynecologic Surgical Procedures / methods. Humans. Injections, Intralesional. Middle Aged. Neoplasm Staging. Paclitaxel / administration & dosage. Sclerosing Solutions / administration & dosage. Sclerotherapy / methods. Treatment Outcome

  • MedlinePlus Health Information. consumer health - Cervical Cancer.
  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • International Agency for Research on Cancer - Screening Group. diagnostics - Histopathology and cytopathology of the uterine cervix - digital atlas .
  • Hazardous Substances Data Bank. TAXOL .
  • Hazardous Substances Data Bank. CARBOPLATIN .
  • Hazardous Substances Data Bank. EPIRUBICIN .
  • Hazardous Substances Data Bank. ETHANOL .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16122201.001).
  • [ISSN] 0392-2936
  • [Journal-full-title] European journal of gynaecological oncology
  • [ISO-abbreviation] Eur. J. Gynaecol. Oncol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Italy
  • [Chemical-registry-number] 0 / Sclerosing Solutions; 3K9958V90M / Ethanol; 3Z8479ZZ5X / Epirubicin; BG3F62OND5 / Carboplatin; P88XT4IS4D / Paclitaxel
  •  go-up   go-down


100. Zhu H, Sun K, Ward SC, Schwartz M, Thung SN, Qin L: Primary hepatic signet ring cell neuroendocrine tumor: a case report with literature review. Semin Liver Dis; 2010 Nov;30(4):422-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Primary hepatic signet ring cell neuroendocrine tumor: a case report with literature review.
  • Primary hepatic signet ring cell neuroendocrine tumor is extremely rare and is characterized by distinct intracytoplasmic hyaline vacuoles that are mucin negative and cytokeratin positive.
  • The unique histological features may cause difficulty in diagnosis and delay patient care.
  • Here the authors report a 49-year-old man with an incidental finding of a 2.7 cm liver mass in the absence of chronic liver disease.
  • Many of the tumor cells had eccentric, pale intracytoplasmic vacuoles resembling signet ring cells in adenocarcinoma.
  • A diagnosis of primary hepatic signet ring cell neuroendocrine tumor was established.
  • [MeSH-major] Carcinoma, Signet Ring Cell / diagnosis. Liver Neoplasms / diagnosis. Neuroendocrine Tumors / diagnosis

  • Genetic Alliance. consumer health - Pancreatic islet cell tumors.
  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] © Thieme Medical Publishers.
  • (PMID = 20960381.001).
  • [ISSN] 1098-8971
  • [Journal-full-title] Seminars in liver disease
  • [ISO-abbreviation] Semin. Liver Dis.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / CDX2 protein, human; 0 / Gastrointestinal Agents; 0 / Homeodomain Proteins; RWM8CCW8GP / Octreotide
  •  go-up   go-down






Advertisement